Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Research Team

Group by: Date | Item Type | Source
Jump to: 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007

2025

Multimodal longitudinal optical imaging reveals optic neuritis preceding retinal pathology in experimental autoimmune encephalomyelitis.
Raspe, R., Günther, R., Uecker, R., Rakhymzhan, A., Paul, F., Radbruch, H., Niesner, R.A. and Hauser, A.E.
Neurology Neuroimmunology & Neuroinflammation 12 (1): e200338. January 2025

2024

The real-world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody-associated disease criteria in a Latin American cohort.
Carnero Contentti, E., Pestchanker, C., Ciampi, E., Castro Suarez, S., Caparo Zamalloa, C., Daccach Marques, V., Messias, K., Gortari, J.I., Tkachuk, V., Silva, B., Mainella, C., Reyes, S., Toro, J., Rodriguez, J., Correa-Diaz, E., Rojas, J.I. and Paul, F.
European Journal of Neurology 31 (12): e16445. December 2024

Association of peripapillary retinal nerve fiber layer atrophy with cognitive impairment in patients with neuromyelitis optica spectrum disorder.
Barzegar, M., Ashtari, F., Kafieh, R., Karimi, Z., Dehghani, A., Ghalamkari, A., Afshari-Safavi, A. and Paul, F.
Neurological Sciences 29 November 2024 (In Press)

Brain lesion characteristics in Chinese multiple sclerosis patients: a 7-T MRI cohort study.
Su, L., Zhang, Z., Gao, C., Guo, A., Zhang, M., Shi, X., Liu, X., Song, T., Xu, W., Wang, H., Kuchling, J., Jing, J., Tian, D.C., Liu, Y., Duan, Y., Paul, F. and Shi, F.D.
Annals of Clinical and Translational Neurology 22 November 2024 (In Press)

Eculizumab use in neuromyelitis optica spectrum disorders: routine clinical care data from a european cohort.
Ringelstein, M., Asseyer, S., Lindenblatt, G., Fischer, K., Pul, R., Skuljec, J., Revie, L., Giglhuber, K., Häußler, V., Karenfort, M., Hellwig, K., Paul, F., Bellmann-Strobl, J., Otto, C., Ruprecht, K., Ziemssen, T., Emmer, A., Rothhammer, V., Nickel, F.T., Angstwurm, K., Linker, R., Laurent, S.A., Warnke, C., Jarius, S., Korporal-Kuhnke, M., Wildemann, B., Wolff, S., Seipelt, M., Yalachkov, Y., Retzlaff, N., Zettl, U.K., Rommer, P.S., Kowarik, M.C., Wickel, J., Geis, C., Hümmert, M.W., Trebst, C., Senel, M., Gold, R., Klotz, L., Kleinschnitz, C., Meuth, S.G., Aktas, O., Berthele, A. and Ayzenberg, I.
Neurology 103 (9): e209888. 12 November 2024

Barriers in healthcare to the use of optical coherence tomography angiography in multiple sclerosis.
Reeß, L.G., Salih, H., Delikaya, M., Paul, F. and Oertel, F.C.
Neurology and Therapy 5 November 2024 (In Press)

How to avoid missing a diagnosis of neuromyelitis optica spectrum disorder.
Carnero Contentti, E., Rotstein, D., Okuda, D.T. and Paul, F.
Multiple Sclerosis Journal : 13524585241292797. 5 November 2024 (In Press)

Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.
Schwake, C., Ladopoulos, T., Häußler, V., Kleiter, I., Ringelstein, M., Aktas, O., Kümpfel, T., Engels, D., Havla, J., Hümmert, M.W., Kretschmer, J.R., Tkachenko, D., Trebst, C., Ayroza Galvão Ribeiro Gomes, A.B., Pröbstel, A.K., Korporal-Kuhnke, M., Wildemann, B., Jarius, S., Pul, R., Pompsch, M., Krämer, M., Then Bergh, F., Gödel, C., Schwarz, P., Kowarik, M.C., Rommer, P.S., Vardakas, I., Senel, M., Winkelmann, A., Retzlaff, N., Weber, M.S., Husseini, L., Walter, A., Schindler, P., Bellmann-Strobl, J., Paul, F., Gold, R. and Ayzenberg, I.
Journal of Neurology, Neurosurgery, and Psychiatry 4 November 2024 (In Press)

Aquaporin-4 immunoglobulin g-seropositive neuromyelitis optica spectrum disorder MRI characteristics: data analysis from the international real-world PAMRINO study cohort.
Chien, C., Cruz E Silva, V., Geiter, E., Meier, D., Zimmermann, H., Bichuetti, D.B., Idagawa, M.I., Altintas, A., Tanriverdi, U., Siritho, S., Pandit, L., Dcunha, A., Sá, M.J., Figueiredo, R., Qian, P., Tongco, C., Lotan, I., Khasminsky, V., Hellmann, M.A., Stiebel-Kalish, H., Rotstein, D.L., Waxman, L., Ontaneda, D., Nakamura, K., Abboud, H., Subei, M.O., Mao-Draayer, Y., Havla, J., Asgari, N., Skejø, P.B., Kister, I., Ringelstein, M., Broadley, S., Arnett, S., Marron, B., Jolley, A.M., Wunderlich, M., Green, S., Cook, L.J., Yeaman, M.R., Smith, T.J., Brandt, A.U., Wuerfel, J. and Paul, F.
Radiology 313 (2): e233099. November 2024

Diagnostic value of inter-eye difference metrics on OCT for myelin oligodendrocyte glycoprotein antibody-associated optic neuritis.
Volpe, G., Jurkute, N., Girafa, G., Zimmermann, H.G., Motamedi, S., Bereuter, C., Pandit, L., D'Cunha, A., Yeaman, M.R., Smith, T.J., Cook, L.J., Brandt, A.U., Paul, F., Petzold, A. and Oertel, F.C.
Neurology Neuroimmunology & Neuroinflammation 11 (6): e200291. November 2024

Non-invasive assessment of cerebral hemodynamics using resting-state functional magnetic resonance imaging in multiple sclerosis and age-related white matter lesions.
Khalil, A., Asseyer, S., Rust, R., Schmitz-Hübsch, T., Fiebach, J.B., Paul, F. and Chien, C.
Human Brain Mapping 45 (16): e70076. November 2024

Rapid differentiation of MOGAD and MS after a single optic neuritis.
Pakeerathan, T., Havla, J., Schwake, C., Salmen, A., Ringelstein, M., Aktas, O., Weise, M., Gernert, J.A., Kornek, B., Bsteh, G., Pröbstel, A.K., Papadopoulou, A., Kulsvehagen, L., Ayroza Galvão Ribeiro Gomes, A.B., Cerdá-Fuertes, N., Oertel, F.C., Duchow, A.S., Paul, F., Stellmann, J.P., Stolowy, N., Hellwig, K., Schneider-Gold, C., Kümpfel, T., Gold, R., Albrecht, P. and Ayzenberg, I.
Journal of Neurology 271 (11): 7222-7231. November 2024

At home e-based physical exercise programs in patients with multiple sclerosis: a scoping review.
Adnan, R., Roikjaer, S.G., Samadzadeh, S., Richter, C.J., Weinshenker, B.G., Paul, F., Skou, S.T., Dalgas, U. and Asgari, N.
Frontiers in Neurology 15 : 1449519. 15 October 2024

Autoantigen-specific CD4(+) T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases.
Saggau, C., Bacher, P., Esser, D., Rasa, M., Meise, S., Mohr, N., Kohlstedt, N., Hutloff, A., Schacht, S.S., Dargvainiene, J., Martini, G.R., Stürner, K.H., Schröder, I., Markewitz, R., Hartl, J., Hastermann, M., Duchow, A., Schindler, P., Becker, M., Bautista, C., Gottfreund, J., Walter, J., Polansky, J.K., Yang, M., Naghavian, R., Wendorff, M., Schuster, E.M., Dahl, A., Petzold, A., Reinhardt, S., Franke, A., Wieczorek, M., Henschel, L., Berger, D., Heine, G., Holtsche, M., Häußler, V., Peters, C., Schmidt, E., Fillatreau, S., Busch, D.H., Wandinger, K.P., Schober, K., Martin, R., Paul, F., Leypoldt, F. and Scheffold, A.
Immunity 57 (10): 2416-2432.e8. 8 October 2024

A quantitative multi-parameter mapping protocol standardized for clinical research in autoimmune neuroinflammatory diseases with white matter abnormalities.
Trang, H., Hartung, T., Chen, Q., Hetzer, S., Chien, C., Sperber, P.S., Schmitz-Hübsch, T., Asseyer, S., Rust, R., Mewes, D., Anderhalten, L.C., Sy, M., Brandt, A.U., Finke, C. and Paul, F.
medRxiv : 2024.10.07.24315008. 7 October 2024

B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity.
Bennett, J.L., Pittock, S.J., Paul, F., Kim, H.J., Irani, S.R., O'Connor, K.C., Patterson, K.R., Smith, M.A., Gunsior, M., Mittereder, N., Rees, W.A., Cimbora, D. and Cree, B.A.C.
Annals of Clinical and Translational Neurology 11 (10): 2792-2798. October 2024

NMOSD and MOGAD: an evolving disease spectrum.
Uzawa, A., Oertel, F.C., Mori, M., Paul, F. and Kuwabara, S.
Nature Reviews Neurology 20 (10): 602-619. October 2024

Relapse-independent disease activity in neuromyelitis optica spectrum disorder: a systematic review.
Etemadifar, M., Alaei, S.A., Akaishi, T., Salari, M., Norouzi, M., Samadzadeh, S. and Paul, F.
Multiple Sclerosis and Related Disorders 90 : 105843. October 2024

The influence of MOGAD on diagnosis of multiple sclerosis using MRI.
Geraldes, R., Arrambide, G., Banwell, B., Rovira, À., Cortese, R., Lassmann, H., Messina, S., Rocca, M.A., Waters, P., Chard, D., Gasperini, C., Hacohen, Y., Mariano, R., Paul, F., DeLuca, G.C., Enzinger, C., Kappos, L., Leite, M.I., Sastre-Garriga, J., Yousry, T., Ciccarelli, O., Filippi, M., Barkhof, F. and Palace, J.
Nature Reviews Neurology 20 (10): 620-635. October 2024

Effects of a 6-week treadmill training with and without virtual reality on frailty in people with multiple sclerosis: Frailty rehabilitation in multiple sclerosis.
Zanotto, T., Galperin, I., Kumar, D.P., Mirelman, A., Yehezkyahu, S., Regev, K., Karni, A., Schmitz-Hübsch, T., Paul, F., Lynch, S.G., Akinwuntan, A.E., He, J., Troen, B.R., Devos, H., Hausdorff, J.M. and Sosnoff, J.J.
Archives of Physical Medicine and Rehabilitation 26 September 2024 (In Press)

Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network.
Klyscz, P., Asseyer, S., Alonso, R., Bereuter, C., Bialer, O., Bick, A., Carta, S., Chen, J.J., Cohen, L., Cohen-Tayar, Y., Contentti, E.C., Dale, R.C., Flanagan, E.P., Gernert, J.A., Haas, J., Havla, J., Heesen, C., Hellmann, M., Levin, N., Lopez, P., Lotan, I., Luis, M.B., Mariotto, S., Mayer, C., Vergara, A.J.M., Ocampo, C., Ochoa, S., Oertel, F.C., Olszewska, M., Uribe, J.L.P., Sastre-Garriga, J., Scocco, D., Ramanathan, S., Rattanathamsakul, N., Shi, F.D., Shifa, J., Simantov, I., Siritho, S., Tiosano, A., Tisavipat, N., Torres, I., Dembinsky, A.V., Vidal-Jordana, A., Wilf-Yarkoni, A., Wu, Ti, Zamir, S., Zarco, L.A., Zimmermann, H.G., Petzold, A., Paul, F. and Stiebel-Kalish, H.
Annals of Clinical and Translational Neurology 11 (9): 2473-2484. September 2024

Das visuelle System als Modell in der translationalen Forschung [The visual system as a model in translational research].
Sindi, M., Oertel, F.C., Paul, F., Meuth, S.G. and Albrecht, P.
Klinische Neurophysiologie 55 (03): 139-146. September 2024

Der Stellenwert funktioneller Outcome-Parameter des afferent visuellen Systems bei neuroinflammatorischen Erkrankungen [The significance of functional outcome parameters of the afferent visual system in neuroinflammatory disorders].
Manthey, L.M., Buenrostro, G.S., Paul, F. and Oertel, F.C.
Klinische Neurophysiologie 55 (03): 147-152. September 2024

Emerging MRI and biofluid biomarkers in the diagnosis and prognosis of multiple sclerosis.
Anderhalten, L., Wohlrab, F. and Paul, F.
Lancet Regional Health - Europe 44 : 101023. September 2024

Hippocampal hub failure is linked to long-term memory impairment in anti-NMDA-receptor encephalitis: insights from structural connectome graph theoretical network analysis.
Hechler, A., Kuchling, J., Müller-Jensen, L., Klag, J., Paul, F., Prüss, H. and Finke, C.
Journal of Neurology 271 (9): 5886-5898. September 2024

Individual prognostication of disease activity and disability worsening in multiple sclerosis with retinal layer thickness z scores.
Lin, T.Y., Motamedi, S., Asseyer, S., Chien, C., Saidha, S., Calabresi, P.A., Fitzgerald, K.C., Samadzadeh, S., Villoslada, P., Llufriu, S., Green, A.J., Preiningerova, J.L., Petzold, A., Leocani, L., Garcia-Martin, E., Oreja-Guevara, C., Outteryck, O., Vermersch, P., Balcer, L.J., Kenney, R., Albrecht, P., Aktas, O., Costello, F., Frederiksen, J., Uccelli, A., Cellerino, M., Frohman, E.M., Frohman, T.C., Bellmann-Strobl, J., Schmitz-Hübsch, T., Ruprecht, K., Brandt, A.U., Zimmermann, H.G. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 11 (5): e200269. September 2024

Retinal changes in double-antibody seronegative neuromyelitis optica spectrum disorders.
Oertel, F.C., Zimmermann, H.G., Motamedi, S., Bereuter, C., Manthey, L.M., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., D'Cunha, A., Aktas, O., Albrecht, P., Ringelstein, M., Martinez-Lapiscina, E.H., Sanchez Dalmau, B.F., Villoslada, P., Asgari, N., Marignier, R., Cobo-Calvo, A., Leocani, L., Pisa, M., Radaelli, M., Palace, J., Roca-Fernandez, A., Leite, M.I.S., Sharma, S., De Seze, J., Senger, T., Yeaman, M.R., Smith, T.J., Cook, L.J., Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 11 (5): e200273. September 2024

A future of AI-driven personalized care for people with multiple sclerosis.
Praet, J., Anderhalten, L., Comi, G., Horakova, D., Ziemssen, T., Vermersch, P., Lukas, C., van Leemput, K., Steppe, M., Aguilera, C., Kadas, E.M., Bertrand, A., van Rampelbergh, J., de Boer, E., Zingler, V., Smeets, D., Ribbens, A. and Paul, F.
Frontiers in Immunology 15 : 1446748. 19 August 2024

Fasting, ketogenic and anti-inflammatory diets stabilized active relapsing-remitting multiple sclerosis over 18 months, a randomized, controlled study.
Bahr, Lina Samira, Bellmann-Strobl, J., Koppold, D.A., Rust, R., Schmitz-Hübsch, T., Olszewska, M., Stadlbauer, J., Bock, M., Scheel, M., Chien, C., Multmeier, J., Krannich, A., Michalsen, A., Paul, F. and Mähler, A.
medRxiv : 2024.08.13.24311863. 14 August 2024

Altered brain perfusion and oxygen levels relate to sleepiness and attention in post-COVID syndrome.
Chien, C., Heine, J., Khalil, A., Schlenker, L., Hartung, T.J., Boesl, F., Schwichtenberg, K., Rust, R., Bellmann-Strobl, J., Franke, C., Paul, F. and Finke, C.
Annals of Clinical and Translational Neurology 11 (8): 2016-2029. August 2024

Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis.
Noteboom, S., Seiler, M., Chien, C., Rane, R.P., Barkhof, F., Strijbis, E.M.M., Paul, F., Schoonheim, M.M. and Ritter, K.
Journal of Neurology 271 (8): 5577-5589. August 2024

Impact of sex on clinical outcome in early multiple sclerosis.
Gottwald, N.S., Asseyer, S., Chien, C., Brasanac, J., Nauman, A.T., Rust, R., Schmitz-Hübsch, T., Bellmann-Strobl, J., Ruprecht, K., Paul, F., Regitz-Zagrosek, V., Gold, S.M. and Sperber, P.S.
Multiple Sclerosis and Related Disorders 88 : 105749. August 2024

Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: a descriptive cohort study.
Schindler, P., Bellmann-Strobl, J., Kuhle, J., Wildemann, B., Jarius, S., Paul, F. and Ruprecht, K.
Multiple Sclerosis and Related Disorders 88 : 105729. August 2024

Quantitative gait and balance outcomes for ataxia trials: consensus recommendations by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers.
Ilg, W., Milne, S., Schmitz-Hübsch, T., Alcock, L., Beichert, L., Bertini, E., Mohamed Ibrahim, N., Dawes, H., Gomez, C.M., Hanagasi, H., Kinnunen, K.M., Minnerop, M., Németh, A.H., Newman, J., Ng, Y.S., Rentz, C., Samanci, B., Shah, V.V., Summa, S., Vasco, G., McNames, J. and Horak, F.B.
Cerebellum 23 (4): 1566-1592. August 2024

Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
Arnett, S., Chew, S.H., Leitner, U., Hor, J.Y., Paul, F., Yeaman, M.R., Levy, M., Weinshenker, B.G., Banwell, B.L., Fujihara, K., Abboud, H., Dujmovic Basuroski, I., Arrambide, G., Neubrand, V. E., Quan, C., Melamed, E., Palace, J., Sun, J., Asgari, N. and Broadley, S.A
Journal of Neurology 271 (8): 4794-4812. August 2024

Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study).
Passoke, S., Stern, C., Häußler, V., Kümpfel, T., Havla, J., Engels, D., Jarius, S., Wildemann, B., Korporal-Kuhnke, M., Senel, M., Stellmann, J.P., Warnke, C., Grothe, M., Schülke, R., Gingele, S., Kretschmer, J.R., Klotz, L., Walter, A., Then Bergh, F., Aktas, O., Ringelstein, M., Ayzenberg, I., Schwake, C., Kleiter, I., Sperber, P.S., Rust, R., Schindler, P., Bellmann-Strobl, J., Paul, F., Kopp, B., Trebst, C. and Hümmert, M.W.
Journal of Neurology Neurosurgery and Psychiatry 30 July 2024 (In Press)

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT).
Samadzadeh, S., Adnan, R., Berglova, P., Barzegar, M., Debrabant, B., Roikjaer, S.G., Levy, M., Petzold, A., Palace, J., Flanagan, E.P., Mariotto, S., Skou, S.T., Froelich, A., Lotan, I., Messina, S., Geraldes, R., Asseyer, S., Stiebel-Kalish, H., Oertel, F.C., Shaygannejad, V., Sahraian, M.A., Kim, H.J., Bennett, J.L., Böttcher, C., Zimmermann, H.G., Weinshenker, B.G., Paul, F. and Asgari, N.
Frontiers in Immunology 15 : 1380025. 2 July 2024

Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity - a potential diagnostic pitfall in patients with MOG-EM/MOGAD.
Jarius, S., Ringelstein, M., Schanda, K., Ruprecht, K., Korporal-Kuhnke, M., Viehöver, A., Hümmert, M.W., Schindler, P., Endmayr, V., Gastaldi, M., Trebst, C., Franciotta, D., Aktas, O., Höftberger, R., Haas, J., Komorowski, L., Paul, F., Reindl, M. and Wildemann, B.
Journal of Neurology 271 (7): 4660-4671. July 2024

SARA captures disparate progression and responsiveness in spinocerebellar ataxias.
Petit, E., Schmitz-Hübsch, T., Coarelli, G., Jacobi, H., Heinzmann, A., Figueroa, K.P., Perlman, S.L., Gomez, C.M., Wilmot, G.R., Schmahmann, J.D., Ying, S.H., Zesiewicz, T.A., Paulson, H.L., Shakkottai, V.G., Bushara, K.O., Kuo, S.H., Geschwind, M.D., Xia, G., Pulst, S.M., Subramony, S.H., Ewenczyk, C., Brice, A., Durr, A., Klockgether, T., Ashizawa, T. and Tezenas du Montcel, S.
Journal of Neurology 271 (7): 3743-3753. July 2024

Serum proteomics distinguish subtypes of NMO spectrum disorder and MOG antibody-associated disease and highlight effects of B-cell depletion.
Gawde, S., Siebert, N., Ruprecht, K., Kumar, G., Ko, R.M., Massey, K., Guthridge, J.M., Mao-Draayer, Y., Schindler, P., Hastermann, M., Pardo, G., Paul, F. and Axtell, R.C.
Neurology Neuroimmunology & Neuroinflammation 11 (4): e200268. July 2024

Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis.
Krämer, J., Balloff, C., Weise, M., Koska, V., Uthmeier, Y., Esderts, I., Nguyen-Minh, M., Zimmerhof, M., Hartmann, A., Dietrich, M., Ingwersen, J., Lee, J.I., Havla, J., Kümpfel, T., Kerschensteiner, M., Häußler, V., Heesen, C., Stellmann, J.P., Zimmermann, H.G., Oertel, F.C., Ringelstein, M., Brandt, A.U., Paul, F., Aktas, O., Hartung, H.P., Wiendl, H., Meuth, S.G. and Albrecht, P.
Nature Communications 15 (1): 5243. 19 June 2024

Cognitive-motor interference in multiple sclerosis and healthy controls: results from single, dual, and triple task posturography.
Althoff, P., Rosenthal, F., Dorsch, E.M., Drebinger, D., Arsenova, R., Chorschew, A., Rosenkranz, S.C., Bellmann-Strobl, J., Heesen, C., Paul, F., Weygandt, M. and Schmitz-Hübsch, T.
Exploration of Neuroprotective Therapy 4 : 273-287. 12 June 2024

Gait Variability as a Potential motor marker of cerebellar disease—relationship between variability of stride, arm swing and trunk movements, and walking speed.
Kroneberg, D., Nümann, A., Minnerop, M., Rönnefarth, M., Endres, M., Kühn, A.A., Paul, F., Doss, S., Solbrig, S., Elshehabi, M., Maetzler, W. and Schmitz-Hübsch, T.
Sensors 24 (11): 3476. 1 June 2024

Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree, B.A.C., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D.M., Fujihara, K., Paul, F., Cutter, G.R., Marignier, R., Green, A.J., Aktas, O., Hartung, H.P., She, D., Rees, W., Smith, M., Cimbora, D., Katz, E. and Bennett, J.L.
Lancet Neurology 23 (6): 588-602. June 2024

Establishment of a high-content compatible platform to assess effects of monocyte-derived factors on neural stem cell proliferation and differentiation.
Campo Garcia, J., Bueno, R.J., Salla, M., Martorell-Serra, I., Seeger, B., Akbari, N., Sperber, P., Stachelscheid, H., Infante-Duarte, C., Paul, F. and Starossom, S.C.
Scientific Reports 14 (1): 12167. 28 May 2024

Grey matter atrophy and its relationship with white matter lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, and multiple sclerosis.
Cortese, R., Battaglini, M., Prados, F., Gentile, G., Luchetti, L., Bianchi, A., Haider, L., Jacob, A., Palace, J., Messina, S., Paul, F., Marignier, R., Durand-Dubief, F., de Medeiros Rimkus, C., Apostolos Pereira, S.L., Sato, D.K., Filippi, M., Rocca, M.A., Cacciaguerra, L., Rovira, À., Sastre-Garriga, J., Arrambide, G., Liu, Y., Duan, Y., Gasperini, C., Tortorella, C., Ruggieri, S., Amato, M.P., Ulivelli, M., Groppa, S., Grothe, M., Llufriu, S., Sepulveda, M., Lukas, C., Bellenberg, B., Schneider, R., Sowa, P., Celius, E.G., Pröbstel, A.K., Granziera, C., Yaldizli, Ö., Müller, J., Stankoff, B., Bodini, B., Barkhof, F., Ciccarelli, O. and De Stefano, N.
Annals of Neurology 92 (2): 276-288. 23 May 2024

An exploratory research report on brain mineralization in postoperative delirium and cognitive decline.
Lammers-Lietz, F., Borchers, F., Feinkohl, I., Hetzer, S., Kanar, C., Konietschke, F., Lachmann, G., Chien, C., Spies, C., Winterer, G., Zaborszky, L., Zacharias, N. and Paul, F.
European Journal of Neuroscience 59 (10): 2646-2664. May 2024

Clinical characterization and ancillary tests in Susac syndrome: a systematic review.
Wilf-Yarkoni, A., Zmira, O., Tolkovsky, A., Pflantzer, B., Gofrit, S.G., Kleffner, I., Paul, F. and Dörr, J.
Neurology Neuroimmunology & Neuroinflammation 11 (3): e200209. May 2024

Impaired hand grip strength correlates with greater disability and symptom severity in post-COVID myalgic encephalomyelitis/chronic fatigue syndrome.
Paffrath, A., Kim, L., Kedor, C., Stein, E., Rust, R., Freitag, H., Hoppmann, U., Hanitsch, L.G., Bellmann-Strobl, J., Wittke, K., Scheibenbogen, C. and Sotzny, F.
Journal of Clinical Medicine 13 (7): 2153. 8 April 2024

Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosis.
Meyer-Arndt, L., Brasanac, J., Gamradt, S., Bellmann-Strobl, J., Maurer, L., Mai, K., Steward, T., Spranger, J., Schmitz-Hübsch, T., Paul, F., Gold, S.M. and Weygandt, M.
Journal of Neurology 271 (4): 1584-1598. April 2024

Scale for the assessment and rating of ataxia (SARA): Übersetzung und kulturelle Anpassung an den deutschsprachigen Raum.
Silberbauer, J., Schidl, S., Diermayr, G., Schmitz-Hübsch, T. and Greisberger, A.
Wiener Medizinische Wochenschrift 174 (5-6): 111-122. April 2024

Time to disability milestones and annualized relapse rates in NMOSD and MOGAD.
Duchow, A., Bellmann-Strobl, J., Friede, T., Aktas, O., Angstwurm, K., Ayzenberg, I., Berthele, A., Dawin, E., Engels, D., Fischer, K., Flaskamp, M., Giglhuber, K., Grothe, M., Havla, J., Hümmert, M.W., Jarius, S., Kaste, M., Kern, P., Kleiter, I., Klotz, L., Korporal-Kuhnke, M., Kraemer, M., Krumbholz, M., Kümpfel, T., Lohmann, L., Ringelstein, M., Rommer, P., Schindler, P., Schubert, C., Schwake, C., Senel, M., Bergh, F.T., Tkachenko, D., Tumami, H., Trebst, C., Vardakas, I., Walter, A., Warnke, C., Weber, M.S., Wickel, J., Wildemann, B., Winkelmann, A., Paul, F., Stellmann, J.P. and Häußler, V.
Annals of Neurology 95 (4): 720-732. April 2024

CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis.
Cortes-Figueiredo, F., Asseyer, S., Chien, C., Zimmermann, H.G., Ruprecht, K., Schmitz-Hübsch, T., Bellmann-Strobl, J., Paul, F. and Morais, V.A.
Scientific Reports 14 (1): 7507. 29 March 2024

The T1-weighted/T2-weighted ratio as a biomarker of anti-NMDA receptor encephalitis.
Hartung, T.J., Cooper, G., Jünger, V., Komnenić, D., Ryan, L., Heine, J., Chien, C., Paul, F., Prüss, H. and Finke, C.
Journal of Neurology Neurosurgery and Psychiatry 95 (4): 366-373. 13 March 2024

Persistent cognitive deficits in anti-LGI1 encephalitis are linked to a reorganization of structural brain networks.
Krohn, S., Müller-Jensen, L., Kuchling, J., Romanello, A., Bartsch, T., Leypoldt, F., Paul, F., Püss, H. and Finke, C.
bioRxiv : 2024.03.07.583948. 11 March 2024

Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
Gross, C.C., Schulte-Mecklenbeck, A., Steinberg, O.V., Wirth, T., Lauks, S., Bittner, S., Schindler, P., Baranzini, S.E., Groppa, S., Bellmann-Strobl, J., Bünger, N., Chien, C., Dawin, E., Eveslage, M., Fleischer, V., Gonzalez-Escamilla, G., Gisevius, B., Haas, J., Kerschensteiner, M., Kirstein, L., Korsukewitz, C., Lohmann, L., Lünemann, J.D., Luessi, F., Meyer Zu Hörste, G., Motte, J., Ruck, T., Ruprecht, K., Schwab, N., Steffen, F., Meuth, S.G., Paul, F., Wildemann, B., Kümpfel, T., Gold, R., Hahn, T., Zipp, F., Klotz, L. and Wiendl, H.
Science Translational Medicine 16 (740): eade8560. March 2024

Predicting disease severity in multiple sclerosis using multimodal data and machine learning.
Andorra, M., Freire, A., Zubizarreta, I., de Rosbo, N.K., Bos, S.D., Rinas, M., Høgestøl, E.A., de Rodez Benavent, S.A., Berge, T., Brune-Ingebretse, S., Ivaldi, F., Cellerino, M., Pardini, M., Vila, G., Pulido-Valdeolivas, I., Martinez-Lapiscina, E.H., Llufriu, S., Saiz, A., Blanco, Y., Martinez-Heras, E., Solana, E., Bäcker-Koduah, P., Behrens, J., Kuchling, J., Asseyer, S., Scheel, M., Chien, C., Zimmermann, H., Motamedi, S., Kauer-Bonin, J., Brandt, A., Saez-Rodriguez, J., Alexopoulos, L.G., Paul, F., Harbo, H.F., Shams, H., Oksenberg, J., Uccelli, A., Baeza-Yates, R. and Villoslada, P.
Journal of Neurology 271 (3): 1133-1149. March 2024

The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
Golubnitschaja, O., Polivka, J., Potuznik, P., Pesta, M., Stetkarova, I., Mazurakova, A., Lackova, L., Kubatka, P., Kropp, M., Thumann, G., Erb, C., Fröhlich, H., Wang, W., Baban, B., Kapalla, M., Shapira, N., Richter, K., Karabatsiakis, A., Smokovski, I., Schmeel, L.C., Gkika, E., Paul, F., Parini, P. and Polivka, J.
EPMA Journal 15 (1): 1-23. March 2024

Multiple Sklerose.
Paul, F. and Seifert, R.
In: Arzneiverordnungs-Report 2023. Springer, Berlin, Heidelberg, Berlin, Heidelberg, Germany, 531-552. ISBN 978-3-662-68371-2 22 February 2024

Preferences, adherence, and satisfaction: three years of treatment experiences of people with multiple sclerosis.
Hoffmann, O., Paul, F., Haase, R., Kern, R. and Ziemssen, T.
Patient preference and adherence 18 : 455-466. 22 February 2024

Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders.
Nishiyama, S., Seok, J.M., Wright, A.E., Lotan, I., Mikami, T., Drosu, N.C., Bobrowski-Khoury, N., Anderson, M.R., Bilodeau, P.A., Schindler, P., Paul, F., Aoki, M., Yeaman, M.R. and Levy, M.
Scientific Reports 14 (1): 3146. 7 February 2024

Associations of C-reactive protein with depressive symptoms over time after mild to moderate ischemic stroke in the PROSCIS-B cohort.
Schaeff, V.L.K., Sperber, P.S., Piper, S.K., Giesers, N.K., Gertz, K., Heuschmann, P.U., Endres, M. and Liman, T.G.
Journal of Neurology 271 (2): 909-917. February 2024

Multiscale networks in multiple sclerosis.
Kennedy, K.E., Kerlero de Rosbo, N., Uccelli, A., Cellerino, M., Ivaldi, F., Contini, P., De Palma, R., Harbo, H.F., Berge, T., Bos, S.D., Høgestøl, E.A., Brune-Ingebretsen, S., de Rodez Benavent, S.A., Paul, F., Brandt, A.U., Bäcker-Koduah, P., Behrens, J., Kuchling, J., Asseyer, S., Scheel, M., Chien, C., Zimmermann, H., Motamedi, S., Kauer-Bonin, J., Saez-Rodriguez, J., Rinas, M., Alexopoulos, L.G., Andorra, M., Llufriu, S., Saiz, A., Blanco, Y., Martinez-Heras, E., Solana, E., Pulido-Valdeolivas, I., Martinez-Lapiscina, E.H., Garcia-Ojalvo, J. and Villoslada, P.
PLoS Computational Biology 20 (2): e1010980. February 2024

Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD.
Asseyer, S., Zmira, O., Busse, L., Pflantzer, B., Schindler, P., Schmitz-Hübsch, T., Paul, F. and Chien, C.
Frontiers in Neurology 15 : 1308498. 26 January 2024

Cortical matrix remodeling as a hallmark of relapsing-remitting neuroinflammation in MR elastography and quantitative MRI.
Silva, R.V., Morr, A.S., Herthum, H., Koch, S.P., Mueller, S., Batzdorf, C.S., Bertalan, G., Meyer, T., Tzschätzsch, H., Kühl, A.A., Boehm-Sturm, P., Braun, J., Scheel, M., Paul, F., Infante-Duarte, C. and Sack, I.
Acta Neuropathologica 147 (1): 8. 4 January 2024

Central intra-lesional iron deposits as a possible novel imaging marker at 7 Tesla MRI in Susac Syndrome - an exploratory study.
Strunk, D., Sinnecker, T., Kleffner, I., Doerr, J., Ringelstein, M., Gross, C.C., Deuschl, C., Maderwald, S., Quick, H.H., Yamac, E., Wrede, K.H. and Kraemer, M.
BMC Medical Imaging 24 (1): 4. 2 January 2024

Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.
Boesl, F., Goereci, Y., Gerhard, A., Bremer, B., Raeder, V., Schweitzer, F., Hoppmann, U., Behrens, J., Bellmann-Strobl, J., Paul, F., Wildemann, B., Jarius, S., Prüss, H., Audebert, H.J., Warnke, C. and Franke, C.
Journal of Neurology 271 (1): 59-70. January 2024

Differentiation between Parkinson’s disease and the parkinsonian subtype of multiple system atrophy using the magnetic resonance T1w/T2w ratio in the middle cerebellar peduncle.
Wang, J., Sugiyama, A., Yokota, H., Hirano, S., Yamamoto, T., Yamanaka, Y., Araki, N., Ito, S., Paul, F. and Kuwabara, S.
Diagnostics 14 (2): 201. January 2024

Interactions of optic radiation lesions with retinal and brain atrophy in early multiple sclerosis.
Lin, T.Y., Chien, C., Kuchling, J., Asseyer, S., Motamedi, S., Bellmann-Strobl, J., Schmitz-Hübsch, T., Ruprecht, K., Brandt, A.U., Zimmermann, H.G. and Paul, F.
Annals of Clinical and Translational Neurology 11 (1): 45-56. January 2024

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel, T., Giglhuber, K., Aktas, O., Ayzenberg, I., Bellmann-Strobl, J., Häußler, V., Havla, J., Hellwig, K., Hümmert, M.W., Jarius, S., Kleiter, I., Klotz, L., Krumbholz, M., Paul, F., Ringelstein, M., Ruprecht, K., Senel, M., Stellmann, J.P., Bergh, F.T., Trebst, C., Tumani, H., Warnke, C., Wildemann, B. and Berthele, A.
Journal of Neurology 271 (1): 141-176. January 2024

Inebilizumab for neuromyelitis optica spectrum disorders.
Schindler, P. and Paul, F.
touchREVIEWS in Neurology 20 (1): 16-22. 2024

Superficial white matter integrity in neuromyelitis optica spectrum disorder and multiple sclerosis.
Komnenić, D., Phillips, O.R., Joshi, S.H., Chien, C., Schmitz-Hübsch, T., Asseyer, S., Paul, F. and Finke, C.
Multiple Sclerosis Journal Experimental Translational and Clinical 10 (1): 20552173231226107. 2024

Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N., Ellenberger, D., Stahmann, A., Fneish, F., Lüftenegger, D., Salmen, H.C., Schirduan, K., Schaak, T.P.A., Flachenecker, P., Kleinschnitz, C., Paul, F., Krefting, D., Zettl, U.K., Peters, M. and Warnke, C.
Therapeutic Advances in Neurological Disorders 17 : 17562864241239740. 2024

2023

Bruton's tyrosine kinase-bearing B cells and microglia in neuromyelitis optica spectrum disorder.
Liu, Y., Huang, Z., Zhang, T.X., Han, B., Yang, G., Jia, D., Yang, L., Liu, Q., Lau, A.Y.L., Paul, F., Verkhratsky, A., Shi, F.D. and Zhang, C.
Journal of Neuroinflammation 20 (1): 309. 21 December 2023

Occurrence and risk factors of relapse activity after vaccination against COVID-19 in people with multiple sclerosis: 1-year follow-up results from a nationwide longitudinal observational study.
Fneish, F., Frahm, N., Peters, M., Ellenberger, D., Haas, J., Löbermann, M., Pöhlau, D., Röper, A.L., Schilling, S., Stahmann, A., Temmes, H., Paul, F. and Zettl, U.K.
Vaccines 11 (12): 1859. 16 December 2023

Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: pathological and clinical aspects.
Samadzadeh, S., Olesen, M.N., Wirenfeldt, M., Möller, S., Misu, T., Soelberg, K., Frederiksen, J.L., Heegaard, S., Mariotto, S., Fujihara, K., Ruprecht, K., Andersen, T.L., Marignier, R., Lillevang, S.T., Flanagan, E.P., Pittock, S.J., Kim, H.J., Bennett, J.L., Paul, F., Sorensen, G.L., Weinshenker, B.G., Lassmann, H. and Asgari, N.
Multiple Sclerosis Journal 29 (14): 1721-1735. 14 December 2023

Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles.
Aschman, T., Wyler, E., Baum, O., Hentschel, A., Rust, R., Legler, F., Preusse, C., Meyer-Arndt, L., Büttnerova, I., Förster, A., Cengiz, D., Teixeira Alves, L.G., Schneider, J., Kedor, C., Bellmann-Strobl, J., Sanchin, A., Goebel, H.H., Landthaler, M., Corman, V., Roos, A., Heppner, F.L., Radbruch, H., Paul, F., Scheibenbogen, C., Dengler, N.F. and Stenzel, W.
Acta Neuropathologica Communications 11 (1): 193. 8 December 2023

Delimiting MOGAD as a disease entity using translational imaging.
Oertel, F.C., Hastermann, M. and Paul, F.
Frontiers in Neurology 14 : 1216477. 7 December 2023

Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
Wilf-Yarkoni, A., Feldmann, K., Rubarth, K., Dorsch, E.M., Rust, R., Urman, I., Hellmann, M.A., Friedman, Y., Lotan, I., Bialer, O., Buenrostro, G.S., Zimmermann, H.G., Leutloff, C., Schmitz-Hübsch, T., Paul, F., Asseyer, S. and Stiebel-Kalish, H.
PLoS ONE 18 (12): e0288366. 7 December 2023

Depressive symptoms and anti-N-methyl-D-aspartate-receptor GluN1 antibody seropositivity in the PROSpective cohort with incident stroke.
Sperber, P.S., Gebert, P., Broersen, L.H.A., Kufner, A., Huo, S., Piper, S.K., Teegen, B., Heuschmann, P.U., Prüss, H., Endres, M., Liman, T.G. and Siegerink, B.
Brain Behavior & Immunity - Health 34 : 100705. December 2023

Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
Kim, H.J., Aktas, O., Patterson, K.R., Korff, S., Kunchok, A., Bennett, J.L., Weinshenker, B.G., Paul, F., Hartung, H.P., Cimbora, D., Smith, M.A., Mittereder, N., Rees, W.A., She, D. and Cree, B.A.C.
Annals of Clinical and Translational Neurology 10 (12): 2413-2420. December 2023

Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases.
Wang, M., Dehlinger, A., Fernández Zapata, C., Golan, M., Gallaccio, G., Sander, L.E., Schlickeiser, S., Kunkel, D., Schmitz-Hübsch, T., Sawitzki, B., Karni, A., Braun, J., Loyal, L., Thiel, A., Bellmann-Strobl, J., Paul, F., Meyer-Arndt, L. and Boettcher, C.
Nature Communications 14 (1): 7728. 25 November 2023

Synapsin autoantibodies during pregnancy are associated with fetal abnormalities.
Bünger, I., Talucci, I., Kreye, J., Höltje, M., Makridis, K.L., Foverskov Rasmussen, H., van Hoof, S., Cordero-Gomez, C., Ullrich, T., Sedlin, E., Kreissner, K.O., Hoffmann, C., Milovanovic, D., Turko, P., Paul, F., Meckies, J., Verlohren, S., Henrich, W., Chaoui, R., Maric, H.M., Kaindl, A.M. and Prüss, H.
Brain, Behavior & Immunity - Health 33 : 100678. November 2023

The OSCAR-MP consensus criteria for quality assessment of retinal optical coherence tomography angiography.
Wicklein, R., Yam, C., Noll, C., Aly, L., Banze, N., Romahn, E.F., Wolf, E., Hemmer, B., Oertel, F.C., Zimmermann, H., Albrecht, P., Ringelstein, M., Baumann, C., Feucht, N., Penkava, J., Havla, J., Gernert, J.A., Mardin, C., Vasileiou, E.S., Van Der Walt, A., Al-Louzi, O., Cabello, S., Vidal-Jordana, A., Krämer, J., Wiendl, H., Preiningerova, J.L., Ciccarelli, O., Garcia-Martin, E., Kana, V., Calabresi, P.A., Paul, F., Saidha, S., Petzold, A., Toosy, A.T. and Knier, B.
Neurology Neuroimmunology & Neuroinflammation 10 (6): e200169. November 2023

Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité fatigue center.
Steiner, S., Fehrer, A., Hoheisel, F., Schoening, S., Aschenbrenner, A., Babel, N., Bellmann-Strobl, J., Finke, C., Fluge, Ø., Froehlich, L., Goebel, A., Grande, B., Haas, J.P., Hohberger, B., Jason, L.A., Komaroff, A.L., Lacerda, E., Liebl, M., Maier, A., Mella, O., Nacul, L., Paul, F., Prusty, B.K., Puta, C., Riemekasten, G., Ries, W., Rowe, P.C., Sawitzki, B., Shoenfeld, Y., Schultze, J.L., Seifert, M., Sepúlveda, N., Sotzny, F., Stein, E., Stingl, M., Ufer, F., Veauthier, C., Westermeier, F., Wirth, K., Wolfarth, B., Zalewski, P., Behrends, U. and Scheibenbogen, C.
Autoimmunity Reviews 22 (11): 103452. November 2023

Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: a study from the RelevarEM registry.
Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Criniti, J., Pappolla, A., Miguez, J., Cristiano, E., Patrucco, L., Liwacki, S., Tkachuk, V., Balbuena, M.E., Vrech, C., Deri, N., Correale, J., Marrodan, M., Ysrraelit, M.C., Leguizamon, F., Luetic, G., Menichini, M.L., Tavolini, D., Mainella, C., Zanga, G., Burgos, M., Hryb, J., Barboza, A., Lazaro, L., Alonso, R., Fernández Liguori, N., Nadur, D., Alonso Serena, M., Caride, A., Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal Experimental Translational and Clinical 9 (4): 20552173231205444. 17 October 2023

Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.
Rosenkranz, S.C., Gutmann, L., Has Silemek, A.C., Dorr, M., Häußler, V., Lüpke, M., Mönch, A., Reinhardt, S., Kuhle, J., Tilsley, P., Heesen, C., Friese, M.A., Brandt, A., Paul, F., Zimmermann, H. and Stellmann, J.P.
Journal of Neurology, Neurosurgery, and Psychiatry 94 (11): 924-933. 12 October 2023

Progression events defined by home-based assessment of motor function in multiple sclerosis: protocol of a prospective study.
Dorsch, E.M., Röhling, H.M., Zocholl, D., Hafermann, L., Paul, F. and Schmitz-Hübsch, T.
Frontiers in Neurology 14 : 1258635. 10 October 2023

Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
Chorschew, A., Kesgin, F., Bellmann-Strobl, J., Flachenecker, P., Schiffmann, I., Rosenthal, F., Althoff, P., Drebinger, D., Arsenova, R., Rasche, L., Dorsch, E.M., Heesen, C., Paul, F., Stellmann, J.P. and Schmitz-Hübsch, T.
Health and Quality of Life Outcomes 21 (1): 110. 9 October 2023

Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
Jacobi, H., Schaprian, T., Schmitz-Hübsch, T., Schmid, M. and Klockgether, T.
Annals of Clinical and Translational Neurology 10 (10): 1833-1843. October 2023

Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial.
Gold, S.M., Friede, T., Meyer, B., Moss-Morris, R., Hudson, J., Asseyer, S., Bellmann-Strobl, J., Leisdon, A., Ißels, L., Ritter, K., Schymainski, D., Pomeroy, H., Lynch, S.G., Cozart, J.S., Thelen, J., Román, C.A.F., Cadden, M., Guty, E., Lau, S., Pöttgen, J., Ramien, C., Seddiq-Zai, S., Kloidt, A.M., Wieditz, J., Penner, I.K., Paul, F., Sicotte, N.L., Bruce, J.M., Arnett, P.A. and Heesen, C.
Lancet Digital Health 5 (10): e668-e678. October 2023

Retinal changes after acute and late optic neuritis in aquaporin-4 antibody seropositive NMOSD.
Oertel, F.C., Zimmermann, H.G., Motamedi, S., Bereuter, C., Asseyer, E.S., Chien, C., Marignier, R., Cobo-Calvo, A., Leocani, L., Pisa, M., Radaelli, M., Villoslada, P., Sanchez-Dalmau, B., Martinez-Lapiscina, E.H., Lana-Peixoto, M.A., Fontenelle, M.A., Aktas, O., Ringelstein, M., Albrecht, P., Green, A.J., Yeaman, M.R., Smith, T.J., Cook, L., Paul, F. and Brandt, A.U.
Journal of Neuro-Ophthalmology 29 September 2023 (In Press)

Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis.
Brune-Ingebretsen, S., Høgestøl, E.A., de Rosbo, N.K., Berg-Hansen, P., Brunborg, C., Blennow, K., Zetterberg, H., Paul, F., Uccelli, A., Villoslada, P., Harbo, H.F and Berge, T.
Journal of Neuroimmunology 382 : 578175. 15 September 2023

Similar neural pathways link psychological stress and brain-age in health and multiple sclerosis.
Schulz, M.A., Hetzer, S., Eitel, F., Asseyer, S., Meyer-Arndt, L., Schmitz-Hübsch, T., Bellmann-Strobl, J., Cole, J.H., Gold, S.M., Paul, F., Ritter, K. and Weygandt, M.
iScience 26 (9): 107679. 15 September 2023

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.
Salmen, A., Hoepner, R., Fleischer, V., Heldt, M., Gisevius, B., Motte, J., Ruprecht, K., Schneider, R., Fisse, A.L., Grüter, T., Lukas, C., Berthele, A., Giglhuber, K., Flaskamp, M., Mühlau, M., Kirschke, J., Bittner, S., Groppa, S., Lüssi, F., Bayas, A., Meuth, S., Heesen, C., Trebst, C., Wildemann, B., Then Bergh, F., Antony, G., Kümpfel, T., Paul, F., Nischwitz, S., Tumani, H., Zettl, U., Hemmer, B., Wiendl, H., Zipp, F. and Gold, R.
Therapeutic Advances in Neurological Disorders 16 : 17562864231197309. 8 September 2023

Discrimination of multiple sclerosis using OCT images from two different centers.
Khodabandeh, Z., Rabbani, H., Ashtari, F., Zimmermann, H.G., Motamedi, S., Brandt, A.U., Paul, F. and Kafieh, R.
Multiple Sclerosis and Related Disorders 77 : 104846. September 2023

Do early relapses predict the risk of long-term relapsing disease in an adult and paediatric cohort with MOGAD?
Chen, B., Gomez-Figueroa, E., Redenbaugh, V., Francis, A., Satukijchai, C., Wu, Y., Messina, S., Sa, M., Woodhall, M., Paul, F., Robertson, N.P., Lim, M., Wassmer, E., Kneen, R., Huda, S., Blain, C., Halfpenny, C., Hemingway, C., O'Sullivan, E., Hobart, J., Fisniku, L.K., Martin, R.J., Dobson, R., Cooper, S.A., Williams, V., Waters, P., Chen, J.J., Pittock, S.J., Ramdas, S., Leite, M.I., Flanagan, E.P., Geraldes, R. and Palace, J.
Annals of Neurology 94 (3): 508-517. September 2023

Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Carnero Contentti, E., Lopez, P.A., Tkachuk, V., Vrech, C., Zarate, M.A., Correale, J., Deri, N., Luetic, G., Marrodan, M., Pagani Cassara, F., Tavolini, D., Ysrraelit, M.C., Balbuena, M.E., Hryb, J., Chiganer, E., Leguizamon, F., Knorre, E., Zanga, G., Pestchanker, C., Barboza, A., Nadur, D., Cristiano, E., Patrucco, L., Alonso, R., Alonso Serena, M., Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal 29 (10): 1240-1249. September 2023

Immunoglobulin A antibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with central nervous system demyelination.
Ayroza Galvão Ribeiro Gomes, A.B., Kulsvehagen, L., Lipps, P., Cagol, A., Cerdá-Fuertes, N., Neziraj, T., Flammer, J., Lerner, J., Lecourt, A.C., de Oliveira S Siebenborn, N., Cortese, R., Schaedelin, S., Andreoli Schoeps, V., de Moura Brasil Matos, A., Trombini Mendes, N., Dos Reis Pereira, C., Ribeiro Monteiro, M.L., Dos Apóstolos-Pereira, S.L., Schindler, P., Chien, C., Schwake, C., Schneider, R., Pakeerathan, T., Aktas, O., Fischer, U., Mehling, M., Derfuss, T., Kappos, L., Ayzenberg, I., Ringelstein, M., Paul, F., Callegaro, D., Kuhle, J., Papadopoulou, A., Granziera, C. and Pröbstel, A.K.
JAMA Neurology 80 (9): 989-995. September 2023

MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease.
Carnero Contentti, E., Okuda, D.T., Rojas, J.I., Chien, C., Paul, F. and Alonso, R.
Journal of Neuroimaging 33 (5): 688-702. September 2023

Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
Aktas, O., Hartung, H.P., Smith, M.A., Rees, W.A., Fujihara, K., Paul, F., Marignier, R., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D.M., Cutter, G., She, D., Gunsior, M., Cimbora, D., Katz, E. and Cree, B.A.
Journal of Neurology Neurosurgery and Psychiatry 94 (9): 757-768. September 2023

Functional connectome fingerprinting and stability in multiple sclerosis.
Mantwill, M., Asseyer, S., Chien, C., Kuchling, J., Schmitz-Hübsch, T., Brandt, A.U., Haynes, J.D., Paul, F. and Finke, C.
Multiple Sclerosis Journal Experimental Translational and Clinical 9 (3): 20552173231195879. 25 August 2023

Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
Legler, F., Meyer-Arndt, L., Mödl, L., Kedor, C., Freitag, H., Stein, E., Hoppmann, U., Rust, R., Wittke, K., Siebert, N., Behrens, J., Thiel, A., Konietschke, F., Paul, F., Scheibenbogen, C. and Bellmann-Strobl, J.
EClinicalMedicine 63 : 102146. 19 August 2023

HIF prolyl hydroxylase 2/3 deletion disrupts astrocytic integrity and exacerbates neuroinflammation.
Rosiewicz, K.S., Muinjonov, B., Kunz, S., Radbruch, H., Chen, J., Jüttner, R., Kerkering, J., Ucar, J., Crowley, T., Wielockx, B., Paul, F., Alisch, M. and Siffrin, V.
Glia 71 (8): 2024-2044. August 2023

Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.
Lotan, I., Chen, J.J., Hacohen, Y., Abdel-Mannan, O., Mariotto, S., Huda, S., Gibbons, E., Wilf-Yarkoni, A., Hellmann, M.A., Stiebel-Kalish, H., Pittock, S.J., Flanagan, E.P., Molazadeh, N., Anderson, M., Salky, R., Romanow, G., Schindler, P., Duchow, A.S., Paul, F. and Levy, M.
Multiple Sclerosis Journal 29 (9): 1080-1089. August 2023

Safety and discontinuation rate of dimethyl fumarate (Zadiva®) in patients with multiple sclerosis: an observational retrospective study.
Abolfazli, R., Sahraian, M.A., Tayebi, A., Kafi, H. and Samadzadeh, S.
Journal of Clinical Medicine 12 (15): 4937. 27 July 2023

iPSC-derived reactive astrocytes from patients with multiple-sclerosis protect cocultured neurons in inflammatory conditions.
Kerkering, J., Muinjonov, B., Rosiewicz, K.S., Diecke, S., Biese, C., Schiweck, J., Chien, C., Zocholl, D., Conrad, T., Paul, F., Alisch, M. and Siffrin, V.
Journal of Clinical Investigation 133 (13): e164637. 3 July 2023

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
Weinshenker, B.G., Wingerchuk, D.M., Green, A.J., Bennett, J.L., Kim, H.J., Pittock, S.J., Fujihara, K., Paul, F., Cutter, G., Marignier, R., Aktas, O., Hartung, H.P., She, D., Smith, M., Rees, W., Patterson, K., Cimbora, D., Katz, E. and Cree, B.A.
Multiple Sclerosis Journal 29 (8): 945-955. July 2023

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.
Oertel, F.C., Zimmermann, H.G., Motamedi, S., Chien, C., Aktas, O., Albrecht, P., Ringelstein, M., Dcunha, A., Pandit, L., Martinez-Lapiscina, E.H., Sanchez-Dalmau, B., Villoslada, P., Palace, J., Roca-Fernández, A., Leite, M.I., Sharma, S.M., Leocani, L., Pisa, M., Radaelli, M., Lana-Peixoto, M.A., Fontenelle, M.A., Havla, J., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Marignier, R., Cobo-Calvo, A., Asgari, N., Jacob, A., Huda, S., Mao-Draayer, Y., Green, A.J., Kenney, R., Yeaman, M.R., Smith, T.J., Cook, L., Brandt, A.U., Paul, F. and Petzold, A.
Journal of Neurology, Neurosurgery, and Psychiatry 94 (7): 560-566. July 2023

International delphi consensus on the management of AQP4-IgG+ NMOSD: recommendations for eculizumab, inebilizumab, and satralizumab.
Paul, F., Marignier, R., Palace, J., Arrambide, G., Asgari, N., Bennett, J.L., Cree, B.A.C., De Sèze, J., Fujihara, K., Kim, H.J., Hornby, R., Huda, S., Kissani, N., Kleiter, I., Kuwabara, S., Lana-Peixoto, M., Law, L., Leite, M.I., Pandit, L., Pittock, S.J., Quan, C., Ramanathan, S., Rotstein, D., Saiz, A., Sato, D.K. and Vaknin-Dembinsky, A.
Neurology Neuroimmunology & Neuroinflammation 10 (4): e200124. July 2023

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
Jarius, S., Aktas, O., Ayzenberg, I., Bellmann-Strobl, J., Berthele, A., Giglhuber, K., Häußler, V., Havla, J., Hellwig, K., Hümmert, M.W., Kleiter, I., Klotz, L., Krumbholz, M., Kümpfel, T., Paul, F., Ringelstein, M., Ruprecht, K., Senel, M., Stellmann, J.P., Bergh, F.T., Tumani, H., Wildemann, B. and Trebst, C.
Journal of Neurology 270 (7): 3341-3368. July 2023

Autoimmunenzephalitis - ein Update [Autoimmune encephalitis - an update].
Heine, J., Duchow, A., Rust, R., Paul, F., Prüß, H. and Finke, C.
Nervenarzt 94 (6): 525-537. June 2023

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Cortese, R., Battaglini, M., Prados, F., Bianchi, A., Haider, L., Jacob, A., Palace, J., Messina, S., Paul, F., Wuerfel, J., Marignier, R., Durand-Dubief, F., de Medeiros Rimkus, C., Callegaro, D., Sato, D.K., Filippi, M., Rocca, M.A., Cacciaguerra, L., Rovira, A., Sastre-Garriga, J., Arrambide, G., Liu, Y., Duan, Y., Gasperini, C., Tortorella, C., Ruggieri, S., Amato, M.P., Ulivelli, M., Groppa, S., Grothe, M., Llufriu, S., Sepulveda, M., Lukas, C., Bellenberg, B., Schneider, R., Sowa, P., Celius, E.G., Proebstel, A.K., Yaldizli, Ö., Müller, J., Stankoff, B., Bodini, B., Carmisciano, L., Sormani, M.P., Barkhof, F., De Stefano, N. and Ciccarelli, O.
Brain 146 (6): 2489-2501. June 2023

Cognition in patients with neuromyelitis optica spectrum disorders: a prospective multicentre study of 217 patients (CogniNMO-Study).
Hümmert, M.W., Stern, C., Paul, F., Duchow, A., Bellmann-Strobl, J., Ayzenberg, I., Schwake, C., Kleiter, I., Hellwig, K., Jarius, S., Wildemann, B., Senel, M., Berthele, A., Giglhuber, K., Luessi, F., Grothe, M., Klotz, L., Schülke, R., Gingele, S., Faiss, J.H., Walter, A., Warnke, C., Then Bergh, F., Aktas, O., Ringelstein, M., Stellmann, J.P., Häußler, V., Havla, J., Pellkofer, H., Kümpfel, T., Kopp, B. and Trebst, C.
Multiple Sclerosis Journal 29 (7): 819-831. June 2023

Health-related quality of life in patients with spinocerebellar ataxia: a validation study of the EQ-5D-3L.
Buchholz, M., Weber, N., Rädke, A., Faber, J., Schmitz-Hübsch, T., Jacobi, H., Xie, F., Klockgether, T. and Michalowsky, B.
Cerebellum 23 (3): 1020-1030. June 2023

Inflammatory cytokines associated with multiple sclerosis directly induce alterations of neuronal cytoarchitecture in human neurons.
Meyer-Arndt, L., Kerkering, J., Kuehl, T., Gil Infante, A., Paul, F., Rosiewicz, K.S., Siffrin, V. and Alisch, M.
Journal of Neuroimmune Pharmacology 18 (1-2): 145-159. June 2023

Ravulizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Pittock, S.J., Barnett, M., Bennett, J.L., Berthele, A., de Seze, J., Levy, M., Nakashima, I., Oreja-Guevara, C., Palace, J., Paul, F., Pozzilli, C., Yountz, M., Allen, K., Mashhoon, Y. and Kim, H.J.
Annals of Neurology 93 (6): 1053-1068. June 2023

Clinical rating scales for ataxia.
Schmitz-Hübsch, T.
Contemporary Clinical Neuroscience : 317-345. 30 May 2023

Immunomodulatory effects of new phenanthrene derivatives from Dendrobium crumenatum.
Kongkatitham, V., Dehlinger, A., Wang, M., Poldorn, P., Weidinger, C., Letizia, M., Chaotham, C., Otto, C., Ruprecht, K., Paul, F., Rungrotmongkol, T., Likhitwitayawuid, K., Böttcher, C. and Sritularak, B.
Journal of Natural Products 86 (5): 1294-1306. 26 May 2023

Frequency and predictors of relapses following SARS-CoV-2 vaccination in patients with multiple sclerosis: interim results from a longitudinal observational study.
Frahm, N., Fneish, F., Ellenberger, D., Haas, J., Löbermann, M., Peters, M., Pöhlau, D., Röper, A.L., Schilling, S., Stahmann, A., Temmes, H., Paul, F. and Zettl, U.K.
Journal of Clinical Medicine 12 (11): 3640. 24 May 2023

A review on multiple sclerosis prognostic findings from imaging, inflammation, and mental health studies.
Brasanac, J. and Chien, C.
Frontiers in Human Neuroscience 17 : 1151531. 11 May 2023

Increased flexibility of brain dynamics in patients with multiple sclerosis.
von Schwanenflug, N., Koch, S.P., Krohn, S., Broeders, T.A.A., Lydon-Staley, D.M., Bassett, D.S., Schoonheim, M.M., Paul, F. and Finke, C.
Brain Communications 5 (3): fcad143. 3 May 2023

Association between frailty and free-living walking performance in people with multiple sclerosis.
Zanotto, T., Galperin, I., Mirelman, A., Chen, L., Regev, K., Karni, A., Schmitz-Hübsch, T., Paul, F., Lynch, S.G., Akinwuntan, A.E., Devos, H., Hausdorff, J.M. and Sosnoff, J.J.
Physical Therapy 103 (5): pzad032. May 2023

Discriminating promiscuous from target-specific autoantibodies in COVID-19.
Lebedin, M., Vazquez Garcia, C., Spatt, L., Ratswohl, C., Thibeault, C., Ostendorf, L., Alexander, T., Paul, F., Sander, L.E., Kurth, F. and de la Rosa, K.
European Journal of Immunology 53 (5): e2250210. May 2023

Visually evoked potential as prognostic biomarker for neuroaxonal damage in multiple sclerosis from a multicenter longitudinal cohort.
Oertel, F.C., Krämer, J., Motamedi, S., Keihani, A., Zimmermann, H.G., Dimitriou, N.G., Condor-Montes, S., Bereuter, C., Cordano, C., Abdelhak, A., Trip, A., Aktas, O., Meuth, S.G., Wiendl, H., Ruprecht, K., Bellmann-Strobl, J., Paul, F., Petzold, A., Brandt, A.U., Albrecht, P. and Green, A.J.
Neurology Neuroimmunology & Neuroinflammation 10 (3): e200092. May 2023

Multiple sclerosis and circadian rhythms: Can diet act as a treatment?
Pivovarova-Ramich, O., Zimmermann, H.G. and Paul, F.
Acta Physiologica 237 (4): e13939. April 2023

Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
Cagol, A., Fuertes, N.C., Stoessel, M., Barakovic, M., Schaedelin, S., D'Souza, M., Würfel, J., Brandt, A.U., Kappos, L., Sprenger, T., Naegelin, Y., Kuhle, J., Granziera, C. and Papadopoulou, A.
Journal of Neurology 270 (4): 2139-2148. April 2023

Retinal ganglion cell loss is associated with future disability worsening in early relapsing remitting multiple sclerosis.
Wauschkuhn, J., Solorza Buenrostro, G., Aly, L., Asseyer, S., Wicklein, R., Hartberger, J.M., Ruprecht, K., Mühlau, M., Schmitz-Hübsch, T., Chien, C., Berthele, A., Brandt, A.U., Korn, T., Paul, F., Hemmer, B., Zimmermann, H.G. and Knier, B.
European Journal of Neurology 30 (4): 982-990. April 2023

Structural brain changes in patients with post-COVID fatigue: a prospective observational study.
Heine, J., Schwichtenberg, K., Hartung, T.J., Rekers, S., Chien, C., Boesl, F., Rust, R., Hohenfeld, C., Bungenberg, J., Costa, A.S., Scheibenbogen, C., Bellmann-Strobl, J., Paul, F., Franke, C., Reetz, K. and Finke, C.
EClinicalMedicine 58 : 101874. April 2023

Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis.
Mohammadi, S., Gouravani, M., Salehi, M.A., Arevalo, J.F., Galetta, S.L., Harandi, H., Frohman, E.M., Frohman, T.C., Saidha, S., Sattarnezhad, N. and Paul, F.
Journal of Neuroinflammation 20 (1): 85. 27 March 2023

Brain inflammation induces alterations in glycosaminoglycan metabolism and subsequent changes in CS-4S and hyaluronic acid.
Silva, R.V., Biskup, K., Zabala-Jouvin, J.K., Batzdorf, C.S., Stellmach, C., Morr, A.S., Sack, I., Ludwig, A., Blanchard, V. and Infante-Duarte, C.
International Journal of Biological Macromolecules 230 : 123214. March 2023

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
Banwell, B., Bennett, J.L., Marignier, R., Kim, H.J., Brilot, F., Flanagan, E.P., Ramanathan, S., Waters, P., Tenembaum, S., Graves, J.S., Chitnis, T., Brandt, A.U., Hemingway, C., Neuteboom, R., Pandit, L., Reindl, M., Saiz, A., Sato, D.K., Rostasy, K., Paul, F., Pittock, S.J., Fujihara, K. and Palace, J.
Lancet Neurology 22 (3): 268-282. March 2023

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases: COPANMO(G)-Study.
Hümmert, M.W., Bütow, F., Tkachenko, D., Ayzenberg, I., Pakeerathan, T., Hellwig, K., Klotz, L., Häußler, V., Stellmann, J.P., Warnke, C., Goereci, Y., Etgen, T., Luessi, F., Bronzlik, P., Gingele, S., Lauenstein, A.S., Kleiter, I., Rommer, P.S., Paul, F., Bellmann-Strobl, J., Duchow, A., Then Bergh, F., Pul, R., Walter, A., Pellkofer, H., Kümpfel, T., Pompsch, M., Kraemer, M., Albrecht, P., Aktas, O., Ringelstein, M., Senel, M., Giglhuber, K., Berthele, A., Jarius, S., Wildemann, B. and Trebst, C.
Neurology Neuroimmunology & Neuroinflammation 10 (2): e200082. March 2023

Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trial.
Galperin, I., Mirelman, A., Schmitz-Hübsch, T., Hsieh, K.L., Regev, K., Karni, A., Brozgol, M., Cornejo Thumm, P., Lynch, S.G., Paul, F., Devos, H., Sosnoff, J. and Hausdorff, J.M.
Journal of Neurology 270 (3): 1388-1401. March 2023

The Acute Optic Neuritis Network (ACON): study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis.
Asseyer, S., Asgari, N., Bennett, J., Bialer, O., Blanco, Y., Bosello, F., Camos-Carreras, A., Carnero Contentti, E., Carta, S., Chen, J., Chien, C., Chomba, M., Dale, R.C., Dalmau, J., Feldmann, K., Flanagan, E.P., Froment Tilikete, C., Garcia-Alfonso, C., Havla, J., Hellmann, M., Kim, H.J., Klyscz, P., Konietschke, F., La Morgia, C., Lana-Peixoto, M., Leite, M.I., Levin, N., Levy, M., Llufriu, S., Lopez, P., Lotan, I., Lugaresi, A., Marignier, R., Mariotto, S., Mollan, S.P., Ocampo, C., Oertel, F.C., Olszewska, M., Palace, J., Pandit, L., Peralta Uribe, J.L., Pittock, S., Ramanathan, S., Rattanathamsakul, N., Saiz, A., Samadzadeh, S., Sanchez-Dalmau, B., Saylor, D., Scheel, M., Schmitz-Hübsch, T., Shifa, J., Siritho, S., Sperber, P.S., Subramanian, P.S., Tiosano, A., Vaknin-Dembinsky, A., Mejia Vergara, A.J., Wilf-Yarkoni, A., Zarco, L.A., Zimmermann, H.G., Paul, F. and Stiebel-Kalish, H.
Frontiers in Neurology 14 : 1102353. 24 February 2023

Machine learning-based prediction of clinical outcomes after first-ever ischemic stroke.
Fast, L., Temuulen, U., Villringer, K., Kufner, A., Ali, H.F., Siebert, E., Huo, S., Piper, S.K., Sperber, P.S., Liman, T., Endres, M. and Ritter, K.
Frontiers in Neurology 14 : 1114360. 21 February 2023

Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke.
Arends, C.M., Liman, T.G., Strzelecka, P.M., Kufner, A., Löwe, P., Huo, S., Stein, C.M., Piper, S.K., Tilgner, M., Sperber, P.S., Dimitriou, S., Heuschmann, P., Hablesreiter, R., Harms, C., Bullinger, L., Weber, J.E., Endres, M. and Damm, F.
Blood 141 (7): 787-799. 16 February 2023

First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod.
Starke, L., Millward, J.M., Prinz, C., Sherazi, F., Waiczies, H., Lippert, C., Nazaré, M., Paul, F., Niendorf, T. and Waiczies, S.
Theranostics 13 (4): 1217-1234. 5 February 2023

Multiple Sklerose.
Seifert, R. and Paul, F.
In: Arzneiverordnungs-Report 2022. Springer, Berlin, Heidelberg, 497-517. ISBN 978-3-662-66302-8 3 February 2023

Early spinal cord pseudoatrophy in interferon-beta treated multiple sclerosis.
Matusche, B., Litvin, L., Schneider, R., Bellenberg, B., Mühlau, M., Pongratz, V., Berthele, A., Groppa, S., Muthuraman, M., Zipp, F., Paul, F., Wiendl, H., Meuth, S.G., Sämann, P., Weber, F., Linker, R.A., Kümpfel, T., Gold, R. and Lukas, C.
European Journal of Neurology 30 (2): 453-462. February 2023

Accelerated simultaneous T2 and T2* mapping of multiple sclerosis lesions using compressed sensing reconstruction of radial RARE-EPI MRI.
Herrmann, C.J.J., Starke, L., Millward, J.M., Kuchling, J., Paul, F. and Niendorf, T.
Tomography 9 (1): 299-314. 31 January 2023

Time-to-care metrics in patients with interhospital transfer for mechanical thrombectomy in north-east Germany: primary telestroke centers in rural areas vs. primary stroke centers in a metropolitan area.
Riegler, C., Behrens, J.R., Gorski, C., Angermaier, A., Kinze, S., Ganeshan, R., Rocco, A., Kunz, A., Müller, T.J., Bitsch, A., Grüger, A., Weber, J.E., Siebert, E., Bollweg, K., von Rennenberg, R., Audebert, H.J., Nolte, C.H. and Erdur, H.
Frontiers in Neurology 13 : 1046564. 9 January 2023

Pathophysiology and differentiation from other symptoms and diseasess.
Paul, F.
In: Fatigue in Multiple Sclerosis. Springer, Cham, 27-39. ISBN 978-3-031-13497-5 2 January 2023

Association of obesity with disease outcome in multiple sclerosis.
Lutfullin, I., Eveslage, M., Bittner, S., Antony, G., Flaskamp, M., Luessi, F., Salmen, A., Gisevius, B., Klotz, L., Korsukewitz, C., Berthele, A., Groppa, S., Then Bergh, F., Wildemann, B., Bayas, A., Tumani, H., Meuth, S.G., Trebst, C., Zettl, U.K., Paul, F., Heesen, C., Kuempfel, T., Gold, R., Hemmer, B., Zipp, F., Wiendl, H. and Lünemann, J.D.
Journal of Neurology Neurosurgery and Psychiatry 94 (1): 57-61. January 2023

Digital motor biomarkers of cerebellar ataxia using an RGB-Depth camera-based motion analysis system.
Suzuki, M., Hirano, S., Otte, K., Schmitz-Hübsch, T., Izumi, M., Tamura, M., Kuroiwa, R., Sugiyama, A., Mori, M., Röhling, H.M., Brandt, A.U., Murata, A., Paul, F. and Kuwabara, S:
Cerebellum 23 (3): 1031-1041. January 2023

Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.
Schindler, P., Aktas, O., Ringelstein, M., Wildemann, B., Jarius, S., Paul, F. and Ruprecht, K.
Expert Review of Clinical Immunology 19 (1): 71-91. January 2023

N2 year in review.
Dalmau, J., Dalakas, M.C., Kolson, D.L., Paul, F., Sánchez-Valle, R. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 10 (1): e200076. January 2023

Fighting post-COVID and ME/CFS - development of curative therapies.
Scheibenbogen, C., Bellmann-Strobl, J.T., Heindrich, C., Wittke, K., Stein, E., Franke, C., Prüss, H., Preßler, H., Machule, M.L., Audebert, H., Finke, C., Zimmermann, H.G., Sawitzki, B., Meisel, C., Toelle, M., Krueger, A., Aschenbrenner, A.C., Schultze, J.L., Beyer, M.D., Ralser, M., Mülleder, M., Sander, L.E., Konietschke, F., Paul, F., Stojanov, S., Bruckert, L., Hedderich, D.M., Knolle, F., Riemekasten, G., Vehreschild, M.J.G.T., Cornely, O.A., Behrends, U. and Burock, S.
Frontiers in Medicine 10 2023

2022

RGB-Depth camera-based assessment of motor capacity: normative data for six standardized motor tasks.
Röhling, H.M., Otte, K., Rekers, S., Finke, C., Rust, R., Dorsch, E.M., Behnia, B., Paul, F. and Schmitz-Hübsch, T.
International Journal of Environmental Research and Public Health 19 (24): 16989. 17 December 2022

Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study.
Sperber, P.S., Brandt, A.U., Zimmermann, H.G., Bahr, L.S., Chien, C., Rekers, S., Mähler, A., Böttcher, C., Asseyer, S., Duchow, A.S., Bellmann-Strobl, J., Ruprecht, K., Paul, F. and Schmitz-Hübsch, T.
BMC Neurology 22 (1): 479. 14 December 2022

Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder.
Nishiyama, S., Wright, A.E., Lotan, I., Mikami, T., Paul, F., Aoki, M. and Levy, M.
Journal of Neuroinflammation 19 (1): 296. 12 December 2022

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.
Stiebel-Kalish, H., Rubarth, K., Shouchane-Blum, K., Tiosano, A., Lotan, I., Hellmann, M.A., Wilf-Yarkoni, A., Bialer, O., Flanagan, E.P., Pittock, S.J., Bhatti, M.T., Schmitz-Hübsch, T., Paul, F., Asseyer, S. and Chen, J.J.
Scientific Reports 12 (1): 21312. 9 December 2022

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial.
Bennett, J.L., Aktas, O., Rees, W.A., Smith, M.A., Gunsior, M., Yan, L., She, D., Cimbora, D., Pittock, S.J., Weinshenker, B.G., Paul, F., Marignier, R., Wingerchuk, D., Cutter, G., Green, A., Hartung, H.P., Kim, H.J., Fujihara, K., Levy, M., Katz, E. and Cree, B.A.C.
EBioMedicine 86 : 104321. December 2022

Diagnosis and classification of optic neuritis.
Petzold, A., Fraser, C.L., Abegg, M., Alroughani, R., Alshowaeir, D., Alvarenga, R., Andris, C., Asgari, N., Barnett, Y., Battistella, R., Behbehani, R., Berger, T., Bikbov, M.M., Biotti, D., Biousse, V., Boschi, A., Brazdil, M., Brezhnev, A., Calabresi, P.A., Cordonnier, M., Costello, F., Cruz, F.M., Cunha, L.P., Daoudi, S., Deschamps, R., de Seze, J., Diem, R., Etemadifar, M., Flores-Rivera, J., Fonseca, P., Frederiksen, J., Frohman, E., Frohman, T., Tilikete, C.F., Fujihara, K., Gálvez, A., Gouider, R., Gracia, F., Grigoriadis, N., Guajardo, J.M., Habek, M., Hawlina, M., Martínez-Lapiscina, E.H., Hooker, J., Hor, J.Y., Howlett, W., Huang-Link, Y., Idrissova, Z., Illes, Z., Jancic, J., Jindahra, P., Karussis, D., Kerty, E., Kim, H.J., Lagrèze, W., Leocani, L., Levin, N., Liskova, P., Liu, Y., Maiga, Y., Marignier, R., McGuigan, C., Meira, D., Merle, H., Monteiro, M.L.R., Moodley, A., Moura, F., Muñoz, S., Mustafa, S., Nakashima, I., Noval, S., Oehninger, C., Ogun, O., Omoti, A., Pandit, L., Paul, F., Rebolleda, G., Reddel, S., Rejdak, K., Rejdak, R., Rodriguez-Morales, A.J., Rougier, M.B., Sa, M.J., Sanchez-Dalmau, B., Saylor, D., Shatriah, I., Siva, A., Stiebel-Kalish, H., Szatmary, G., Ta, L., Tenembaum, S., Tran, H., Trufanov, Y., van Pesch, V., Wang, A.G., Wattjes, M.P., Willoughby, E., Zakaria, M., Zvornicanin, J., Balcer, L. and Plant, G.T.
Lancet Neurology 21 (12): 1120-1134. December 2022

Normative data and conversion equation for spectral-domain optical coherence tomography in an international healthy control cohort.
Kenney, R., Liu, M., Hasanaj, L., Joseph, B., Al-Hassan, A.A., Balk, L., Behbehani, R., Brandt, A.U., Calabresi, P.A., Frohman, E.M., Frohman, T., Havla, J., Hemmer, B., Jiang, H., Knier, B., Korn, T., Leocani, L., Martínez-Lapiscina, E.H., Papadopoulou, A., Paul, F., Petzold, A., Pisa, M., Villoslada, P., Zimmermann, H., Ishikawa, H., Schuman, J.S., Wollstein, G., Chen, Y., Saidha, S., Thorpe, L.E., Galetta, S.L. and Balcer, L.J.
Journal of Neuro-Ophthalmology 42 (4): 442-453. December 2022

Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
Meaton, I., Altokhis, A., Allen, C.M., Clarke, M.A., Sinnecker, T., Meier, D., Enzinger, C., Calabrese, M., De Stefano, N., Pitiot, A., Giorgio, A., Schoonheim, M.M., Paul, F., Pawlak, M.A., Schmidt, R., Granziera, C., Kappos, L., Montalban, X., Rovira, À., Wuerfel, Jens and Evangelou, N.
Multiple Sclerosis Journal 28 (14): 2212-2220. December 2022

Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer's disease.
Fernández Zapata, C., Giacomello, G., Spruth, E.J., Middeldorp, J., Gallaccio, G., Dehlinger, A., Dames, C., Leman, J.K.H., van Dijk, R.E., Meisel, A., Schlickeiser, S., Kunkel, D., Hol, E.M., Paul, F., Parr, M.K., Priller, J. and Böttcher, C.
Nature Communications 13 (1): 7210. 23 November 2022

Neuroophthalmologische Präsentation der Retrobulbärneuritis im Rahmen der Myelin-Oligodendrozyten-Glykoprotein-Antikörper-assoziierten Erkrankung [Neuro-ophthalmological presentation of optic neuritis in myelin oligodendrocyte glycoprotein antibody-associated disease].
Lin, T.Y., Asseyer, S., Buenrostro, G.S., Feldmann, K., Hamann, S., Paul, F. and Zimmermann, H.G.
Klinische Monatsblatter fur Augenheilkunde 239 (11): 1305-1314. 21 November 2022

Diagnostik der Neuromyelitis-optica-Spektrum-Erkrankung (NMOSD) und der MOG-Antikörper-assoziierten Erkrankung (MOGAD) [Diagnosis of neuromyelitis optica spectrum disorder (NMOSD) and MOG Antibody-associated disease (MOGAD)].
Mewes, D., Kuchling, J., Schindler, P., Khalil, A.A.A., Jarius, S., Paul, F. and Chien, C.
Klinische Monatsblatter fur Augenheilkunde 239 (11): 1315-1324. November 2022

Prior optic neuritis detection on peripapillary ring scans using deep learning.
Motamedi, S., Yadav, S.K., Kenney, R.C., Lin, T.Y., Kauer-Bonin, J., Zimmermann, H.G., Galetta, S.L., Balcer, L.J., Paul, F. and Brandt, A.U.
Annals of Clinical and Translational Neurology 9 (11): 1682-1691. November 2022

Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Lin, T.Y., Schindler, P., Grittner, U., Oertel, F.C., Lu, A., Motamedi, S., Yadav, S.K., Duchow, A.S., Jarius, S., Kuhle, J., Benkert, P., Brandt, A.U., Bellmann-Strobl, J., Schmitz-Hübsch, T., Paul, F., Ruprecht, K. and Zimmermann, H.G.
Multiple Sclerosis and Related Disorders 67 : 104100. November 2022

Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.
Gigengack, N.K., Oertel, F.C., Motamedi, S., Bereuter, C., Duchow, A., Rust, R., Bellmann‑Strobl, J., Ruprecht, K., Schmitz-Hübsch, T., Paul, F., Brandt, A.U. and Zimmermann, H.G.
Scientific Reports 12 (1): 17545. 20 October 2022

CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.
Fuchs, L., Mausner-Fainberg, K., Luban, A., Asseyer, S.E., Golan, M., Benhamou, M., Volovitz, I., Regev, K., Vigiser, I., Piura, Y., Kolb, H., Paul, F. and Karni, A.
Journal of Neuroimmunology 371 : 577936. 15 October 2022

Mechanical properties of murine hippocampal subregions investigated by atomic force microscopy and in vivo magnetic resonance elastography.
Morr, A.S., Nowicki, M., Bertalan, G., Silva, R.V., Infante Duarte, C., Koch, S.P., Boehm-Sturm, P., Krügel, U., Braun, J., Steiner, B., Käs, J.A., Fuhs, T. and Sack, I.
Scientific Reports 12 (1): 16723. 6 October 2022

Different impact of gadopentetate and gadobutrol on inflammation-promoted retention and toxicity of gadolinium within the mouse brain.
Anderhalten, L., Silva, R.V., Morr, A., Wang, S., Smorodchenko, A., Saatz, J., Traub, H., Mueller, S., Boehm-Sturm, P., Rodriguez-Sillke, Y., Kunkel, D., Hahndorf, J., Paul, F., Taupitz, M., Sack, I. and Infante-Duarte, C.
Investigative Radiology 57 (10): 677-688. 1 October 2022

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD.
Schroeder-Castagno, M., Del Rio-Serrato, A., Wilhelm, A., Romero-Suárez, S., Schindler, P., Alvarez-González, C., Duchow, A.S., Bellmann-Strobl, J., Ruprecht, K., Hastermann, M., Grütz, G., Wildemann, B., Jarius, S., Schmitz-Hübsch, T., Paul, F. and Infante-Duarte, C.
Journal of Neuroinflammation 19 (1): 239. 1 October 2022

Bin-based visualization of cytokine-co-expression patterns of IL-10-producing CD4 T cell subsets.
Mohr, E., Hinnenthal, T., Gryzik, S., Hoang, Y., Lischke, T., Retzlaff, J., Mekonnen, A., Paul, F., Valleriani, A., Radbruch, A., Vera, J. and Baumgrass, R.
European Journal of Immunology 52 (10): 1684-1687. October 2022

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.
Brune, S., Høgestøl, E.A., de Rodez Benavent, S.A., Berg-Hansen, P., Beyer, M.K., Leikfoss, I.S., Bos, S.D., Sowa, P., Brunborg, C., Andorra, M., Pulido Valdeolivas, I., Asseyer, S., Brandt, A., Chien, C., Scheel, M., Blennow, K., Zetterberg, H., Kerlero de Rosbo, N., Paul, F., Uccelli, A., Villoslada, P., Berge, T. and Harbo, H.F.
Multiple Sclerosis Journal 28 (12): 1859-1870. October 2022

Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.
Sotzny, F., Filgueiras, I.S., Kedor, C., Freitag, H., Wittke, K., Bauer, S., Sepúlveda, N., Mathias da Fonseca, D.L., Baiocchi, G.C., Marques, A.H.C., Kim, M., Lange, T., Plaça, D.R., Luebber, F., Paulus, F.M., De Vito, R., Jurisica, I., Schulze-Forster, K., Paul, F., Bellmann-Strobl, J., Rust, R., Hoppmann, U., Shoenfeld, Y., Riemekasten, G., Heidecke, H., Cabral-Marques, O. and Scheibenbogen, C.
Frontiers in Immunology 13 : 981532. 27 September 2022

The role of optical coherence tomography criteria and machine learning in multiple sclerosis and optic neuritis diagnosis.
Kenney, R.C., Liu, M., Hasanaj, L., Joseph, B., Al-Hassan, A.A., Balk, L.J., Behbehani, R., Brandt, A., Calabresi, P.A., Frohman, E., Frohman, T.C., Havla, J., Hemmer, B., Jiang, H., Knier, B., Korn, T., Leocani, L., Martinez-Lapiscina, E.H., Papadopoulou, A., Paul, F., Petzold, A., Pisa, M., Villoslada, P., Zimmermann, H., Thorpe, L.E., Ishikawa, H., Schuman, J.S., Wollstein, G., Chen, Y., Saidha, S., Galetta, S. and Balcer, L.J.
Neurology 99 (11): e1100-e1112. 13 September 2022

Walking parameters of older adults from a lower back inertial measurement unit, a 6-year longitudinal observational study.
Elshehabi, M., Del Din, S., Hobert, M.A., Warmerdam, E., Sünkel, U., Schmitz-Hübsch, T., Behncke, L.M., Heinzel, S., Brockmann, K., Metzger, F.G., Schlenstedt, C., Rochester, L., Hansen, C., Berg, D. and Maetzler, W.
Frontiers in Aging Neuroscience 14 : 789220. 8 September 2022

Fragmentation, circadian amplitude, and fractal pattern of daily-living physical activity in people with multiple sclerosis: is there relevant information beyond the total amount of physical activity?
Salomon, A., Galperin, I., Buzaglo, D., Mirelman, A., Regev, K., Karni, A., Schmitz-Hübsch, T., Paul, F., Devos, H., Sosnoff, J.J., Tamir, R., Shimoni, N. and Hausdorff, J.M.
Multiple Sclerosis and Related Disorders 68 : 104108. 2 September 2022

Fibrin-targeting molecular MRI in inflammatory CNS disorders.
Lohmeier, J., Silva, R.V., Tietze, A., Taupitz, M., Kaneko, T., Prüss, H., Paul, F., Infante-Duarte, C., Hamm, B., Caravan, P. and Makowski, M.R.
European Journal of Nuclear Medicine and Molecular Imaging 49 (11): 3692–3704. September 2022

Longitudinal retinal changes in MOGAD.
Oertel, F.C., Sotirchos, E.S., Zimmermann, H.G., Motamedi, S., Specovius, S., Asseyer, E.S., Chien, C., Cook, L., Vasileiou, E., Filippatou, A., Calabresi, P.A., Saidha, S., Pandit, L., D'Cunha, A., Outteryck, O., Zéphir, H., Pittock, S., Flanagan, E.P., Bhatti, M.T., Rommer, P.S., Bsteh, G., Zrzavy, T., Kuempfel, T., Aktas, O., Ringelstein, M., Albrecht, P., Ayzenberg, I., Pakeerathan, T., Knier, B., Aly, L., Asgari, N., Soelberg, K., Marignier, R., Tilikete, C.F., Calvo, A.C., Villoslada, P., Sanchez-Dalmau, B., Martinez-Lapiscina, E.H., Llufriu, S., Green, A.J., Yeaman, M.R., Smith, T.J., Brandt, A.U., Chen, J., Paul, F. and Havla, J.
Annals of Neurology 92 (3): 476-485. September 2022

Overnight unilateral withdrawal of thalamic deep brain stimulation to identify reversibility of gait disturbances.
Kroneberg, D., Al-Fatly, B., Schmitz-Hübsch, T., Gandor, F., Gruber, D., Ebersbach, G., Horn, A. and Kühn, A.A.
Experimental Neurology 355 : 114135. September 2022

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.
Meyer-Arndt, L., Braun, J., Fauchere, F., Vanshylla, K., Loyal, L., Henze, L., Kruse, B., Dingeldey, M., Jürchott, K., Mangold, M., Maraj, A., Braginets, A., Böttcher, C., Nitsche, A., de la Rosa, K., Ratswohl, C., Sawitzki, B., Holenya, P., Reimer, U., Sander, L.E., Klein, F., Paul, F., Bellmann-Strobl, J., Thiel, A. and Giesecke-Thiel, C.
Journal of Neurology Neurosurgery and Psychiatry 93 (9): 960-971. September 2022

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
Kedor, C., Freitag, H., Meyer-Arndt, L., Wittke, K., Hanitsch, L.G., Zoller, T., Steinbeis, F., Haffke, M., Rudolf, G., Heidecker, B., Bobbert, T., Spranger, J., Volk, H.D., Skurk, C., Konietschke, F., Paul, F., Behrends, U., Bellmann-Strobl, J. and Scheibenbogen, C.
Nature Communications 13 (1): 5104. 30 August 2022

Protocol and reference values for minimal detectable change of MyotonPRO and ultrasound imaging measurements of muscle and subcutaneous tissue.
Muckelt, P.E., Warner, M.B., Cheliotis-James, T., Muckelt, R., Hastermann, M., Schoenrock, B., Martin, D., MacGregor, R., Blottner, D. and Stokes, M.
Scientific Reports 12 (1): 13654. 11 August 2022

Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo-controlled proof-of-concept phase-2 clinical trial.
Huehnchen, P., Bangemann, N., Lischewski, S., Märschenz, S., Paul, F., Schmitz-Hübsch, T., Blohmer, J.U., Eberhardt, C., Rauch, G., Flöel, A., Adam, S., Schwenkenbecher, P., Meinhold-Heerlein, I., Hoffmann, O., Ziemssen, T., Endres, M. and Boehmerle, W.
Frontiers in Medicine 9 : 967964. 11 August 2022

Alterations of NK cell phenotype during pregnancy in multiple sclerosis.
Wisgalla, A., Ramien, C., Streitz, M., Schlickeiser, S., Lupu, A.R., Diemert, A., Tolosa, E., Arck, P.C., Bellmann-Strobl, J., Siebert, N., Heesen, C., Paul, F., Friese, M.A., Infante-Duarte, C. and Gold, S.M.
Frontiers in Immunology 13 : 907994. 4 July 2022

A response to: Letter to the editor regarding "Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder".
Wingerchuk, D.M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F. and Pittock, S.J.
Neurology and Therapy 2 July 2022

Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity.
Chien, C., Seiler, M., Eitel, F., Schmitz-Hübsch, T., Paul, F. and Ritter, K.
Multiple Sclerosis Journal Experimental Translational and Clinical 8 (3): 20552173221109770. 1 July 2022

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Foley, J.F., Defer, G., Ryerson, L.Z., Cohen, J.A., Arnold, D.L., Butzkueven, H., Cutter, G., Giovannoni, G., Killestein, J., Wiendl, H., Smirnakis, K., Xiao, S., Kong, G., Kuhelj, R. and Campbell, N.
Lancet Neurology 21 (7): 608-619. July 2022

Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: a longitudinal multicenter study.
Rise, H.H., Brune, S., Chien, C., Berge, T., Bos, S.D., Andorrà, M., Valdeolivas, I.P., Beyer, M.K., Sowa, P., Scheel, M., Brandt, A.U., Asseyer, S., Blennow, K., Pedersen, M.L., Zetterberg, H., de Schotten, M.T., Cellerino, M., Uccelli, A., Paul, F., Villoslada, P., Harbo, H.F., Westlye, L.T. and Høgestøl, E.A.
NeuroImage: Clinical 35 : 103099. 28 June 2022

Prefrontal-amygdala emotion regulation and depression in multiple sclerosis.
Meyer-Arndt, L., Kuchling, J., Brasanac, J., Hermann, A., Asseyer, S., Bellmann-Strobl, J., Paul, F., Gold, S.M. and Weygandt, M.
Brain Communications 4 (3): fcac152. 13 June 2022

Hypoxia differentially affects healthy men and women during a daytime nap with a dose-response relationship: a randomized, cross-over pilot study.
Riveros-Rivera, A., Penzel, T., Gunga, H.C., Opatz, O., Paul, F., Klug, L., Boschmann, M. and Mähler, A.
Frontiers in Physiology 13 : 899636. 24 May 2022

Preventing axonal sodium overload or mitochondrial calcium uptake protects axonal mitochondria from oxidative stress-induced alterations.
Ulshöfer, R., Bros, H., Hauser, A.E., Niesner, R.A., Paul, F., Malla, B. and Infante-Duarte, C.
Oxidative Medicine and Cellular Longevity 2022 : 6125711. 24 May 2022

Intraretinal layer segmentation using cascaded compressed U-Nets.
Yadav, S.K., Kafieh, R., Zimmermann, H.G., Kauer-Bonin, J., Nouri-Mahdavi, K., Mohammadzadeh, V., Shi, L., Kadas, E.M., Paul, F., Motamedi, S. and Brandt, A.U.
Journal of Imaging 8 (5): 139. 17 May 2022

Motor signature of autism spectrum disorder in adults without intellectual impairment.
Cho, A.B., Otte, K., Baskow, I., Ehlen, F., Maslahati, T., Mansow-Model, S., Schmitz-Hübsch, T., Behnia, B. and Roepke, S.
Scientific Reports 12 (1): 7670. 10 May 2022

Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease.
Chen, J.J., Huda, S., Hacohen, Y., Levy, M., Lotan, I., Wilf-Yarkoni, A., Stiebel-Kalish, H., Hellmann, M.A., Sotirchos, E.S., Henderson, A.D., Pittock, S.J., Bhatti, M.T., Eggenberger, E.R., Di Nome, M., Kim, H.J., Kim, S.H., Saiz, A., Paul, F., Dale, R.C., Ramanathan, S., Palace, J., Camera, V., Leite, M.I., Lam, B.L., Bennett, J.L., Mariotto, S., Hodge, D., Audoin, B., Maillart, E., Deschamps, R., Pique, J., Flanagan, E.P. and Marignier, R.
JAMA Neurology 79 (5): 518-525. 1 May 2022

Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder: a retrospective, cross-sectional analysis.
Müller, J., Sinnecker, T., Wendebourg, M.J., Schläger, R., Kuhle, J., Schädelin, S., Benkert, P., Derfuss, T., Cattin, P., Jud, C., Spiess, F., Amann, M., Lincke, T., Barakovic, M., Cagol, A., Tsagkas, C., Parmar, K., Pröbstel, A.K., Reimann, S., Asseyer, S., Duchow, A., Brandt, A., Ruprecht, K., Hadjikhani, N., Fukumoto, S., Watanabe, M., Masaki, K., Matsushita, T., Isobe, N., Kira, J.I., Kappos, L., Würfel, J., Granziera, C., Paul, F. and Yaldizli, Ö.
Neurology Neuroimmunology & Neuroinflammation 9 (3): e1147. May 2022

Efficacy and safety of masitinib in progressive forms of multiple sclerosis: a randomized, phase 3, clinical trial.
Vermersch, P., Brieva-Ruiz, L., Fox, R.J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O. and Maciejowski, M.
Neurology Neuroimmunology & Neuroinflammation 9 (3): e1148. May 2022

Diagnostic efficacy of the magnetic resonance T1w/T2w ratio for the middle cerebellar peduncle in multiple system atrophy and spinocerebellar ataxia: a preliminary study.
Wang, J., Sugiyama, A., Yokota, H., Hirano, S., Cooper, G., Mukai, H., Ohira, K., Koide, K., Ito, S., Finke, C., Brandt, A.U., Paul, F. and Kuwabara, S.
PLoS ONE 17 (4): e0267024. 15 April 2022

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage.
Hyun, J.W., Kim, Y., Kim, K.H., Kim, S.H., Olesen, M.N., Asgari, N., Siritho, S., Paul, F. and Kim, H.J.
Journal of Neuroinflammation 19 (1): 86. 12 April 2022

Central stress processing, T-cell responsivity to stress hormones, and disease severity in multiple sclerosis.
Brasanac, J., Hetzer, S., Asseyer, S., Kuchling, J., Bellmann-Strobl, J., Ritter, K., Gamradt, S., Scheel, M., Haynes, J.D., Brandt, A.U., Paul, F., Gold, S.M. and Weygandt, M.
Brain Communications 4 (2): fcac086. 4 April 2022

Anatomical and functional visual network patterns in progressive multiple sclerosis.
Backner, Y., Zamir, S., Petrou, P., Paul, F., Karussis, D. and Levin, N.
Human Brain Mapping 43 (5): 1590-1597. 1 April 2022

Proposal for post hoc quality control in instrumented motion analysis using markerless motion capture: development and usability study.
Röhling, H.M., Althoff, P., Arsenova, R., Drebinger, D., Gigengack, N., Chorschew, A., Kroneberg, D., Rönnefarth, M., Ellermeyer, T., Rosenkranz, S.C., Heesen, C., Behnia, B., Hirano, S., Kuwabara, S., Paul, F., Brandt, A.U. and Schmitz-Hübsch, T.
JMIR Human Factors 9 (2): e26825. 1 April 2022

Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders.
Ayadi, N., Oertel, F.C., Asseyer, S., Rust, R., Duchow, A., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Klistorner, A., Brandt, A.U., Paul, F. and Zimmermann, H.G.
Multiple Sclerosis Journal 28 (5): 757-767. April 2022

Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
Haffke, M., Freitag, H., Rudolf, G., Seifert, M., Doehner, W., Scherbakov, N., Hanitsch, L., Wittke, K., Bauer, S., Konietschke, F., Paul, F., Bellmann-Strobl, J., Kedor, C., Scheibenbogen, C. and Sotzny, F.
Journal of Translational Medicine 20 (1): 138. 22 March 2022

Costs and health-related quality of life in patients with NMO spectrum disorders and MOG-antibody-associated disease: CHANCE(NMO) study.
Hümmert, M.W., Schöppe, L.M., Bellmann-Strobl, J., Siebert, N., Paul, F., Duchow, A., Pellkofer, H., Kümpfel, T., Havla, J., Jarius, S., Wildemann, B., Berthele, A., Bergh, F.T., Pawlitzki, M., Klotz, L., Kleiter, I., Stangel, M., Gingele, S., Weber, M.S., Faiss, J.H., Pul, R., Walter, A., Zettl, U., Senel, M., Stellmann, J.P., Häußler, V., Hellwig, K., Ayzenberg, I., Aktas, O., Ringelstein, M., Schreiber-Katz, O. and Trebst, C.
Neurology 98 (11): e1184-e1196. 15 March 2022

Cutting edge: Serum but not mucosal antibody responses are associated with pre-existing SARS-CoV-2 spike cross-reactive CD4(+) T cells following BNT162b2 vaccination in the elderly.
Meyer-Arndt, L., Schwarz, T., Loyal, L., Henze, L., Kruse, B., Dingeldey, M., Gürcan, K., Uyar-Aydin, Z., Müller, M.A., Drosten, C., Paul, F., Sander, L.E., Demuth, I., Lauster, R., Giesecke-Thiel, C., Braun, J., Corman, V.M. and Thiel, A.
Journal of Immunology 208 (5): 1001-1008. 1 March 2022

Leveraging visual outcome measures to advance therapy development in neuroimmunologic disorders.
Graves, J.S., Oertel, F.C., Van der Walt, A., Collorone, S., Sotirchos, E.S., Pihl-Jensen, G., Albrecht, P., Yeh, E.A., Saidha, S., Frederiksen, J., Newsome, S.D. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 9 (2): e1126. March 2022

Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
Wingerchuk, D.M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F. and Pittock, S.J.
Neurology and Therapy 11 (1): 123-135. March 2022

Therapy switches in fingolimod-treated patients with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N., Fneish, F., Ellenberger, D., Flachenecker, P., Paul, F., Warnke, C., Kleinschnitz, C., Parciak, T., Krefting, D., Hellwig, K., Haas, J., Rommer, P.S., Stahmann, A. and Zettl, U.K.
Neurology and Therapy 11 (1): 319–336. March 2022

Modular deep neural networks for automatic quality control of retinal optical coherence tomography scans.
Kauer-Bonin, J., Yadav, S.K., Beckers, I., Gawlik, K., Motamedi, S., Zimmermann, H.G., Kadas, E.M., Haußer, F., Paul, F. and Brandt, A.U.
Computers in Biology and Medicine 141 : 104822. 1 February 2022

State-dependent signatures of anti-N-methyl-d-aspartate receptor encephalitis.
von Schwanenflug, N., Krohn, S., Heine, J., Paul, F., Prüss, H. and Finke, C.
Brain Communications 4 (1): fcab298. 1 February 2022

Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders.
Lu, A., Zimmermann, H.G., Specovius, S., Motamedi, S., Chien, C., Bereuter, C., Lana-Peixoto, M.A., Fontenelle, M.A., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., D'Cunha, A., Kim, H.J., Hyun, J.W., Jung, S.K., Leocani, L., Pisa, M., Radaelli, M., Siritho, S., May, E.F., Tongco, C., De Sèze, J., Senger, T., Palace, J., Roca-Fernández, A., Leite, M.I., Sharma, S.M., Stiebel-Kalish, H., Asgari, N., Soelberg, K.K., Martinez-Lapiscina, E.H., Havla, J., Mao-Draayer, Y., Rimler, Z., Reid, A., Marignier, R., Cobo-Calvo, A., Altintas, A., Tanriverdi, U., Yildirim, R., Aktas, O., Ringelstein, M., Albrecht, P., Tavares, I.M., Bichuetti, D.B., Jacob, A., Huda, S., Soto de Castillo, I., Petzold, A., Green, A.J., Yeaman, M.R., Smith, T.J., Cook, L., Paul, F., Brandt, A.U. and Oertel, F.C.
Journal of Neurology Neurosurgery and Psychiatry 93 (2): 188-195. February 2022

Estimation and testing of Wilcoxon–Mann–Whitney effects in factorial clustered data designs.
Rubarth, K., Sattler, P., Zimmermann, H.G. and Konietschke, F.
Symmetry 14 (2): 244. February 2022

Immune signature of multiple sclerosis-associated depression.
Brasanac, J., Ramien, C., Gamradt, S., Tänzer, A., Glau, L., Ritter, K., Patas, K., Agorastos, A., Wiedemann, K., Demiralay, C., Fischer, F., Otte, C., Bellmann-Strobl, J., Friese, M.A., Tolosa, E., Paul, F., Heesen, C., Weygandt, M. and Gold, S.M.
Brain Behavior and Immunity 100 : 174-182. February 2022

OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.
Chen, J.J., Sotirchos, E.S., Henderson, A.D., Vasileiou, E.S., Flanagan, E.P., Bhatti, M.T., Jamali, S., Eggenberger, E.R., Dinome, M., Frohman, L.P., Arnold, A.C., Bonelli, L., Seleme, N., Mejia-Vergara, A.J., Moss, H.E., Padungkiatsagul, T., Stiebel-Kalish, H., Lotan, I., Hellmann, M.A., Hodge, D., Oertel, F.C., Paul, F., Saidha, S., Calabresi, P.A. and Pittock, S.J.
Multiple Sclerosis and Related Disorders 58 : 103525. February 2022

Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: evaluation of 794 attacks from a nationwide registry in Argentina.
Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Criniti, J., Pappolla, A., Miguez, J., Patrucco, L., Cristiano, E., Liwacki, S., Tkachuk, V., Balbuena, M.E., Vrech, C., Deri, N., Correale, J., Marrodan, M., Ysrraelit, M.C., Leguizamon, F., Luetic, G., Menichini, M.L., Tavolini, D., Mainella, C., Zanga, G., Burgos, M., Hryb, J., Barboza, A., Lazaro, L., Alonso, R., Fernández Liguori, N., Nadur, D., Chercoff, A., Alonso Serena, M., Caride, A., Paul, F. and Rojas, J.I.
Multiple Sclerosis and Related Disorders 58 : 103466. February 2022

Subcortical volumes as early predictors of fatigue in multiple sclerosis.
Fleischer, V., Ciolac, D., Gonzalez-Escamilla, G., Grothe, M., Strauss, S., Molina Galindo, L.S., Radetz, A., Salmen, A., Lukas, C., Klotz, L., Meuth, S.G., Bayas, A., Paul, F., Hartung, H.P., Heesen, C., Stangel, M., Wildemann, B., Bergh, F.T., Tackenberg, B., Kümpfel, T., Zettl, U.K., Knop, M., Tumani, H., Wiendl, H., Gold, R., Bittner, S., Zipp, F., Groppa, S. and Muthuraman, M.
Annals of Neurology 91 (2): 192-202. February 2022

Teriflunomide preserves neuronal activity and protects mitochondria in brain slices exposed to oxidative stress.
Malla, B., Liotta, A., Bros, H., Ulshöfer, R., Paul, F., Hauser, A.E., Niesner, R. and Infante-Duarte, C.
International Journal of Molecular Sciences 23 (3): 1538. 28 January 2022

Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
Jarius, S., Pache, F., Körtvelyessy, P., Jelčić, I., Stettner, M., Franciotta, D., Keller, E., Neumann, B., Ringelstein, M., Senel, M., Regeniter, A., Kalantzis, R., Willms, J.F., Berthele, A., Busch, M., Capobianco, M., Eisele, A., Reichen, I., Dersch, R., Rauer, S., Sandner, K., Ayzenberg, I., Gross, C.C., Hegen, H., Khalil, M., Kleiter, I., Lenhard, T., Haas, J., Aktas, O., Angstwurm, K., Kleinschnitz, C., Lewerenz, J., Tumani, H., Paul, F., Stangel, M., Ruprecht, K. and Wildemann, B.
Journal of Neuroinflammation 19 (1): 19. 20 January 2022

Retinoids are not linked to risk of multiple sclerosis: a Danish nationwide cohort study.
Cortes-Figueiredo, F., Nielsen, N.M., Stenager, E., Paul, F., Hallas, J. and Kristensen, K.B.
European Journal of Neurology 2 (1): 247-256. 18 January 2022

In vivo stiffness of multiple sclerosis lesions is similar to that of normal-appearing white matter.
Herthum, H., Hetzer, S., Scheel, M., Shahryari, M., Braun, J., Paul, F. and Sack, I.
Acta Biomaterialia 138 : 410-421. 15 January 2022

AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Marignier, R., Pittock, S.J., Paul, F., Kim, H.J., Bennett, J. L., Weinshenker, B.G., Wingerchuk, D.M., Green, A.J., Fujihara, K., Cutter, G., Aktas, O., Hartung, H.P., Drappa, J., Ratchford, J.N., She, D., Smith, M., Rees, W., Cimbora, D., Katz, E. and Cree, B.A.C.
Multiple Sclerosis and Related Disorders 57 : 103356. January 2022

Interleukin-6 receptor blockade in treatment-refractory MOG-IgG-associated disease and neuromyelitis optica spectrum disorders.
Ringelstein, M., Ayzenberg, I., Lindenblatt, G., Fischer, K., Gahlen, A., Novi, G., Hayward-Könnecke, H., Schippling, S., Rommer, P.S., Kornek, B., Zrzavy, T., Biotti, D., Ciron, J., Audoin, B., Berthele, A., Giglhuber, K., Zephir, H., Kümpfel, T., Berger, R., Röther, J., Häußler, V., Stellmann, J.P., Whittam, D., Jacob, A., Kraemer, M., Gueguen, A., Deschamps, R., Bayas, A., Hümmert, M.W., Trebst, C., Haarmann, A., Jarius, S., Wildemann, B., Grothe, M., Siebert, N., Ruprecht, K., Paul, F., Collongues, N., Marignier, R., Levy, M., Karenfort, M., Deppe, M., Albrecht, P., Hellwig, K., Gold, R., Hartung, H.P., Meuth, S.G., Kleiter, I. and Aktas, O.
Neurology Neuroimmunology & Neuroinflammation 9 (1): e1100. January 2022

Arzneimittelversorgung bei Multipler Sklerose.
Paul, F. and Berthele, A.
In: Arzneimittel-Kompass 2022: Qualität der Arzneimittelversorgung. Springer, Berlin, Heidelberg, 139-159. ISBN 978-3-662-66040-9 2022

Functional connectivity dynamics reflect disability and multi-domain clinical impairment in patients with relapsing-remitting multiple sclerosis.
Romanello, A., Krohn, S., von Schwanenflug, N., Chien, C., Bellmann-Strobl, J., Ruprecht, K., Paul, F. and Finke, C.
NeuroImage: Clinical 36 : 103203. 2022

2021

Patch individual filter layers in CNNs to harness the spatial homogeneity of neuroimaging data.
Eitel, F., Albrecht, J.P., Weygandt, M., Paul, F. and Ritter, K.
Scientific Reports 11 (1): 24447. 27 December 2021

Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study.
Paul, F., Calabresi, P.A., Barkhof, F., Green, A.J., Kardon, R., Sastre-Garriga, J., Schippling, S., Vermersch, P., Saidha, S., Gerendas, B.S., Schmidt-Erfurth, U., Agoropoulou, C., Zhang, Y., Seifer, G. and Petzold, A.
Annals of Clinical and Translational Neurology 8 (12): 2235-2251. 14 December 2021

Clinical and neuroimaging findings in MOGAD - MRI and OCT.
Bartels, F., Lu, A., Oertel, F.C., Finke, C., Paul, F. and Chien, C.
Clinical and Experimental Immunology 206 (3): 266-281. December 2021

Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation.
Cooper, G., Chien, C., Zimmermann, H., Bellmann-Strobl, J., Ruprecht, K., Kuchling, J., Asseyer, S., Brandt, A.U., Scheel, M., Finke, C. and Paul, F.
Multiple Sclerosis Journal 27 (14): 2180-2190. December 2021

Pentafluorosulfanyl (SF(5)) as a superior (19)F magnetic resonance reporter group: signal detection and biological activity of teriflunomide derivatives.
Prinz, C., Starke, L., Ramspoth, T.F., Kerkering, J., Martos Riaño, V., Paul, J., Neuenschwander, M., Oder, A., Radetzki, S., Adelhoefer, S., Ramos Delgado, P., Aravina, M., Millward, J.M., Fillmer, A., Paul, F., Siffrin, V., von Kries, J.P., Niendorf, T., Nazaré, M. and Waiczies, S.
ACS Sensors 6 (11): 3948–3956. 26 November 2021

Frailty and falls in people living with multiple sclerosis.
Zanotto, T., Galperin, I., Mirelman, A., Yehezkiyahu, S., Estes, J., Chen, L., Regev, K., Karni, A., Schmitz-Hübsch, T., Paul, F., Lynch, S.G., Akinwuntan, A.E., Devos, H., Hausdorff, J.M. and Sosnoff, J.J.
Archives of Physical Medicine and Rehabilitation 103 (5): 952-957. 24 November 2021

Neural processes of psychological stress and relaxation predict the future evolution of quality of life in multiple sclerosis.
Meyer-Arndt, L., Schmitz-Hübsch, T., Bellmann-Strobl, J., Brandt, A.U., Haynes, J.D., Gold, S.M., Paul, F. and Weygandt, M.
Frontiers in Neurology 12 : 753107. 23 November 2021

An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Wirth, K.J., Scheibenbogen, C. and Paul, F.
Journal of Translational Medicine 19 (1): 471. 22 November 2021

Reduced mitochondrial respiration in T cells of patients with major depressive disorder.
Gamradt, S., Hasselmann, H., Taenzer, A., Brasanac, J., Stiglbauer, V., Sattler, A., Sajitz-Hermstein, M., Kierszniowska, S., Ramien, C., Nowacki, J., Mascarell-Maricic, L., Wingenfeld, K., Piber, D., Ströhle, A., Kotsch, K., Paul, F., Otte, C. and Gold, S.M.
iScience 24 (11): 103312. 19 November 2021

C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.
Pache, F., Ringelstein, M., Aktas, O., Kleiter, I., Jarius, S., Siebert, N., Bellmann-Strobl, J., Paul, F. and Ruprecht, K.
Journal of Neuroimmunology 360 : 577699. 15 November 2021

From forensics to clinical research: expanding the variant calling pipeline for the precision ID mtDNA whole genome panel.
Cortes-Figueiredo, F., Carvalho, F.S., Fonseca, A.C., Paul, F., Ferro, J.M., Schönherr, S., Weissensteiner, H. and Morais, V.A.
International Journal of Molecular Sciences 22 (21): 12031. 6 November 2021

Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
Cree, B.A.C., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D., Fujihara, K., Paul, F., Cutter, G.R., Marignier, R., Green, A.J., Aktas, O., Hartung, H.P., Williams, I.M., Drappa, J., She, D., Cimbora, D., Rees, W., Ratchford, J.N. and Katz, E.
Multiple Sclerosis Journal 27 (13): 2052-2061. 1 November 2021

Characteristics of secondary progressive multiple sclerosis: disease activity and provision of care in Germany - a registry-based/multicentric cohort study.
Frahm, N., Ellenberger, D., Fneish, F., Christoph, K., Warnke, C., Zettl, U.K., Paul, F., Rauser, B., Stahmann, A., Vogelmann, V. and Flachenecker, P.
Multiple Sclerosis and Related Disorders 56 : 103281. November 2021

Cognitive impairment in multiple system atrophy is related to white matter damage detected by the T1-weighted/T2-weighted ratio.
Sugiyama, A., Cooper, G., Hirano, S., Yokota, H., Mori, M., Shimizu, K., Yakiyama, M., Finke, C., Brandt, A.U., Paul, F. and Kuwabara, S.
European Neurology 84 (6): 435-443. November 2021

Retinal optical coherence tomography in neuromyelitis optica.
Oertel, F.C., Specovius, S., Zimmermann, H.G., Chien, C., Motamedi, S., Bereuter, C., Cook, L., Lana Peixoto, M.A., Fontanelle, M.A., Kim, H.J., Hyun, J.W., Palace, J., Roca-Fernandez, A., Leite, M.I., Sharma, S., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., D'Cunha, A., Aktas, O., Ringelstein, M., Albrecht, P., May, E., Tongco, C., Leocani, L., Pisa, M., Radaelli, M., Martinez-Lapiscina, E.H., Stiebel-Kalish, H., Siritho, S., de Seze, J., Senger, T., Havla, J., Marignier, R., Cobo-Calvo, A., Bichuetti, D., Tavares, I.M., Asgari, N., Soelberg, K., Altintas, A., Yildirim, R., Tanriverdi, U., Jacob, A., Huda, S., Rimler, Z., Reid, A., Mao-Draayer, Y., Soto de Castillo, I., Petzold, A., Green, A.J., Yeaman, M.R., Smith, T., Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 8 (6): e1068. November 2021

Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
Loyal, L., Braun, J., Henze, L., Kruse, B., Dingeldey, M., Reimer, U., Kern, F., Schwarz, T., Mangold, M., Unger, C., Dörfler, F., Kadler, S., Rosowski, J., Gürcan, K., Uyar-Aydin, Z., Frentsch, M., Kurth, F., Schnatbaum, K., Eckey, M., Hippenstiel, S., Hocke, A., Müller, M.A., Sawitzki, B., Miltenyi, S., Paul, F., Mall, M.A., Wenschuh, H., Voigt, S., Drosten, C., Lauster, R., Lachman, N., Sander, L.E., Corman, V.M., Röhmel, J., Meyer-Arndt, L., Thiel, A. and Giesecke-Thiel, C.
Science 374 (6564): eabh1823. 8 October 2021

Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review.
Lin, T.Y., Chien, C., Lu, A., Paul, F. and Zimmermann, H.G.
Expert Review of Neurotherapeutics 21 (10): 1101-1123. October 2021

Identification of the gliogenic state of human neural stem cells to optimize in vitro astrocyte differentiation.
Alisch, M., Kerkering, J., Crowley, T., Rosiewicz, K., Paul, F. and Siffrin, V.
Journal of Neuroscience Methods 361 : 109284. 1 September 2021

Caution, "normal" BMI: health risks associated with potentially masked individual underweight - EPMA position paper 2021.
Golubnitschaja, O., Liskova, A., Koklesova, L., Samec, M., Biringer, K., Büsselberg, D., Podbielska, H., Kunin, A.A., Evsevyeva, M.E., Shapira, N., Paul, F., Erb, C., Dietrich, D.E., Felbel, D., Karabatsiakis, A., Bubnov, R., Polivka, J., Polivka, J.J., Birkenbihl, C., Fröhlich, H., Hofmann-Apitius, M. and Kubatka, P.
EPMA Journal 12 (3): 243-264. September 2021

Increased serum neurofilament light and thin ganglion cell-inner plexiform layer are additive risk factors for disease activity in early multiple sclerosis.
Lin, T.Y., Vitkova, V., Asseyer, S., Martorell Serra, I., Motamedi, S., Chien, C., Ditzhaus, M., Papadopoulou, A., Benkert, P., Kuhle, J., Bellmann-Strobl, J., Ruprecht, K., Paul, F., Brandt, A.U. and Zimmermann, H.G.
Neurology Neuroimmunology & Neuroinflammation 8 (5): e1051. September 2021

Myelin-oligodendrocyte glycoprotein antibody-associated disease.
Marignier, R., Hacohen, Y., Cobo-Calvo, A., Pröbstel, A.K., Aktas, O., Alexopoulos, H., Amato, M.P., Asgari, N., Banwell, B., Bennett, J., Brilot, F., Capobianco, M., Chitnis, T., Ciccarelli, O., Deiva, K., De Sèze, J., Fujihara, K., Jacob, A., Kim, H.J., Kleiter, I., Lassmann, H., Leite, M.I., Linington, C., Meinl, E., Palace, J., Paul, F., Petzold, A., Pittock, S., Reindl, M., Sato, D.K., Selmaj, K., Siva, A., Stankoff, B., Tintore, M., Traboulsee, A., Waters, P., Waubant, E., Weinshenker, B., Derfuss, T., Vukusic, S. and Hemmer, B.
Lancet Neurology 20 (9): 762-772. September 2021

Simultaneous T(2) and T(2)* mapping of multiple sclerosis lesions with radial RARE-EPI.
Herrmann, C., Els, A., Boehmert, L., Periquito, J., Eigentler, T.W., Millward, J., Waiczies, S., Kuchling, J., Paul, F. and Niendorf, T.
Magnetic Resonance in Medicine 86 (3): 1383-1402. September 2021

Camera-based objective measures of Parkinson's disease gait features.
van Kersbergen, J., Otte, K., de Vries, N.M., Bloem, B.R., Röhling, H.M., Mansow-Model, S., van der Kolk, N.M., Overeem, S., Zinger, S. and van Gilst, M.M.
BMC Research Notes 14 (1): 329. 26 August 2021

Functional connectivity alterations of striato-cortical circuits in multiple sclerosis.
Jaeger, S., Paul, F. and Finke, C.
Multiple Sclerosis Journal 27 (9): 1469-1470. 1 August 2021

The Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence.
Soares-dos-Reis, R., Tsz-Ching, J.L., Kim, S.H., Jacob, A., Whittam, D., Berthelot, E., Paul, F., Nakashima, I., Tye, J.S.N., De Seze, J., Jitprapaikulsan, J., Tan, K., Yang, L., Elsone, L., Leite, M.I., Mealy, M.A., Levy, M., Fan, M., Siebert, N., Asgari, N., Cabre, P., Siritho, S., Pittock, S.J., Wing-Ho, S.C., Senger, T., Yeo, T., Takai, Y., Pandit, L., Kim, H.J. and Palace, J.
Multiple Sclerosis and Related Disorders 53 : 103080. August 2021

Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.
Bernardo-Faura, M., Rinas, M., Wirbel, J., Pertsovskaya, I., Pliaka, V., Messinis, D.E., Vila, G., Sakellaropoulos, T., Faigle, W., Stridh, P., Behrens, J.R., Olsson, T., Martin, R., Paul, F., Alexopoulos, L.G., Villoslada, P. and Saez-Rodriguez, J.
Genome Medicine 13 (1): 117. 16 July 2021

APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies.
Aytulun, A., Cruz-Herranz, A., Aktas, O., Balcer, L.J., Balk, L., Barboni, P., Blanco, A.A., Calabresi, P.A., Costello, F., Sanchez-Dalmau, B., DeBuc, D.C., Feltgen, N., Finger, R.P., Frederiksen, J.L., Frohman, E., Frohman, T., Garway-Heath, D., Gabilondo, I., Graves, J.S., Green, A.J., Hartung, H.P., Havla, J., Holz, F.G., Imitola, J., Kenney, R., Klistorner, A., Knier, B., Korn, T., Kolbe, S., Krämer, J., Lagrèze, W.A., Leocani, L., Maier, O., Martínez-Lapiscina, E.H., Meuth, S., Outteryck, O., Paul, F., Petzold, A., Pihl-Jensen, G., Preiningerova, J.L., Rebolleda, G., Ringelstein, M., Saidha, S., Schippling, S., Schuman, J.S., Sergott, R.C., Toosy, A., Villoslada, P., Wolf, S., Yeh, E.A., Yu-Wai-Man, P., Zimmermann, H.G., Brandt, A.U. and Albrecht, P.
Neurology 97 (2): 68-79. 13 July 2021

Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: data from a nationwide registry in Argentina.
Contentti, E.C., Lopez, P.A., Pettinicchi, J.P., Criniti, J., Pappolla, A., Miguez, J., Patrucco, L., Carnero Contentti, E., Liwacki, S., Tkachuk, V., Balbuena, M.E., Vrech, C., Deri, N., Correale, J., Marrodan, M., Ysrraelit, M.C., Leguizamon, F., Luetic, G., Menichini, M.L., Tavolini, D., Mainella, C., Zanga, G., Burgos, M., Hryb, J., Barboza, A., Lazaro, L., Alonso, R., Liguori, N.F., Nadur, D., Chercoff, A., Alonso Serena, M., Caride, A., Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal Experimental Translational and Clinical 7 (3): 20552173211032334. 1 July 2021

Artificial intelligence extension of the OSCAR-IB criteria.
Petzold, A., Albrecht, P., Balcer, L., Bekkers, E., Brandt, A.U., Calabresi, P.A., Deborah, O.G., Graves, J.S., Green, A., Keane, P.A., Nij Bijvank, J.A., Sander, J.W., Paul, F., Saidha, S., Villoslada, P., Wagner, S.K. and Yeh, E.A.
Annals of Clinical and Translational Neurology 8 (7): 1528-1542. July 2021

Association of a marker of N-acetylglucosamine with progressive multiple sclerosis and neurodegeneration.
Brandt, A.U., Sy, M., Bellmann-Strobl, J., Newton, B.L., Pawling, J., Zimmermann, H.G., Yu, Z., Chien, C., Dörr, J., Wuerfel, J.T., Dennis, J.W., Paul, F. and Demetriou, M.
JAMA Neurology 78 (7): 842-852. July 2021

Fingolimod therapy in multiple sclerosis leads to the enrichment of a subpopulation of aged NK cells.
Schwichtenberg, S.C., Wisgalla, A., Schroeder-Castagno, M., Alvarez-González, C., Schlickeiser, S., Siebert, N., Bellmann-Strobl, J., Wernecke, K.D., Paul, F., Dörr, J. and Infante-Duarte, C.
Neurotherapeutics 18 (3): 1783-1797. July 2021

Foveal changes in aquaporin‐4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive.
Roca-Fernández, A., Oertel, F.C., Yeo, T, Motamedi, S., Probert, F., Craner, M.J., Sastre-Garriga, J., Zimmermann, H.G., Asseyer, S., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Leite, M.I., Paul, F., Brandt, A.U. and Palace, J.
European Journal of Neurology 28 (7): 2280-2293. July 2021

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry.
Ohle, L.M., Ellenberger, D., Flachenecker, P., Friede, T., Haas, J., Hellwig, K., Parciak, T., Warnke, C., Paul, F., Zettl, U.K. and Stahmann, A.
Scientific Reports 11 (1): 13340. 25 June 2021

Distinctive waves of innate immune response in the retina in experimental autoimmune encephalomyelitis.
Cruz-Herranz, A., Oertel, F.C., Kim, K., Cantó, E., Timmons, G., Sin, J.H., Devereux, M., Baker, N., Michel, B., Schubert, R.D., Rani, L., Cordano, C., Baranzini, S.E. and Green, A.J.
JCI Insight 6 (11): e149228. 8 June 2021

Magnetic resonance T1w/T2w ratio in the middle cerebellar peduncle might be a sensitive biomarker for multiple system atrophy.
Sugiyama, A., Yokota, H., Hirano, S., Cooper, G., Mukai, H., Koide, K., Wang, J., Ito, S., Finke, C., Brandt, A.U., Paul, F. and Kuwabara, S.
European Radiology 31 (6): 4277-4284. June 2021

SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients.
Ostendorf, L., Dittert, P., Biesen, R., Duchow, A., Stiglbauer, V., Ruprecht, K., Bellmann-Strobl, J., Seelow, D., Stenzel, W., Niesner, R.A., Hauser, A.E., Paul, F. and Radbruch, H.
Scientific Reports 11 (1): 10299. 13 May 2021

A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.
Solomon, J.M., Paul, F., Chien, C., Oh, J. and Rotstein, D.L.
Therapeutic Advances in Neurological Disorders 14 : 175628642110143. 9 May 2021

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Schindler, P., Grittner, U., Oechtering, J., Leppert, D., Siebert, N., Duchow, A.S., Oertel, F.C., Asseyer, S., Kuchling, J., Zimmermann, H.G., Brandt, A.U., Benkert, P., Reindl, M., Jarius, S., Paul, F., Bellmann-Strobl, J., Kuhle, J. and Ruprecht, K.
Journal of Neuroinflammation 18 (1): 105. 1 May 2021

Accelerating clinical research in neuromyelitis optica spectrum disorders.
Oertel, F.C. and Paul, F.
Clinical and Experimental Neuroimmunology 12 (2): 89-91. May 2021

Development of SARA(home), a new video-based tool for the assessment of ataxia at home.
Grobe-Einsler, M., Taheri Amin, A., Faber, J., Schaprian, T., Jacobi, H., Schmitz-Hübsch, T., Diallo, A., Tezenas du Montcel, S. and Klockgether, T.
Movement Disorders 36 (5): 1242-1246. May 2021

Disability outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Marignier, R., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D., Fujihara, K., Paul, F., Cutter, G.R., Green, A.J., Aktas, O., Hartung, H.P., Lublin, F.D., Williams, I.M., Drappa, J., She, D., Cimbora, D., Rees, W., Smith, M., Ratchford, J.N., Katz, E. and Cree, B.A.C.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e978. May 2021

Epigallocatechin gallate in progressive MS: a randomized, placebo-controlled trial.
Rust, R., Chien, C., Scheel, M., Brandt, A.U., Dörr, J., Wuerfel, J., Klumbies, K., Zimmermann, H., Lorenz, M., Wernecke, K.D., Bellmann-Strobl, J. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e964. May 2021

Epigallocatechin gallate in relapsing-remitting multiple sclerosis: a randomized, placebo-controlled trial.
Bellmann-Strobl, J., Paul, F., Wuerfel, J., Dörr, J., Infante-Duarte, C., Heidrich, E., Körtgen, B., Brandt, A., Pfüller, C., Radbruch, H., Rust, R., Siffrin, V., Aktas, O., Heesen, C., Faiss, J., Hoffmann, F., Lorenz, M., Zimmermann, B., Groppa, S., Wernecke, K.D. and Zipp, F.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e981. May 2021

Inebilizumab in AQP4-Ab-positive neuromyelitis optica spectrum disorder.
Siebert, N., Duchow, A., Paul, F., Infante-Duarte, C. and Bellmann-Strobl, J.
Drugs of Today 57 (5): 321-336. May 2021

Pain, depression and quality of life in adults with MOG-antibody associated disease.
Asseyer, S., Henke, E., Trebst, C., Hümmert, M.W., Wildemann, B., Jarius, S., Ringelstein, M., Aktas, O., Pawlitzki, M., Korsen, M., Klotz, L., Siebert, N., Ruprecht, K., Bellmann-Strobl, J., Wernecke, K.D., Häußler, V., Havla, J., Gahlen, A., Gold, R., Paul, F., Kleiter, I. and Ayzenberg, I.
European Journal of Neurology 28 (5): 1645-1658. May 2021

Pain, depression, and quality of life in neuromyelitis optica spectrum disorder: a cross-sectional study of 166 AQP4 antibody-seropositive patients.
Ayzenberg, I., Richter, D., Henke, E., Asseyer, S., Paul, F., Trebst, C., Hümmert, M.W., Havla, J., Kümpfel, T., Ringelstein, M., Aktas, O., Wildemann, B., Jarius, S., Häußler, V., Stellmann, J.P., Senel, M., Klotz, L., Pellkofer, H.L., Weber, M.S., Pawlitzki, M., Rommer, P.S., Berthele, A., Wernecke, K.D., Hellwig, K., Gold, R. and Kleiter, I.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e985. May 2021

Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker.
Aktas, O., Smith, M.A., Rees, W.A., Bennett, J.L., She, D., Katz, E. and Cree, B.A.C.
Annals of Neurology 89 (5): 895-910. May 2021

Time to diagnosis in multiple sclerosis: epidemiological data from the German Multiple Sclerosis Registry.
Blaschke, S.J., Ellenberger, D., Flachenecker, P., Hellwig, K., Paul, F., Pöhlau, D., Kleinschnitz, C., Rommer, P.S., Rueger, M.A., Zettl, U.K., Stahmann, A. and Warnke, C.
Multiple Sclerosis 28 (6): 865-871. May 2021

Retinal thickness analysis in progressive multiple sclerosis patients treated with epigallocatechin gallate: optical coherence tomography results from the SUPREMES study.
Klumbies, K., Rust, R., Dörr, J., Konietschke, F., Paul, F., Bellmann-Strobl, J., Brandt, A.U. and Zimmermann, H.G.
Frontiers in Neurology 12 : 615790. 28 April 2021

AQP4-IgG autoimmunity in Japan and Germany: differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.
Asseyer, S., Masuda, H., Mori, M., Bellmann-Strobl, J., Ruprecht, K., Siebert, N., Cooper, G., Chien, C., Duchow, A., Schließeit, J., Liu, J., Sugimoto, K., Uzawa, A., Ohtani, R., Paul, F., Brandt, A.U., Kuwabara, S. and Zimmermann, H.G.
Multiple Sclerosis Journal Experimental Translational and Clinical 7 (2): 205521732110068. 1 April 2021

Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.
Liu, J., Mori, M., Zimmermann, H., Brandt, A., Havla, J., Tanaka, S., Sugimoto, K., Oji, S., Uzawa, A., Asseyer, S., Cooper, G., Jarius, S., Bellmann-Strobl, J., Ruprecht, K., Siebert, N., Masuda, H., Uchida, T., Ohtani, R., Nomura, K., Meinl, E., Kuempfel, T., Paul, F. and Kuwabara, S.
Journal of Neurology Neurosurgery and Psychiatry 92 (4): 377-383. April 2021

Differenzialdiagnostik autoimmun-entzündlicher Rückenmarkserkrankungen [Differential diagnostics of autoimmune inflammatory spinal cord diseases].
Oertel, F.C., Scheel, M., Chien, C., Bischof, A., Finke, C. and Paul, F.
Nervenarzt 92 (4): 293-306. April 2021

Neurochemical differences in spinocerebellar ataxia type 14 and 1.
Grosch, A.S., Rinnenthal, J.L., Rönnefarth, M., Lux, S., Scheel, M., Endres, M., Brandt, A.U., Paul, F., Schmitz-Hübsch, T., Minnerop, M. and Doss, S.
Cerebellum 20 (2): 169-178. April 2021

Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult-onset disorder.
Schmitz-Hübsch, T., Lux, S., Bauer, P., Brandt, A.U., Schlapakow, E., Greschus, S., Scheel, M., Gärtner, H., Kirlangic, M.E., Gras, Vi., Timmann, D., Synofzik, M., Giorgetti, A., Carloni, P., Shah, J.N., Schöls, L., Kopp, U., Bußenius, L., Oberwahrenbrock, T., Zimmermann, H., Pfueller, C., Kadas, E.M., Rönnefarth, M., Grosch, A.S., Endres, M., Amunts, K., Paul, F., Doss, S. and Minnerop, M.
Annals of Clinical and Translational Neurology 8 (4): 774-789. April 2021

Anti-aquaporin 4 IgG is not associated with any clinical disease characteristics in Neuromyelitis Optica Spectrum Disorder.
Schmetzer, O., Lakin, E., Roediger, B., Duchow, A., Asseyer, S., Paul, F. and Siebert, N.
Frontiers in Neurology 12 : 635419. 12 March 2021

Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: a longitudinal study.
Papadopoulou, A., Oertel, F.C., Chien, C., Kuchling, J., Zimmermann, H.G., Siebert, N., Motamedi, S., D'Souza, M., Asseyer, S., Bellmann-Strobl, J., Ruprecht, K., Chakravarty, M.M., Scheel, M., Magon, S., Wuerfel, J., Paul, F. and Brandt, A.U.
NeuroImage: Clinical 30 : 102608. 4 March 2021

COVID-19: a simple statistical model for predicting intensive care unit load in exponential phases of the disease.
Ritter, M., Ott, D.V.M., Paul, F., Haynes, J.D. and Ritter, K.
Scientific Reports 11 (1): 5018. 3 March 2021

Effect of nabiximols on goal attainment scale scores in patients with treatment-resistant multiple sclerosis spasticity.
Paul, F. and Silván, C.V.
Neurodegenerative Disease Management 11 (2): 143-153. 1 March 2021

Cultural bias in motor function patterns: potential relevance for predictive, preventive, and personalized medicine.
Otte, K., Ellermeyer, T., Suzuki, M., Röhling, H.M., Kuroiwa, R., Cooper, G., Mansow-Model, S., Mori, M., Zimmermann, H., Brandt, A.U., Paul, F., Hirano, S., Kuwabara, S. and Schmitz-Hübsch, T.
EPMA Journal 12 (1): 91-101. March 2021

Magnetic resonance imaging of multiple sclerosis at 7.0 Tesla.
Waiczies, S., Els, A., Kuchling, J., Markenroth Bloch, K., Pankowska, A., Waiczies, H., Herrmann, C., Chien, C., Finke, C., Paul, F. and Niendorf, T.
Journal of Visualized Experiments (168): e62142. 19 February 2021

Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany - a first analysis of a prospective observational study.
Kedor, C., Freitag, H., Meyer-Arndt, L., Wittke, K., Zoller, t., Steinbeis, F., Haffke, M., Gordon, R., Heidecker, B., Volk, H.D., Skurk, C., Paul, F., Bellmann-Strobl, J. and Scheibenbogen, C.
medRxiv : 2021.02.06.21249256. 8 February 2021

Longitudinal analysis of primary and secondary factors related to fatigue in multiple sclerosis.
Schließeit, J., Oertel, F.C., Cooper, G., Brandt, A.U. and Bellmann-Strobl, J.
Acta Neurologica Belgica 121 (1): 271-274. February 2021

Practical recognition tools of immunoglobulin G serum antibodies against the myelin oligodendrocyte glycoprotein‐positive optic neuritis and its clinical implications.
Lotan, I., Oertel, F.C., Chien, C., Asseyer, S., Paul, F. and Stiebel‐Kalish, H.
Clinical and Experimental Neuroimmunology 12 (1): 42-53. February 2021

Satralizumab in the treatment of neuromyelitis optica spectrum disorder.
Duchow, A. and Bellmann-Strobl, J.
Neurodegenerative Disease Management 11 (1): 49-59. February 2021

The worm-specific immune response in multiple sclerosis patients receiving controlled Trichuris suis ova immunotherapy.
Yordanova, I.A., Ebner, F., Schulz, A.R., Steinfelder, S., Rosche, B., Bolze, A., Paul, F., Mei, H.E. and Hartmann, S.
Life 11 (2): 101. 29 January 2021

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Ostkamp, P., Salmen, A., Pignolet, B., Görlich, D., Andlauer, T.F.M., Schulte-Mecklenbeck, A., Gonzalez-Escamilla, G., Bucciarelli, F., Gennero, I., Breuer, J., Antony, G., Schneider-Hohendorf, T., Mykicki, N., Bayas, A., Then Bergh, F., Bittner, S., Hartung, H.P., Friese, M.A., Linker, R.A., Luessi, F., Lehmann-Horn, K., Mühlau, M., Paul, F., Stangel, M., Tackenberg, B., Tumani, H., Warnke, C., Weber, F., Wildemann, B., Zettl, U.K., Ziemann, U., Müller-Myhsok, B., Kümpfel, T., Klotz, L., Meuth, S.G., Zipp, F., Hemmer, B., Hohlfeld, R., Brassat, D., Gold, R., Gross, C.C., Lukas, C., Groppa, S., Loser, K., Wiendl, H. and Schwab, N.
Proceedings of the National Academy of Sciences of the United States of America 118 (1): e2018457118. 5 January 2021

A novel investigation method for axonal damage in neuromyelitis optica spectrum disorder: In vivo corneal confocal microscopy.
Altıntaş, A., Yildiz-Tas, A., Yilmaz, S., Bayraktutar, B.N., Comert, M.C., Zimmermann, H., Brandt, A.U., Paul, F. and Sahin, A.
Multiple Sclerosis Journal Experimental Translational and Clinical 7 (1): 2055217321998060. 1 January 2021

In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy.
Prinz, C., Starke, L., Millward, J.M., Fillmer, A., Delgado, P.R., Waiczies, H., Pohlmann, A., Rothe, M., Nazaré, M., Paul, F., Niendorf, T. and Waiczies, S.
Theranostics 11 (6): 2490-2504. 1 January 2021

Spinal cord and brain MRI should be routinely performed during follow-up in patients with NMOSD - commentary.
Paul, F.
Multiple Sclerosis Journal 27 (1): 16-18. 1 January 2021

Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry.
Simbrich, A., Thibaut, J., Khil, L., Maximov, S., Wiendl, H. and Berger, K.
Drug Safety 44 (1): 7-15. January 2021

N2 year in review.
Dalmau, J., Dalakas, M.C., Kolson, D.L., Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 8 (1): e925. January 2021

2020

SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of MS patients.
Ostendorf, L., Dittert, P., Biesen, R., Duchow, A., Stiglbauer, V., Ruprecht, K., Seelow, D., Niesner, R.A., Hauser, A.E., Paul, F. and Radbruch, H.
medRxiv : 2020.12.18.20248500. 22 December 2020

N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation.
Sy, M., Brandt, A.U., Lee, S.U., Newton, B. L., Pawling, J., Golzar, A., Rahman, A.A., Yu, Z., Cooper, G., Scheel, M., Paul, F., Dennis, J.W. and Demetriou, M.
Journal of Biological Chemistry 295 (51): 17413-17424. 18 December 2020

New algorithms improving PML risk stratification in MS patients treated with natalizumab.
Toboso, I., Tejeda-Velarde, A., Alvarez-Lafuente, R., Arroyo, R., Hegen, H., Deisenhammer, F., Sainz de la Maza, S., Alvarez-Cermeño, J.C., Izquierdo, G., Paramo, D., Oliva, P., Casanova, B., Agüera-Morales, E., Franciotta, D., Gastaldi, M., Fernández, O., Urbaneja, P., Garcia-Dominguez, J.M., Romero, F., Laroni, A., Uccelli, A., Perez-Sempere, A., Saiz, A., Blanco, Y., Galimberti, D., Scarpini, E., Espejo, C., Montalban, X., Rasche, L., Paul, F., González, I., Álvarez, E., Ramo, C., Caminero, A.B., Aladro, Y., Calles, C., Eguía, P., Belenguer-Benavides, A., Ramió-Torrentà, L., Quintana, E., Martínez-Rodríguez, J.E., Oterino, A., López de Silanes, C., Casanova, L.I., Landete, L., Frederiksen, J., Bsteh, G., Mulero, P., Comabella, M., Hernández, M.A., Espiño, M., Prieto, J.M., Pérez, D., Otano, M., Padilla, F., García-Merino, J.A., Navarro, L., Muriel, A., Frossard, L.C. and Villar, L.M.
Frontiers in Neurology 11 : 579438. 17 December 2020

Quantitative multi-parameter mapping optimized for the clinical routine.
Cooper, G., Hirsch, S., Scheel, M., Brandt, A.U., Paul, F., Finke, C., Boehm-Sturm, P. and Hetzer, S.
Frontiers in Neuroscience 14 : 611194. 7 December 2020

Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
Petrou, P., Kassis, I., Levin, N., Paul, F., Backner, Y., Benoliel, T., Oertel, F.C., Scheel, M., Hallimi, M., Yaghmour, N., Hur, T.B., Ginzberg, A., Levy, Y., Abramsky, O. and Karussis, D.
Brain 143 (12): 3574-3588. December 2020

Treatment of MOG antibody associated disorders: results of an international survey.
Whittam, D.H., Karthikeayan, V., Gibbons, E., Kneen, R., Chandratre, S., Ciccarelli, O., Hacohen, Y., de Seze, J., Deiva, K., Hintzen, R.Q., Wildemann, B., Jarius, S., Kleiter, I., Rostasy, K., Huppke, P., Hemmer, B., Paul, F., Aktas, O., Pröbstel, A.K., Arrambide, G., Tintore, M., Amato, M.P., Nosadini, M., Mancardi, M.M., Capobianco, M., Illes, Z., Siva, A., Altintas, A., Akman-Demir, G., Pandit, L., Apiwattankul, M., Hor, J.Y., Viswanathan, S., Qiu, W., Kim, H.J., Nakashima, I., Fujihara, K., Ramanathan, S., Dale, R.C., Boggild, M., Broadley, S., Lana-Peixoto, M.A., Sato, D.K., Tenembaum, S., Cabre, P., Wingerchuk, D.M., Weinshenker, B.G., Greenberg, B., Matiello, M., Klawiter, E.C., Bennett, J.L., Wallach, A.I., Kister, I., Banwell, B.L., Traboulsee, A., Pohl, D., Palace, J., Leite, M.I., Levy, M., Marignier, R., Solomon, T., Lim, M., Huda, S. and Jacob, A.
Journal of Neurology 367 (12): 3565-3577. December 2020

Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis.
Millward, J.M., Delgado, P.R., Smorodchenko, A., Boehmert, L., Periquito, J., Reimann, H.M., Prinz, C., Els, A., Scheel, M., Bellmann-Strobl, J., Waiczies, H., Wuerfel, J., Infante-Duarte, C., Chien, C., Kuchling, J., Pohlmann, A., Zipp, F., Paul, F., Niendorf, T. and Waiczies, S.
JCI Insight 5 (21): e140040. 5 November 2020

Vascular cognitive impairment in the mouse reshapes visual, spatial network functional connectivity.
Hall, G.R., Boehm-Sturm, P., Dirnagl, U., Finke, C., Foddis, M., Harms, C., Koch, S.P., Kuchling, J., Madan, C.R., Mueller, S., Sassi, C., Sotiropoulos, S.N., Trueman, R.C., Wallis, M., Yildirim, F. and Farr, T.D.
bioRxiv : 2020.11.04.366294. 5 November 2020

Conduction delays in the visual pathways of progressive multiple sclerosis patients covary with brain structure.
Berman, S., Backner, Y., Krupnik, R., Paul, F., Petrou, P., Karussis, D., Levin, N. and Mezer, A.A.
NeuroImage 221 : 117204. 1 November 2020

Aggressive multiple sclerosis - a matter of measurement and timing.
Ellenberger, D., Flachenecker, P., Fneish, F., Frahm, N., Hellwig, K., Paul, F., Stahmann, A., Warnke, C., Rommer, P.S. and Zettl, U.K.
Brain 143 (11): e97. November 2020

Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis.
Meyer-Arndt, L., Hetzer, S., Asseyer, S., Bellmann-Strobl, J., Scheel, M., Stellmann, J.Pa., Heesen, C., Engel, A.K., Brandt, A.U., Haynes, J.D., Paul, F., Gold, S.M. and Weygandt, M.
Neurobiology of Stress 13 : 100244. November 2020

Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration.
Ellenberger, D., Flachenecker, P., Haas, J., Hellwig, K., Paul, F., Stahmann, A., Warnke, C., Zettl, U.K. and Rommer, P.S.
Multiple Sclerosis and Related Disorders 46 : 102485. November 2020

Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders.
Asseyer, S., Kuchling, J., Gaetano, L., Komnenić, D., Siebert, N., Chien, C., Scheel, M., Oertel, F.C., Ruprecht, K., Bellmann-Strobl, J., Finke, C., Chakravarty, M.M., Magon, S., Wuerfel, J., Paul, F., Papadopoulou, A. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 46 : 102579. November 2020

Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).
Specovius, S., Zimmermann, H.G., Oertel, F.C., Chien, C., Bereuter, C., Cook, L.J., Lana Peixoto, M.A., Fontenelle, M.A., Kim, H.J., Hyun, J.W., Jung, S.K., Palace, J., Roca-Fernandez, A., Diaz, A.R., Leite, M.I., Sharma, S.M., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., Dcunha, A., Aktas, O., Ringelstein, M., Albrecht, P., May, E., Tongco, C., Leocani, L., Pisa, M., Radaelli, M., Martinez-Lapiscina, E.H., Stiebel-Kalish, H., Hellmann, M., Lotan, I., Siritho, S., de Seze, J., Senger, T., Havla, J., Marignier, R., Tilikete, C., Cobo Calvo, A., Bichuetti, D.B., Tavares, I.M., Asgari, N., Soelberg, K., Altintas, A., Yildirim, R., Tanriverdi, U., Jacob, A., Huda, S., Rimler, Z., Reid, A., Mao-Draayer, Y., de Castillo, I.S., Yeaman, M.R., Smith, T.J., Brandt, A.U. and Paul, F.
BMJ Open 10 (10): e035397. 29 October 2020

An international standardized magnetic resonance imaging protocol for diagnosis and follow-up of patients with multiple sclerosis.
Saslow, L., Li, D.K.B., Halper, J., Banwell, B., Barkhof, F., Barlow, L., Costello, K., Damiri, P., Dunn, J., Giri, S., Maes, M., Morrow, S.A., Newsome, S.D., Oh, J., Paul, F., Quarterman, P., Reich, D.S., Shewchuk, J.R., Shinohara, R.T., Van Hecke, W., van de Ven, K., Wallin, M.T., Wolinsky, J.S. and Traboulsee, A.
International Journal of MS Care 22 (5): 226-232. 27 October 2020

Neuromyelitis optica.
Jarius, S., Paul, F., Weinshenker, B.G., Levy, M., Kim, H.J. and Wildemann, B.
Nature Reviews Disease Primers 6 (1): 85. 22 October 2020

Altered coupling of psychological relaxation and regional volume of brain reward areas in multiple sclerosis.
Wakonig, K., Eitel, F., Ritter, K., Hetzer, S., Schmitz-Hübsch, T., Bellmann-Strobl, J., Haynes, J.D., Brandt, A.U., Gold, S.M., Paul, F. and Weygandt, M.
Frontiers in Neurology 11 : 568850. 6 October 2020

Instrumental assessment of stepping in place captures clinically relevant motor symptoms of Parkinson's disease.
Otte, K., Ellermeyer, T., Vater, T.S., Voigt, M., Kroneberg, D., Rasche, L., Krüger, T., Röhling, H.M., Kayser, B., Mansow-Model, S., Klostermann, F., Brandt, A.U., Paul, F., Lipp, A. and Schmitz-Hübsch, T.
Sensors 20 (19): 5465. 1 October 2020

A multi-modal virtual reality treadmill intervention for enhancing mobility and cognitive function in people with multiple sclerosis: protocol for a randomized controlled trial.
Hsieh, K.L., Mirelman, A., Shema-Shiratzky, S., Galperin, I., Regev, K., Shen, S., Schmitz-Hübsch, T., Karni, A., Paul, F., Devos, H., Sosnoff, J.J. and Hausdorff, J.M.
Contemporary Clinical Trials 97 : 106122. October 2020

Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders.
Chavarro, V.S., Bellmann-Strobl, J., Zimmermann, H.G., Scheel, M., Chien, C., Oertel, F.C., Weygandt, M., Ruprecht, K., Paul, F., Finke, C. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 45 : 102406. October 2020

Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders: a comparative study.
Schmidt, F.A., Chien, C., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Siebert, N., Asseyer, S., Jarius, S., Brandt, A.U., Scheel, M. and Paul, F.
Frontiers in Neurology 11 : 499910. 30 September 2020

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
Jarius, S., Pellkofer, H., Siebert, N., Korporal-Kuhnke, M., Hümmert, M.W., Ringelstein, M., Rommer, P.S., Ayzenberg, I., Ruprecht, K., Klotz, L., Asgari, N., Zrzavy, T., Höftberger, R., Tobia, R., Buttmann, M., Fechner, K., Schanda, K., Weber, M., Asseyer, S., Haas, J., Lechner, C., Kleiter, I., Aktas, O., Trebst, C., Rostasy, K., Reindl, M., Kümpfel, T., Paul, F. and Wildemann, B.
Journal of Neuroinflammation 17 (1): 261. 3 September 2020

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
Jarius, S., Lechner, C., Wendel, E.M., Baumann, M., Breu, M., Schimmel, M., Karenfort, M., Marina, A.D., Merkenschlager, A., Thiels, C., Blaschek, A., Salandin, M., Leiz, S., Leypoldt, F., Pschibul, A., Hackenberg, A., Hahn, A., Syrbe, S., Strautmanis, J., Häusler, M., Krieg, P., Eisenkölbl, A., Stoffels, J., Eckenweiler, M., Ayzenberg, I., Haas, J., Höftberger, R., Kleiter, I., Korporal-Kuhnke, M., Ringelstein, M., Ruprecht, K., Siebert, N., Schanda, K., Aktas, O., Paul, F., Reindl, M., Wildemann, B. and Rostásy, K.
Journal of Neuroinflammation 17 (1): 262. 3 September 2020

Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.
Motamedi, S., Oertel, F.C., Yadav, S.K., Kadas, E.M., Weise, M., Havla, J., Ringelstein, M., Aktas, O., Albrecht, P., Ruprecht, K., Bellmann-Strobl, J., Zimmermann, H.G., Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 7 (5): e805. September 2020

Current and emerging biologics for the treatment of neuromyelitis optica spectrum disorders.
Duchow, A., Paul, F. and Bellmann-Strobl, J.
Expert Opinion on Biological Therapy 20 (9): 1061-1072. September 2020

Effect of vitamin D supplementation on N-glycan branching and cellular immunophenotypes in MS.
Bäcker-Koduah, P., Infante-Duarte, C., Ivaldi, F., Uccelli, A., Bellmann-Strobl, J., Wernecke, K.D., Sy, M., Demetriou, M., Dörr, J., Paul, F. and Brandt, A.U.
Annals of Clinical and Translational Neurology 7 (9): 1628-1641. September 2020

Emerging drugs for the treatment of neuromyelitis optica.
Duchow, A., Chien, C., Paul, F. and Bellmann-Strobl, J.
Expert Opinion on Emerging Drugs 25 (3): 285-297. September 2020

Genetic determinants of the humoral immune response in MS.
Gasperi, C., Andlauer, T.F.M., Keating, A., Knier, B., Klein, A., Pernpeintner, V., Lichtner, P., Gold, R., Zipp, F., Then Bergh, F., Stangel, M., Tumani, H., Wildemann, B., Wiendl, H., Bayas, A., Kümpfel, T., Zettl, U.K., Linker, R.A., Ziemann, U., Knop, M., Warnke, C., Friese, M.A., Paul, F., Tackenberg, B., Berthele, A. and Hemmer, B.
Neurology Neuroimmunology & Neuroinflammation 7 (5): e827. September 2020

Identifying progression in multiple sclerosis: new perspectives.
Filippi, M., Preziosa, P., Langdon, D., Lassmann, H., Paul, F., Rovira, À., Schoonheim, M.M., Solari, A., Stankoff, B. and Rocca, M.A.
Annals of Neurology 88 (3): 438-452. September 2020

Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.
Juenger, V., Cooper, G., Chien, C., Chikermane, M., Oertel, F.C., Zimmermann, H., Ruprecht, K., Jarius, S., Siebert, N., Kuchling, J., Papadopoulou, A., Asseyer, S., Bellmann-Strobl, J., Paul, F., Brandt, A.U. and Scheel, M.
European Radiology 30 (9): 5048-5058. September 2020

Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients.
Whittam, D.H., Cobo-Calvo, A., Lopez-Chiriboga, A.S., Pardo, S., Gornall, M., Cicconi, S., Brandt, A., Berek, K., Berger, T., Jelcic, I., Gombolay, G., Oliveira, L.M., Callegaro, D., Kaneko, K., Misu, T., Capobianco, M., Gibbons, E., Karthikeayan, V., Brochet, B., Audoin, B., Mathey, G., Laplaud, D., Thouvenot, E., Cohen, M., Tourbah, A., Maillart, E., Ciron, J., Deschamps, R., Biotti, D., Rostasy, K., Neuteboom, R., Hemingway, C., Forsyth, R., Matiello, M., Webb, S., Hunt, D., Murray, K., Hacohen, Y., Lim, M., Leite, M.I., Palace, J., Solomon, T., Lutterotti, A., Fujihara, K., Nakashima, I., Bennett, J.L., Pandit, L., Chitnis, T., Weinshenker, B.G., Wildemann, B., Sato, D.K., Kim, S.H., Huda, S., Kim, H.J., Reindl, M., Levy, M., Jarius, S., Tenembaum, S., Paul, F., Pittock, S., Marignier, R. and Jacob, A.
Multiple Sclerosis and Related Disorders 44 : 102251. September 2020

Sex differences in brain atrophy in multiple sclerosis.
Voskuhl, R.R., Patel, K., Paul, F., Gold, S.M., Scheel, M., Kuchling, J., Cooper, G., Asseyer, S., Chien, C., Brandt, A.U., Meyer, C.E. and MacKenzie-Graham, A.
Biology of Sex Differences 11 (1): 49. 28 August 2020

Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies.
Asseyer, S., Cooper, G. and Paul, F.
Frontiers in Neurology 11 : 778. 21 August 2020

Wisdom of the expert crowd prediction of response for 3 neurology randomized trials.
Atanasov, P., Diamantaras, A., MacPherson, A., Vinarov, E., Benjamin, D.M., Shrier, I., Paul, F., Dirnagl, U. and Kimmelman, J.
Neurology 95 (5): e488-e498. 4 August 2020

Emotional experience in patients with clinically isolated syndrome and early multiple sclerosis.
Hälbig, T.D., Wüstenberg, T., Giess, R.M., Kunte, H., Bellmann-Strobl, J., Ruprecht, K. and Paul, F.
European Journal of Neurology 27 (8): 1537-1545. August 2020

Investigation of visual system involvement in spinocerebellar ataxia type 14.
Ihl, T., Kadas, E.M., Oberwahrenbrock, T., Endres, M., Klockgether, T., Schroeter, J., Brandt, A.U., Paul, F., Minnerop, M., Doss, S., Schmitz-Hübsch, T. and Zimmermann, H.G.
Cerebellum 19 (4): 469-482. August 2020

Harnessing spatial homogeneity of neuroimaging data: patch individual filter layers for CNNs.
Eitel, F., Albrecht, J.P., Weygandt, M., Paul, F. and Ritter, K.
arXiv : 2007.11899. 23 July 2020

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
Abrahamyan, S., Eberspächer, B., Hoshi, M.M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S.G., Schroeder, C., Grüter, T., Tackenberg, B., Paul, F., Then-Bergh, F., Kümpfel, T., Weber, F., Stangel, M., Bayas, A., Wildemann, B., Heesen, C., Zettl, U., Warnke, C., Antony, G., Hessler, N., Wiendl, H., Bittner, S., Hemmer, B., Gold, R., Salmen, A. and Ruprecht, K.
Journal of Neurology Neurosurgery and Psychiatry 91 (7): 681-686. July 2020

Functionally relevant maculopathy and optic atrophy in spinocerebellar ataxia type 1.
Oertel, F.C., Zeitz, O., Rönnefarth, M., Bereuter, C., Motamedi, S., Zimmermann, H.G., Kuchling, J., Grosch, A.S., Doss, S., Browne, A., Paul, F., Schmitz-Hübsch, T. and Brandt, A.U.
Movement Disorders Clinical Practice 7 (5): 502-508. July 2020

Is APOE ε4 associated with cognitive performance in early MS?
Engel, S., Graetz, C., Salmen, A., Muthuraman, M., Toenges, G., Ambrosius, B., Bayas, A., Berthele, A., Heesen, C., Klotz, L., Kümpfel, T., Linker, R.A., Meuth, S.G., Paul, F., Stangel, M., Tackenberg, B., Then Bergh, F., Tumani, H., Weber, F., Wildemann, B., Zettl, U.K., Antony, G., Bittner, S., Groppa, S., Hemmer, B., Wiendl, H., Gold, R., Zipp, F., Lill, C.M. and Luessi, F.
Neurology Neuroimmunology & Neuroinflammation 7 (4): e728. July 2020

Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders.
Chawla, S., Ge, Y., Wuerfel, J., Asadollahi, S., Mohan, S., Paul, F., Sinnecker, T. and Kister, I.
Multiple Sclerosis and Related Disorders 42 : 102066. July 2020

Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide.
Hor, J.Y., Asgari, N., Nakashima, I., Broadley, S.A., Leite, M.I., Kissani, N., Jacob, A., Marignier, R., Weinshenker, B.G., Paul, F., Pittock, S.J., Palace, J., Wingerchuk, D.M., Behne, J.M., Yeaman, M.R. and Fujihara, K.
Frontiers in Neurology 11 : 501. 26 June 2020

Visualizing the central nervous system: imaging tools for multiple sclerosis and neuromyelitis optica spectrum disorders.
Kuchling, J. and Paul, F.
Frontiers in Neurology 11 : 450. 17 June 2020

Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica.
Agasing, A.M., Wu, Q., Khatri, B., Borisow, N., Ruprecht, K., Brandt, A.U., Gawde, S., Kumar, G., Quinn, J.L., Ko, R.M., Mao-Draayer, Y., Lessard, C.J., Paul, F. and Axtell, R.C.
Nature Communications 11 (1): 2856. 5 June 2020

Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study.
Bittner, S., Steffen, F., Uphaus, T., Muthuraman, M., Fleischer, V., Salmen, A., Luessi, F., Berthele, A., Klotz, L., Meuth, S.G., Bayas, A., Paul, F., Hartung, H.P., Linker, R., Heesen, C., Stangel, M., Wildemann, B., Then Bergh, F., Tackenberg, B., Kuempfel, T., Weber, F., Zettl, U.K., Ziemann, U., Tumani, H., Groppa, S., Mühlau, M., Lukas, C., Hemmer, B., Wiendl, H., Gold, R. and Zipp, F.
EBioMedicine 56 : 102807. June 2020

Diagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: results of an international survey.
D'Souza, M., Papadopoulou, A., Levy, M., Jacob, A., Yeaman, M.R., Kümpfel, T., Marignier, R., Paul, F. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 41 : 102027. June 2020

Dysphagia affecting quality of life in cerebellar ataxia - a large survey.
Rönnefarth, M., Hanisch, N., Brandt, A.U., Mähler, A., Endres, M., Paul, F. and Doss, S.
Cerebellum 19 (3): 437-445. June 2020

Lipid mediator profiles predict response to therapy with an oral frankincense extract in relapsing-remitting multiple sclerosis.
Stürner, K.H., Werz, O., Koeberle, A., Otto, M., Pless, O., Leypoldt, F., Paul, F. and Heesen, C.
Scientific Reports 10 (1): 8776. 29 May 2020

SynergyNet: a fusion framework for multiple sclerosis brain MRI segmentation with local refinement.
Vang, Y.S., Cao, Y., Chang, P.D., Chow, D.S., Brandt, A.U., Paul, F., Scheel, M. and Xie, X.
In: 2020 IEEE 17th International Symposium on Biomedical Imaging (ISBI), 3-7 Apr 2020, Iowa City, IA, USA. 22 May 2020

Binding patterns and functional properties of human antibodies to AQP4 and MOG on murine optic nerve and retina.
Faissner, S., Graz, F., Reinehr, S., Petrikowski, L., Haupeltshofer, S., Ceylan, U., Stute, G., Winklmeier, S., Pache, F., Paul, F., Ruprecht, K., Meinl, E., Dick, H.B., Gold, R., Kleiter, I. and Joachim, S.C.
Journal of Neuroimmunology 342 : 577194. 15 May 2020

Cortical topological network changes following optic neuritis.
Backner, Y., Ben-Shalom, I., Kuchling, J., Siebert, N., Scheel, M., Ruprecht, K., Brandt, A., Paul, F. and Levin, N.
Neurology Neuroimmunology & Neuroinflammation 7 (3): e687. May 2020

Impact of treatment on cellular immunophenotype in MS: a cross-sectional study.
Cellerino, M., Ivaldi, F., Pardini, M., Rotta, G., Vila, G., Bäcker-Koduah, P., Berge, T., Laroni, A., Lapucci, C., Novi, G., Boffa, G., Sbragia, E., Palmeri, S., Asseyer, S., Høgestøl, E., Campi, C., Piana, M., Inglese, M., Paul, F., Harbo, H.F., Villoslada, P., Kerlero de Rosbo, N. and Uccelli, A.
Neurology Neuroimmunology & Neuroinflammation 7 (3): e693. May 2020

Prodromal headache in MOG-antibody positive optic neuritis.
Asseyer, S., Hamblin, J., Messina, S., Mariano, R., Siebert, N., Everett, R., Küker, W., Bellmann-Strobl, J., Ruprecht, K., Jarius, S., Leite, M.I., Brandt, A., Paul, F. and Palace, J.
Multiple Sclerosis and Related Disorders 40 : 101965. May 2020

Association between fatigue and motor exertion in patients with multiple sclerosis - a prospective study.
Drebinger, D., Rasche, L., Kroneberg, D., Althoff, P., Bellmann-Strobl, J., Weygandt, M., Paul, F., Brandt, A.U. and Schmitz-Hübsch, T.
Frontiers in Neurology 11 : 208. 15 April 2020

Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study.
Heitmann, H., Haller, B., Tiemann, L., Mühlau, M., Berthele, A., Tölle, T.R., Salmen, A., Ambrosius, B., Bayas, A., Asseyer, S., Hartung, H.P., Heesen, C., Stangel, M., Wildemann, B., Haars, S., Groppa, S., Luessi, F., Kümpfel, T., Nischwitz, S., Meuth, S.G., Klotz, L., Linker, R.A., Zettl, U.K., Ziemann, U., Tumani, H., Tackenberg, B., Zipp, F., Wiendl, H., Gold, R., Hemmer, B. and Ploner, M.
Pain 161 (4): 787-796. April 2020

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Dietrich, M., Koska, V., Hecker, C., Göttle, P., Hilla, A.M., Heskamp, A., Lepka, K., Issberner, A., Hallenberger, A., Baksmeier, C., Steckel, J., Balk, L., Knier, B., Korn, T., Havla, J., Martínez-Lapiscina, E.H., Solà-Valls, N., Manogaran, P., Olbert, E.D., Schippling, S., Cruz-Herranz, A., Yiu, H., Button, J., Caldito, N.G., von Gall, C., Mausberg, A.K., Stettner, M., Zimmermann, H.G., Paul, F., Brandt, A.U., Küry, P., Goebels, N., Aktas, O., Berndt, C., Saidha, S., Green, A.J., Calabresi, P.A., Fischer, D., Hartung, H.P. and Albrecht, P.
Brain 143 (4): 1127-1142. April 2020

Evaluation of the 'ring sign' and the 'core sign' as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis.
Blindenbacher, N., Brunner, E., Asseyer, S., Scheel, M., Siebert, N., Rasche, L., Bellmann-Strobl, J., Brandt, A., Ruprecht, K., Meier, D., Wuerfel, J., Paul, F. and Sinnecker, T.
Multiple Sclerosis Journal Experimental Translational and Clinical 6 (1): 2055217320915480. 30 March 2020

Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.
Albert, C., Mikolajczak, J., Liekfeld, A., Piper, S.K., Scheel, M., Zimmermann, H.G., Nowak, C., Dörr, J., Bellmann-Strobl, J., Chien, C., Brandt, A.U., Paul, F. and Hoffmann, O.
BMC Neurology 20 (1): 75. 3 March 2020

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.
Stork, L., Ellenberger, D., Ruprecht, K., Reindl, M., Beißbarth, T., Friede, T., Kümpfel, T., Gerdes, L.A., Gloth, M., Liman, T., Paul, F., Brück, W. and Metz, I.
Acta Neuropathologica 139 (3): 547-564. March 2020

Vitamin D and disease severity in multiple sclerosis-baseline data from the randomized controlled trial (EVIDIMS).
Bäcker-Koduah, P., Bellmann-Strobl, J., Scheel, M., Wuerfel, J., Wernecke, K.D., Dörr, J., Brandt, A.U. and Paul, F.
Frontiers in Neurology 11 : 129. 25 February 2020

DeepWAS: multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning.
Arloth, J., Eraslan, G., Andlauer, T.F.M., Martins, J., Iurato, S., Kühnel, B., Waldenberger, M., Frank, J., Gold, R., Hemmer, B., Luessi, F., Nischwitz, S., Paul, F., Wiendl, H., Gieger, C., Heilmann-Heimbach, S., Kacprowski, T., Laudes, M., Meitinger, T., Peters, A., Rawal, R., Strauch, K., Lucae, S., Müller-Myhsok, B., Rietschel, M., Theis, F.J., Binder, E.B. and Mueller, N.S.
PLoS Computational Biology 16 (2): e1007616. 3 February 2020

Considerations for mean upper cervical cord area implementation in a longitudinal MRI setting: methods, interrater reliability, and MRI quality control.
Chien, C., Juenger, V., Scheel, M., Brandt, A.U. and Paul, F.
American Journal of Neuroradiology 41 (2): 343-350. 1 February 2020

Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders.
Gkaniatsou, T., Papadopoulou, A., Paul, F., Brandt, A.U. and Oertel, F.C.
Acta Neurologica Belgica 120 (1): 223-225. February 2020

Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
Ringelstein, M., Harmel, J., Zimmermann, H., Brandt, A.U., Paul, F., Haarmann, A., Buttmann, M., Hümmert, M.W., Trebst, C., Schroeder, C., Ayzenberg, I., Kleiter, I., Hellwig, K., Havla, J., Kümpfel, T., Jarius, S., Wildemann, B., Rommer, P., Weber, M.S., Pellkofer, H., Röpke, L., Geis, C., Retzlaff, N., Zettl, U., Deppe, M., Klotz, L., Young, K., Stellmann, J.P., Kaste, M., Kermer, P., Marouf, W., Lauda, F., Tumani, H., Graf, J., Klistorner, A., Hartung, H.P., Aktas, O. and Albrecht, P.
Neurology 94 (4): e407-e418. 28 January 2020

High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial.
Dörr, J., Koduah, P., Wernecke, K.D., Becker, E., Hoffmann, F., Faiss, J., Brockmeier, B., Hoffmann, O., Anvari, K., Wuerfel, J., Piper, S.K., Bellmann-Strobl, J., Brandt, A.U. and Paul, F.
Multiple Sclerosis Journal Experimental Translational and Clinical 6 (1): 2055217320903474. 24 January 2020

Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study.
Bahr, L.S., Bock, M., Liebscher, D., Bellmann-Strobl, J., Franz, L., Prüß, A., Schumann, D., Piper, S.K., Kessler, C.S., Steckhan, N., Michalsen, A., Paul, F. and Mähler, A.
Trials 21 (1): 3. 2 January 2020

Brain iron and metabolic abnormalities in C19orf12 mutation carriers: a 7.0 tesla MRI study in mitochondrial membrane protein-associated neurodegeneration.
Dusek, P., Mekle, R., Skowronska, M., Acosta-Cabronero, J., Huelnhagen, T., Robinson, S.D., Schubert, F., Deschauer, M., Els, A., Ittermann, B., Schottmann, G., Madai, V.I., Paul, F., Klopstock, T., Kmiec, T., Niendorf, T., Wuerfel, J. and Schneider, S.A.
Movement Disorders 35 (1): 142-150. January 2020

N2 year in review.
Dalmau, J., Dalakas, M.C., Kolson, D.L., Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 7 (1): e644. January 2020

Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations.
Malla, B., Cotten, S., Ulshoefer, R., Paul, F., Hauser, A.E., Niesner, R., Bros, H. and Infante-Duarte, C.
Therapeutic Advances in Chronic Disease 11 : 1-14. 2020

Transdiagnostic hippocampal damage patterns in neuroimmunological disorders.
Heine, J., Prüß, H., Scheel, M., Brandt, A.U., Gold, S.M., Bartsch, T., Paul, F. and Finke, C.
NeuroImage: Clinical 28 : 102515. 2020

2019

Multi-parameter immune profiling of peripheral blood mononuclear cells by multiplexed single-cell mass cytometry in patients with early multiple sclerosis.
Böttcher, C., Fernández-Zapata, C., Schlickeiser, S., Kunkel, D., Schulz, A.R., Mei, H.E., Weidinger, C., Gieß, R.M., Asseyer, S., Siegmund, B., Paul, F., Ruprecht, K. and Priller, J.
Scientific Reports 9 (1): 19471. 19 December 2019

Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose : aktueller Stand und Empfehlungen in Deutschland [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : current status and recommendations in Germany].
Bittner, S., Engel, S., Lange, C., Weber, M.S., Haghikia, A., Luessi, F., Korn, T., Klotz, L., Bayas, A., Paul, F., Heesen, C., Stangel, M., Wildemann, B., Bergh, F.T., Tackenberg, B., Trebst, C., Warnke, C., Linker, R., Kerschensteiner, M., Zettl, U., Tumani, H., Brück, W., Meuth, S.G., Kümpfel, T., Hemmer, B., Wiendl, H., Gold, R. and Zipp, F.
Nervenarzt 90 (12): 1245-1253. December 2019

Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis.
Sinnecker, T., Clarke, M.A., Meier, D., Enzinger, C., Calabrese, M., De Stefano, N., Pitiot, A., Giorgio, A., Schoonheim, M.M., Paul, F., Pawlak, M.A., Schmidt, R., Kappos, L., Montalban, X., Rovira, À., Evangelou, N. and Wuerfel, J.
JAMA Neurology 76 (12): 1446-1456. December 2019

Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
Chien, C., Scheel, M., Schmitz-Hübsch, T., Borisow, N., Ruprecht, K., Bellmann-Strobl, J., Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 25 (14): 1926-1936. December 2019

Suggestions for improving the design of clinical trials in multiple sclerosis - results of a systematic analysis of completed phase III trials.
Gehr, S., Kaiser, T., Kreutz, R., Ludwig, W.D. and Paul, F.
EPMA Journal 10 (4): 425-436. December 2019

Low-density granulocytes are a novel immunopathological feature in both multiple sclerosis and neuromyelitis optica spectrum disorder.
Ostendorf, L., Mothes, R., van Koppen, S., Lindquist, R.L., Bellmann-Strobl, J., Asseyer, S., Ruprecht, K., Alexander, T., Niesner, R.A., Hauser, A.E., Paul, F. and Radbruch, H.
Frontiers in Immunology 10 : 2725. 29 November 2019

Contactless recording of sleep apnea and periodic leg movements by nocturnal 3-D-video and subsequent visual perceptive computing.
Veauthier, C., Ryczewski, J., Mansow-Model, S., Otte, K., Kayser, B., Glos, M., Schöbel, C., Paul, F., Brandt, A.U. and Penzel, T.
Scientific Reports 9 (1): 16812. 14 November 2019

Normative data and minimally detectable change for inner retinal layer thicknesses using a semi-automated OCT image segmentation pipeline.
Motamedi, S., Gawlik, K., Ayadi, N., Zimmermann, H.G., Asseyer, S., Bereuter, C., Mikolajczak, J., Paul, F., Kadas, E.M. and Brandt, A.U.
Frontiers in Neurology 10 : 1117. November 2019

Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study.
Chien, C., Oertel, F.C., Siebert, N., Zimmermann, H., Asseyer, S., Kuchling, J., Scheel, M., Ruprecht, K., Bellmann-Strobl, J., Paul, F. and Brandt, A.U.
Brain Communications 1 (1): fcz026. 16 October 2019

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Cree, B.A.C., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D.M., Fujihara, K., Paul, F., Cutter, G.R., Marignier, R., Green, A.J., Aktas, O., Hartung, H.P., Lublin, F.D., Drappa, J., Barron, G., Madani, S., Ratchford, J.N., She, D., Cimbora, D. and Katz, E.
Lancet 394 (10206): 1352-1363. 12 October 2019

Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
Pfuhl, C., Grittner, U., Gieß, R.M., Scheel, M., Behrens, J.R., Rasche, L., Pache, F.C., Wenzel, R., Brandt, A.U., Bellmann-Strobl, J., Paul, F., Ruprecht, K. and Oechtering, J.
Neurology 93 (15): e1439-e1451. 8 October 2019

Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.
Papadopoulou, A., Oertel, F.C., Gaetano, L., Kuchling, J., Zimmermann, H., Chien, C., Siebert, N., Asseyer, S., Bellmann-Strobl, J., Ruprecht, K., Chakravarty, M.M., Scheel, M., Magon, S., Wuerfel, J., Paul, F. and Brandt, A.U.
Journal of Neurology Neurosurgery and Psychiatry 90 (10): 1156-1164. October 2019

Increased retention of gadolinium in the inflamed brain after repeated administration of gadopentetate dimeglumine: a proof-of-concept study in mice combining ICP-MS and micro- and nano-SR-XRF.
Wang, S., Hesse, B., Roman, M., Stier, D., Castillo-Michel, H., Cotte, M., Suuronen, J.P., Lagrange, A., Radbruch, H., Paul, F., Taupitz, M., Schellenberger, E., Sack, I. and Infante-Duarte, C.
Investigative Radiology 54 (10): 617-626. October 2019

Uncovering convolutional neural network decisions for diagnosing multiple sclerosis on conventional MRI using layer-wise relevance propagation.
Eitel, F., Soehler, E., Bellmann-Strobl, J., Brandt, A.U., Ruprecht, K., Giess, R.M., Kuchling, J., Asseyer, S., Weygandt, M., Haynes, J.D., Scheel, M., Paul, F. and Ritter, K.
NeuroImage: Clinical 24 : 102003. 6 September 2019

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.
Cook, L.J., Rose, J.W., Alvey, J.S., Jolley, A.M., Kuhn, R., Marron, B., Pederson, M., Enriquez, R., Yearley, J., McKechnie, S., Han, M.H., Tomczak, A.J., Levy, M., Mealy, M.A., Coleman, J., Bennett, J.L., Johnson, R., Barnes-Garcia, M., Traboulsee, A.L., Carruthers, R.L., Lee, L.E., Schubert, J.J., McMullen, K., Kister, I., Rimler, Z., Reid, A., Sicotte, N.L., Planchon, S.M., Cohen, J.A., Ivancic, D., Sedlak, J.L., Sand, I.K., Repovic, P., Amezcua, L., Pruitt, A., Amundson, E., Chitnis, T., Mullin, D.S., Klawiter, E.C., Russo, A.W., Riley, C.S., Onomichi, K.B., Levine, L., Nelson, K.E., Nealon, N.M., Engel, C., Kruse-Hoyer, M., Marcille, M., Tornes, L., Rumpf, A., Greer, A., Kenneally Behne, M., Rodriguez, R.R., Behne, D.W., Blackway, D.W., Coords, B., Blaschke, T.F., Sheard, J., Smith, T.J., Behne, J.M. and Yeaman, M.R.
Neurology Neuroimmunology & Neuroinflammation 6 (5): e583. September 2019

The use of magnetic resonance imaging in the diagnosis of paediatric transverse myelitis.
Paul, F.
Developmental Medicine and Child Neurology 61 (9): 1001. September 2019

Neural mechanisms of perceptual decision-making and their link to neuropsychiatric symptoms in multiple sclerosis.
Weygandt, M., Behrens, J., Brasanac, J., Söder, E., Meyer-Arndt, L., Wakonig, K., Ritter, K., Brandt, A.U., Bellmann-Strobl, J., Gold, S.M., Haynes, J.D. and Paul, F.
Multiple Sclerosis and Related Disorders 33 : 139-145. August 2019

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.
Levin, J., Maaß, S., Schuberth, M., Giese, A., Oertel, W.H., Poewe, W., Trenkwalder, C., Wenning, G.K., Mansmann, U., Südmeyer, M., Eggert, K., Mollenhauer, B., Lipp, A., Löhle, M., Classen, J., Münchau, A., Kassubek, J., Gandor, F., Berg, D., Egert-Schwender, S., Eberhardt, C., Paul, F., Bötzel, K., Ertl-Wagner, B., Huppertz, H.J., Ricard, I. and Höglinger, G.U.
Lancet Neurology 18 (8): 724-735. August 2019

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study.
Oertel, F.C., Outteryck, O., Knier, B., Zimmermann, H., Borisow, N., Bellmann-Strobl, J., Blaschek, A., Jarius, S., Reindl, M., Ruprecht, K., Meinl, E., Hohlfeld, R., Paul, F., Brandt, A.U., Kümpfel, T. and Havla, J.
Journal of Neuroinflammation 16 (1): 154. 25 July 2019

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study.
Balk, L.J., Coric, D., Knier, B., Zimmermann, H.G., Behbehani, R., Alroughani, R., Martinez-Lapiscina, E.H., Brandt, A.U., Sánchez-Dalmau, B., Vidal-Jordana, A., Albrecht, P., Koska, V., Havla, J., Pisa, M., Nolan, R.C., Leocani, L., Paul, F., Aktas, O., Montalban, X., Balcer, L.J., Villoslada, P., Outteryck, O., Korn, T. and Petzold, A.
Multiple Sclerosis Journal Experimental Translational and Clinical 5 (3): 2055217319871582. 1 July 2019

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
Filippi, M., Preziosa, P., Banwell, B.L., Barkhof, F., Ciccarelli, O., De Stefano, N., Geurts, J.J.G., Paul, F., Reich, D.S., Toosy, A.T., Traboulsee, A., Wattjes, M.P., Yousry, T.A., Gass, A., Lubetzki, C., Weinshenker, B.G. and Rocca, M.A.
Brain 142 (7): 1858-1875. July 2019

Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
Stiebel-Kalish, H., Hellmann, M.A., Mimouni, M., Paul, F., Bialer, O., Bach, M. and Lotan, I.
Neurology Neuroimmunology & Neuroinflammation 6 (4): e572. July 2019

Cognitive impairment in neuromyelitis optica spectrum disorders: a review of clinical and neuroradiological features.
Oertel, F.C., Schließeit, J., Brandt, A.U. and Paul, F.
Frontiers in Neurology 10 : 608. 12 June 2019

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
Klehmet, J., Beutner, S., Hoffmann, S., Dornauer, M., Paul, F., Reilmann, R., Brandt, A.U. and Meisel, A.
BMC Neurology 19 (1): 118. 8 June 2019

Damage of the lateral geniculate nucleus in MS: assessing the missing node of the visual pathway.
Papadopoulou, A., Gaetano, L., Pfister, A., Altermatt, A., Tsagkas, C., Morency, F., Brandt, A.U., Hardmeier, M., Chakravarty, M.M., Descoteaux, M., Kappos, L., Sprenger, T. and Magon, S.
Neurology 92 (19): e2240-e2249. 7 May 2019

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.
Kotelnikova, E., Kiani, N.A., Messinis, D., Pertsovskaya, I., Pliaka, V., Bernardo-Faura, M., Rinas, M., Vila, G., Zubizarreta, I., Pulido-Valdeolivas, I., Sakellaropoulos, T., Faigle, W., Silberberg, G., Masso, M., Stridh, P., Behrens, J., Olsson, T., Martin, R., Paul, F., Alexopoulos, L.G., Saez-Rodriguez, J., Tegner, J. and Villoslada, P.
Proceedings of the National Academy of Sciences of the United States of America 116 (19): 9671-9676. 7 May 2019

Olfactory and gustatory dysfunction in patients with autoimmune encephalitis.
Geran, R., Uecker, F.C., Prüss, H., Haeusler, K.G., Paul, F., Ruprecht, K., Harms, L. and Schmidt, F.A.
Frontiers in Neurology 10 : 480. May 2019

Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: an international study.
Nolan, R.C., Liu, M., Akhand, O., Calabresi, P.A., Paul, F., Petzold, A., Balk, L., Brandt, A.U., Martínez-Lapiscina, E.H., Saidha, S., Villoslada, P., Abu Al-Hassan, A., Behbehani, R., Frohman, E.M., Frohman, T., Havla, J., Hemmer, B., Jiang, H., Knier, B., Korn, T., Leocani, L., Papadopoulou, A., Pisa, M., Zimmermann, H., Galetta, S.L. and Balcer, L.J.
Annals of Neurology 85 (5): 618-629. May 2019

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.
Pasquier, B., Borisow, N., Rasche, L., Bellmann-Strobl, J., Ruprecht, K., Niendorf, T., Derfuss, T.J., Wuerfel, J., Paul, F. and Sinnecker, T.
Neurology Neuroimmunology & Neuroinflammation 6 (3): e541. May 2019

Vision and vision-related measures in progressive multiple sclerosis.
Backner, Y., Petrou, P., Glick-Shames, H., Raz, N., Zimmermann, H., Jost, R., Scheel, M., Paul, F., Karussis, D. and Levin, N.
Frontiers in Neurology 10 : 455. May 2019

Association of intrathecal immunoglobulin G synthesis with disability worsening in multiple sclerosis.
Gasperi, C., Salmen, A., Antony, G., Bayas, A., Heesen, C., Kümpfel, T., Linker, R.A., Paul, F., Stangel, M., Tackenberg, B., Bergh, F.T., Warnke, C., Weber, F., Wiendl, H., Wildemann, B., Zettl, U.K., Ziemann, U., Zipp, F., Tumani, H., Gold, R. and Hemmer, B.
JAMA Neurology 76 (7): 841-849. 29 April 2019

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.
Graetz, C., Gröger, A., Luessi, F., Salmen, A., Zöller, D., Schultz, J., Siller, N., Fleischer, V., Bellenberg, B., Berthele, A., Biberacher, V., Havla, J., Hecker, M., Hohlfeld, R., Infante-Duarte, C., Kirschke, J.S., Kümpfel, T., Linker, R., Paul, F., Pfeuffer, S., Sämann, P., Toenges, G., Weber, F., Zettl, U.K., Jahn-Eimermacher, A., Antony, G., Groppa, S., Wiendl, H., Hemmer, B., Mühlau, M., Lukas, C., Gold, R., Lill, C.M. and Zipp, F.
Multiple Sclerosis Journal 25 (5): 661-668. 1 April 2019

Multiple sclerosis-related fatigue: altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex.
Jaeger, S., Paul, F., Scheel, M., Brandt, A., Heine, J., Pach, D., Witt, C.M., Bellmann-Strobl, J. and Finke, C.
Multiple Sclerosis Journal 25 (4): 554-564. April 2019

Standardization of T1w/T2w ratio improves detection of tissue damage in multiple sclerosis.
Cooper, G., Finke, C., Chien, C., Brandt, A.U., Asseyer, S., Ruprecht, K., Bellmann-Strobl, J., Paul, F. and Scheel, M.
Frontiers in Neurology 10 : 334. April 2019

Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
Olesen, M.N., Soelberg, K., Debrabant, B., Nilsson, A.C., Lillevang, S.T., Grauslund, J., Brandslund, I., Madsen, J.S., Paul, F., Smith, T.J., Jarius, S. and Asgari, N.
Journal of Neuroinflammation 16 (1): 59. 11 March 2019

Sex differences in autoimmune disorders of the central nervous system.
Gold, S.M., Willing, A., Leypoldt, F., Paul, F. and Friese, M.A.
Seminars in Immunopathology 41 (2): 177-188. March 2019

Myelinoclastic diffuse sclerosis (Schilder's disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures.
Jarius, S., Haas, J., Paul, F. and Wildemann, B.
Journal of Neuroinflammation 16 (1): 51. 28 February 2019

Automatic quality evaluation as assessment standard for optical coherence tomography.
Kauer, J., Gawlik, K., Zimmermann, H.G., Kadas, E.M., Bereuter, C., Paul, F., Brandt, A.U., Hausser, F. and Beckers, I.
In: SPIE BiOS 2019, 2-7 Feb 2019, San Francisco, United States. 26 February 2019

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).
Johnen, A., Bürkner, P.C., Landmeyer, N.C., Ambrosius, B., Calabrese, P., Motte, J., Hessler, N., Antony, G., König, I.R., Klotz, L., Hoshi, M.M., Aly, L., Groppa, S., Luessi, F., Paul, F., Tackenberg, B., Bergh, F.T., Kümpfel, T., Tumani, H., Stangel, M., Weber, F., Bayas, A., Wildemann, B., Heesen, C., Zettl, U.K., Zipp, F., Hemmer, B., Meuth, S.G., Gold, R., Wiendl, H. and Salmen, A.
Journal of Neurology 266 (2): 386-397. February 2019

Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
Mealy, M.A., Mossburg, S.E., Kim, S.H., Messina, S., Borisow, N., Lopez-Gonzalez, R., Ospina, J.P., Scheel, M., Yeshokumar, A.K., Awad, A., Leite, M.I., Arango, J.A.J., Paul, F., Palace, J., Kim, H.J. and Levy, M.
Multiple Sclerosis and Related Disorders 28 : 64-68. February 2019

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.
Ciccarelli, O., Cohen, J.A., Reingold, S.C. and Weinshenker, B.G.
Lancet Neurology 18 (2): 185-197. February 2019

Less is more - estimation of the number of strides required to assess gait variability in spatially confined settings.
Kroneberg, D., Elshehabi, M., Meyer, A.C., Otte, K., Doss, S., Paul, F., Nussbaum, S., Berg, D., Kühn, A.A., Maetzler, W. and Schmitz-Hübsch, T.
Frontiers in Aging Neuroscience 10 : 435. 21 January 2019

Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation.
Starossom, S.C., Campo Garcia, J., Woelfle, T., Romero-Suarez, S., Olah, M., Watanabe, F., Cao, L., Yeste, A., Tukker, J.J., Quintana, F.J., Imitola, J., Witzel, F., Schmitz, D., Morkel, M., Paul, F., Infante-Duarte, C. and Khoury, S.J.
Nature Communications 10 (1): 217. 15 January 2019

Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis.
Oertel, F.C., Zimmermann, H.G., Brandt, A.U. and Paul, F.
Expert Review of Neurotherapeutics 19 (1): 31-43. 2 January 2019

Gadolinium in human brain sections and colocalization with other elements.
El-Khatib, A.H., Radbruch, H., Trog, S., Neumann, B., Paul, F., Koch, A., Linscheid, M.W., Jakubowski, N. and Schellenberger, E.
Neurology Neuroimmunology & Neuroinflammation 6 (1): e515. January 2019

N2 year in review and message from the editor to our reviewers.
Dalmau, J., Kolson, D.L., Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 6 (1): e525. January 2019

Flammer syndrome and autoimmune inflammatory conditions of the central nervous system: multifactorial interrelations.
Paul, F.
Advances in Predictive, Preventive and Personalised Medicine 11 : 145-163. 2019

Multiple sclerosis.
Veauthier, C. and Paul, F.
In: Handbook of Sleep Disorders in Medical Conditions. Elsevier / Academic Press, 345-369. ISBN 978-0-12-813014-8 2019

2018

Leptomeningeal and intraparenchymal blood barrier disruption in a MOG-IgG-positive patient.
Mohseni, S.H., Skejoe, H.P.B., Wuerfel, J., Paul, F., Reindl, M., Jarius, S. and Asgari, N.
Case Reports in Neurological Medicine 2018 : 1365175. 9 December 2018

Active contour method for ILM segmentation in ONH volume scans in retinal OCT.
Gawlik, K., Hausser, F., Paul, F., Brandt, A.U. and Kadas, E.M.
Biomedical Optics Express 9 (12): 6497. 1 December 2018

CSF-progranulin and neurofilament light chain levels in patients with radiologically isolated syndrome - sign of inflammation.
Pawlitzki, M., Sweeney-Reed, C.M., Bittner, D., Lux, A., Vielhaber, S., Schreiber, S., Paul, F. and Neumann, J.
Frontiers in Neurology 9 : 1075. December 2018

MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].
Jarius, S., Paul, F., Aktas, O., Asgari, N., Dale, R.C., de Seze, J., Franciotta, D., Fujihara, K., Jacob, A., Kim, H.J., Kleiter, I., Kümpfel, T., Levy, M., Palace, J., Ruprecht, K., Saiz, A., Trebst, C., Weinshenker, B.G. and Wildemann, B.
Nervenarzt 89 (12): 1388-1399. December 2018

Optical coherence tomography in acute optic neuritis: a population-based study.
Soelberg, K., Specovius, S., Zimmermann, H.G., Grauslund, J., Mehlsen, J.J., Olesen, C., Neve, A.S.B., Paul, F., Brandt, A.U. and Asgari, N.
Acta Neurologica Scandinavica 138 (6): 566-573. December 2018

Ozanimod for the treatment of relapsing remitting multiple sclerosis.
Rasche, L. and Paul, F.
Expert Opinion on Pharmacotherapy 19 (18): 2073-2086. December 2018

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.
Oertel, F.C., Havla, J., Roca-Fernández, A., Lizak, N., Zimmermann, H., Motamedi, S., Borisow, N., White, O.B., Bellmann-Strobl, J., Albrecht, P., Ruprecht, K., Jarius, S., Palace, J., Leite, M.I., Kuempfel, T., Paul, F. and Brandt, A.U.
Journal of Neurology Neurosurgery and Psychiatry 89 (12): 1259-1265. December 2018

The International Multiple Sclerosis Visual System Consortium: advancing visual system research in multiple sclerosis.
Balcer, L.J., Balk, L.J., Brandt, A.U., Calabresi, P.A., Martinez-Lapiscina, E.H., Nolan, R.C., Paul, F., Petzold, A. and Saidha, S.
Journal of Neuro-Ophthalmology 38 (4): 494-501. December 2018

Low-frequency and rare-coding variation contributes to multiple sclerosis risk.
Cotsapas, C.
Cell 175 (6): 1679-1687. 29 November 2018

Racial differences in neuromyelitis optica spectrum disorder.
Kim, S.H., Mealy, M.A., Levy, M., Schmidt, F., Ruprecht, K., Paul, F., Ringelstein, M., Aktas, O., Hartung, H.P., Asgari, N., Tsz-Ching, J.L., Siritho, S., Prayoonwiwat, N., Shin, H.J., Hyun, J.W., Han, M., Leite, M.I., Palace, J. and Kim, H.J.
Neurology 91 (22): e2089-e2099. 27 November 2018

Optische Kohärenztomografie bei Erkrankungen des zentralen Nervensystems [Optical coherence tomography in disorders of the central nervous system].
Papadopoulou, A., Oertel, F.C., Zimmermann, H., Zeitz, O., Brandt, A.U. and Paul, F.
Klinische Monatsblaetter fuer Augenheilkunde 235 (11): 1242-1258. 20 November 2018

Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders.
Mealy, M.A., Kim, S.H., Schmidt, F., López, R., Jimenez Arango, J.A., Paul, F., Wingerchuk, D.M., Greenberg, B.M., Kim, H.Jin. and Levy, M.
Multiple Sclerosis Journal 24 (13): 1737-1742. 1 November 2018

Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions.
Kleiter, I., Gahlen, A., Borisow, N., Fischer, K., Wernecke, K.D., Hellwig, K., Pache, F., Ruprecht, K., Havla, J., Kümpfel, T., Aktas, O., Hartung, H.P., Ringelstein, M., Geis, C., Kleinschnitz, C., Berthele, A., Hemmer, B., Angstwurm, K., Stellmann, J.P., Schuster, S., Stangel, M., Lauda, F., Tumani, H., Mayer, C., Krumbholz, M., Zeltner, L., Ziemann, U., Linker, R., Schwab, M., Marziniak, M., Then Bergh, F., Hofstadt-van Oy, U., Neuhaus, O., Zettl, U.K., Faiss, J., Wildemann, B., Paul, F., Jarius, S. and Trebst, C.
Neurology Neuroimmunology & Neuroinflammation 5 (6): e504. November 2018

Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis.
Heine, J., Prüss, H., Kopp, U.A., Wegner, F., Then Bergh, F., Münte, T., Wandinger, K.P., Paul, F., Bartsch, T. and Finke, C.
Journal of Neurology Neurosurgery and Psychiatry 89 (11): 1191-1199. November 2018

Metabolic, mental and immunological effects of normoxic and hypoxic training in multiple sclerosis patients: a pilot study.
Mähler, A., Balogh, A., Csizmadia, I., Klug, L., Kleinewietfeld, M., Steiniger, J., Šušnjar, U., Müller, D.N., Boschmann, M. and Paul, F.
Frontiers in Immunology 9 : 2819. November 2018

Pro-inflammatory monocyte phenotype and cell-specific steroid signaling alterations in unmedicated patients with major depressive disorder.
Hasselmann, H., Gamradt, S., Taenzer, A., Nowacki, J., Zain, R., Patas, K., Ramien, C., Paul, F., Wingenfeld, K., Piber, D., Gold, S.M. and Otte, C.
Frontiers in Immunology 9 : 2693. November 2018

Venoplasty in MS: therapeutic intervention without any evidence.
Paul, F. and Wattjes, M.P.
Neurology 91 (18): 815-816. 30 October 2018

The first night effect in multiple sclerosis patients undergoing home-based polysomnography.
Veauthier, C., Piper, S.K., Gaede, G., Penzel, T. and Paul, F.
Nature and Science of Sleep 10 : 337-344. 23 October 2018

Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis.
Borisow, N., Mori, M., Kuwabara, S., Scheel, M. and Paul, F.
Frontiers in Neurology 9 : 888. October 2018

Disease modification in multiple sclerosis by flupirtine - results of a randomized placebo controlled phase II trial.
Dörr, J., Wernecke, K.D., Würfel, J., Bellmann-Strobl, J., Siffrin, V., Sättler, M.B., Simons, M., Linsa, A., Tumani, H. and Paul, F.
Frontiers in Neurology 9 : 842. October 2018

MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder.
Narayan, R., Simpson, A., Fritsche, K., Salama, S., Pardo, S., Mealy, M., Paul, F. and Levy, M.
Multiple Sclerosis and Related Disorders 25 : 66-72. October 2018

Optic nerve head three-dimensional shape analysis.
Yadav, S.K., Kadas, E.M., Motamedi, S., Polthier, K., Haußer, F., Gawlik, K., Paul, F. and Brandt, A.
Journal of Biomedical Optics 23 (10): 106004. October 2018

Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging.
Chawla, S., Kister, I., Sinnecker, T., Wuerfel, J., Brisset, J.C., Paul, F. and Ge, Y.
PLoS ONE 13 (9): e0202918. 13 September 2018

Temporal visual resolution and disease severity in MS.
Ayadi, N., Dörr, J., Motamedi, S., Gawlik, K., Bellmann-Strobl, J., Mikolajczak, J., Brandt, A.U., Zimmermann, H. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 5 (5): e492. 1 September 2018

VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab.
Pawlitzki, M., Teuber, J., Campe, C., Wagner, M., Schuart, C., Paul, F. and Bittner, D.
Neurology Neuroimmunology & Neuroinflammation 5 (5): e475. 1 September 2018

Association of retinal ganglion cell layer thickness with future disease activity in patients with clinically isolated syndrome.
Zimmermann, H.G., Knier, B., Oberwahrenbrock, T., Behrens, J., Pfuhl, C., Aly, L., Kaminski, M., Hoshi, M.M., Specovius, S., Giess, R.M., Scheel, M., Mühlau, M., Bellmann-Strobl, J., Ruprecht, K., Hemmer, B., Korn, T., Paul, F. and Brandt, A.U.
JAMA Neurology 75 (9): 1071-1079. September 2018

Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies.
Borisow, N., Hellwig, K. and Paul, F.
EPMA Journal 9 (3): 249-256. September 2018

Objective assessment of a relative afferent pupillary defect by B-mode ultrasound.
Schmidt, F.A., Connolly, F., Maas, M.B., Grittner, U., Harms, L., Brandt, A., Paul, F., Schreiber, S. and Ruprecht, K.
PLoS ONE 13 (8): e0202774. 27 August 2018

Brain activity, regional gray matter loss, and decision-making in multiple sclerosis.
Weygandt, M., Wakonig, K., Behrens, J., Meyer-Arndt, L., Söder, E., Brandt, A.U., Bellmann-Strobl, J., Ruprecht, K., Gold, S.M., Haynes, J.D. and Paul, F.
Multiple Sclerosis Journal 24 (9): 1163-1173. 1 August 2018

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.
Behrens, J.R., Wanner, J., Kuchling, J., Ostendorf, L., Harms, L., Ruprecht, K., Niendorf, T., Jarius, S., Wildemann, B., Gieß, R.M., Scheel, M., Bellmann-Strobl, J., Wuerfel, J., Paul, F. and Sinnecker, T.
Annals of Clinical and Translational Neurology 5 (8): 900-912. August 2018

MRI markers and functional performance in patients with CIS and MS: a cross-sectional study.
Rasche, L., Scheel, M., Otte, K., Althoff, P., van Vuuren, A.B., Gieß, R.M., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Paul, F., Brandt, A.U. and Schmitz-Hübsch, T.
Frontiers in Neurology 9 : 718. August 2018

Warum die Deutsche Gesellschaft für Neurologie einen industrieunabhängigen Kongress braucht [Why German neurology needs an annual meeting without industry sponsorship].
Lempert, T., Janzen, R., Diehl, R., Stark, E., Paul, F., Wilke, C., Tavakolian, R., Völzke, E., von Brevern, M. and Möller, P.
Aktuelle Neurologie 45 (6): 429-433. August 2018

MRI-based methods for spinal cord atrophy evaluation: a comparison of cervical cord cross-sectional area, cervical cord volume, and full spinal cord volume in patients with aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.
Chien, C., Brandt, A.U., Schmidt, F., Bellmann-Strobl, J., Ruprecht, K., Paul, F. and Scheel, M.
American Journal of Neuroradiology 39 (7): 1362-1368. 1 July 2018

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders.
Asseyer, S., Schmidt, F., Chien, C., Scheel, M., Ruprecht, K., Bellmann-Strobl, J., Brandt, A.U. and Paul, F.
Multiple Sclerosis Journal Experimental Translational and Clinical 4 (3): 2055217318796684. 1 July 2018

Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder.
Mealy, M.A., Cook, L.J., Pache, F., Velez, D.L., Borisow, N., Becker, D., Jimenez Arango, J.A., Paul, F. and Levy, M.
Multiple Sclerosis and Related Disorders 23 : 78-82. July 2018

Neuromyelitis-optica-Spektrum-Erkrankung und Schwangerschaft [Neuromyelitis optica spectrum disorder and pregnancy].
Borisow, N., Hellwig, K. and Paul, F.
Nervenarzt 89 (6): 666-673. June 2018

The effectiveness of acupuncture and mindfulness-based stress reduction (MBSR) for patients with multiple sclerosis associated fatigue: a study protocol and its rationale for a randomized controlled trial.
Bellmann-Strobl, J., Pach, D., Chang, Y., Pasura, L., Liu, B., Jäger, S.F., Loerch, R., Jin, L., Blödt, S., Brinkhaus, B., Ortiz, M., Reinhold, T., Roll, S., Binting, S., Paul, F., Witt, C.M. and Shi, X.
European Journal of Integrative Medicine 20 : 6-15. June 2018

Worldwide prevalence of neuromyelitis optica spectrum disorders.
Mori, M., Kuwabara, S. and Paul, F.
Journal of Neurology Neurosurgery and Psychiatry 89 (6): 555-556. June 2018

Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
Kuchling, J., Backner, Y., Oertel, F.C., Raz, N., Bellmann-Strobl, J., Ruprecht, K., Paul, F., Levin, N., Brandt, A.U. and Scheel, M.
NeuroImage: Clinical 19 : 538-550. 8 May 2018

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.
Jarius, S., Paul, F., Aktas, O., Asgari, N., Dale, R.C., de Seze, J., Franciotta, D., Fujihara, K., Jacob, A., Kim, H.J., Kleiter, I., Kümpfel, T., Levy, M., Palace, J., Ruprecht, K., Saiz, A., Trebst, C., Weinshenker, B.G. and Wildemann, B.
Journal of Neuroinflammation 15 (1): 134. 3 May 2018

Multicenter reliability of semiautomatic retinal layer segmentation using OCT.
Oberwahrenbrock, T., Traber, G.L., Lukas, S., Gabilondo, I., Nolan, R., Songster, C., Balk, L., Petzold, A., Paul, F., Villoslada, P., Brandt, A.U., Green, A.J. and Schippling, S.
Neurology Neuroimmunology & Neuroinflammation 5 (3): e449. 1 May 2018

Treatment choices and neuropsychological symptoms of a large cohort of early MS.
von Bismarck, O., Dankowski, T., Ambrosius, B., Hessler, N., Antony, Gi., Ziegler, A., Hoshi, M.M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S.G., Tackenberg, B., Stoppe, M., Then Bergh, F., Tumani, H., Kümpfel, T., Stangel, M., Heesen, C., Wildemann, B., Paul, F., Bayas, A., Warnke, C., Weber, F., Linker, R.A., Ziemann, U., Zettl, U.K., Zipp, F., Wiendl, H., Hemmer, B., Gold, R. and Salmen, A.
Neurology Neuroimmunology & Neuroinflammation 5 (3): e446. 1 May 2018

Frequent retinal ganglion cell damage after acute optic neuritis.
Brandt, A.U., Specovius, S., Oberwahrenbrock, T., Zimmermann, H.G., Paul, F. and Costello, F.
Multiple Sclerosis and Related Disorders 22 : 141-147. May 2018

Superficial white matter damage in anti-NMDA receptor encephalitis.
Phillips, O. R., Joshi, S.H., Narr, K.L., Shattuck, D.W., Singh, M., Di Paola, M., Ploner, C.J., Prüss, H., Paul, F. and Finke, C.
Journal of Neurology Neurosurgery and Psychiatry 89 (5): 518-525. May 2018

Omics-based approach reveals complement-mediated inflammation in chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).
Blaabjerg, M., Hemdrup, A.L., Drici, L., Ruprecht, K., Garred, P., Höftberger, R., Kristensen, B.W., Kondziella, D., Sejbaek, T., Hansen, S.W., Nielsen, H.H., Jensen, P., Meyer, M., Paul, F., Lassmann, H., Larsen, M.R. and Illes, Z.
Frontiers in Immunology 9 : 741. 23 April 2018

Identification and treatment of the visual processing asymmetry in MS patients with optic neuritis: The Pulfrich phenomenon.
Sobhanian, M.J., Agarwal, R., Meltzer, E., Kildebeck, E., Frohman, B.S., Frohman, A.N., Galetta, S.L., Saidha, S., White, O., Villoslada, P., Paul, F., Petzold, A., Rennaker, R.L., Martinez-Lapiscina, E.H., Balcer, L.J., Kardon, R., Frohman, E.M. and Frohman, T.C.
Journal of the Neurological Sciences 387 : 60-69. 15 April 2018

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.
Geraldes, R., Ciccarelli, O., Barkhof, F., De Stefano, N., Enzinger, C., Filippi, M., Hofer, M., Paul, F., Preziosa, P., Rovira, A., DeLuca, G.C., Kappos, L., Yousry, T., Fazekas, F., Frederiksen, J., Gasperini, C., Sastre-Garriga, J., Evangelou, N. and Palace, J.
Nature Reviews Neurology 14 (4): 199-213. April 2018

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.
Jarius, S., Ruprecht, K., Stellmann, J.P., Huss, A., Ayzenberg, I., Willing, A., Trebst, C., Pawlitzki, M., Abdelhak, A., Grüter, T., Leypoldt, F., Haas, J., Kleiter, I., Tumani, H., Fechner, K., Reindl, M., Paul, F. and Wildemann, B.
Journal of Neuroinflammation 15 (1): 88. 19 March 2018

A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).
Stürner, K.H., Stellmann, J.P., Dörr, J., Paul, F., Friede, T., Schammler, S., Reinhardt, S., Gellissen, S., Weissflog, G., Faizy, T.D., Werz, O., Fleischer, S., Vaas, L.A.I., Herrmann, F., Pless, O., Martin, R. and Heesen, C.
Journal of Neurology Neurosurgery and Psychiatry 89 (4): 330-338. 15 March 2018

Anatomical wiring and functional networking changes in the visual system following optic neuritis.
Backner, Y., Kuchling, J., Massarwa, S., Oberwahrenbrock, T., Finke, C., Bellmann-Strobl, J., Ruprecht, K., Brandt, A.U., Zimmermann, H., Raz, N., Paul, F. and Levin, N.
JAMA Neurology 75 (3): 287-295. March 2018

Association of visual impairment in neuromyelitis optica spectrum disorder with visual network reorganization.
Finke, C., Zimmermann, H., Pache, F., Oertel, F.C., Chavarro, V.S., Kramarenko, Y., Bellmann-Strobl, J., Ruprecht, K., Brandt, A.U. and Paul, F.
JAMA Neurology 75 (3): 296-303. March 2018

Investigational drugs in development to prevent neuromyelitis optica relapses.
Paul, F., Murphy, O., Pardo, S. and Levy, M.
Expert Opinion on Investigational Drugs 27 (3): 265-271. March 2018

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.
Oertel, F.C., Zimmermann, H., Paul, F. and Brandt, A.U.
EPMA Journal 9 (1): 21-33. March 2018

Perceptions on the value of bodily functions in multiple sclerosis.
Heesen, C., Haase, R., Melzig, S., Poettgen, J., Berghoff, M., Paul, F., Zettl, U., Marziniak, M., Angstwurm, K., Kern, R., Ziemssen, T. and Stellmann, J.P.
Acta Neurologica Scandinavica 137 (3): 356-362. March 2018

Magnetic resonance imaging findings at the first episode of acute optic neuritis.
Soelberg, K., Skejoe, H.P.B., Grauslund, J., Smith, T.J., Lillevang, S.T., Jarius, S., Wildemann, B., Paul, F. and Asgari, N.
Multiple Sclerosis and Related Disorders 20 : 30-36. February 2018

Self-perception and determinants of color vision in Parkinson's disease.
Brandt, A.U., Zimmermann, H.G., Oberwahrenbrock, T., Isensee, J., Müller, T. and Paul, F.
Journal of Neural Transmission 125 (2): 145-152. February 2018

Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
Jarius, S., Würthwein, C., Behrens, J.R., Wanner, J., Haas, J., Paul, F. and Wildemann, B.
Journal of Neuroinflammation 15 (1): 22. 18 January 2018

Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue.
Gaede, G., Tiede, M., Lorenz, I., Brandt, A.U., Pfueller, C., Dörr, J., Bellmann-Strobl, J., Piper, S.K., Roth, Y., Zangen, A., Schippling, S. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 5 (1): e423. 1 January 2018

2017

Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
Grobelny, A., Behrens, J.R., Mertens, S., Otte, K., Mansow-Model, S., Krüger, T., Gusho, E., Bellmann-Strobl, J., Paul, F., Brandt, A.U. and Schmitz-Hübsch, T.
PLoS ONE 12 (12): e0189281. 15 December 2017

B-mode ultrasound assessment of pupillary function: feasibility, reliability and normal values.
Schmidt, F., Ruprecht, K., Connolly, F., Maas, M.B., Paul, F., Hoffmann, J., Harms, L. and Schreiber, S.J.
PLoS ONE 12 (12): e0189016. 6 December 2017

A population-based prospective study of optic neuritis.
Soelberg, K., Jarius, S., Skejoe, H.P.B., Engberg, H., Mehlsen, J.J., Nilsson, A.C., Madsen, J.S., Reindl, M., Wildemann, B., Grauslund, J., Kyvik, K.O., Smith, T.J., Lillevang, S.T., Paul, F., Weinshenker, B.G. and Asgari, N.
Multiple Sclerosis Journal 23 (14): 1893-1901. 1 December 2017

Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.
Mikolajczak, J., Zimmermann, H., Kheirkhah, A., Kadas, E.M., Oberwahrenbrock, T., Muller, R., Ren, A., Kuchling, J., Dietze, H., Prüss, H., Paul, F., Hamrah, P. and Brandt, A.U.
Multiple Sclerosis Journal 23 (14): 1847-1853. 1 December 2017

Optische Kohaerenztomografie in der Neurologie: Methodik und Anwendung in Forschung und Klinik [Optical coherence tomography in neurology: method and application in research and clinical routine].
Zimmermann, H.G., Brandt, A.U. and Paul, F.
Klinische Neurophysiologie 48 (4): 211-225. December 2017

Optische Kohaerenztomographie bei Neuromyelitis optica-Spektrum-Erkrankungen [Optical coherence tomography in neuromyelitis optica spectrum disorders].
Oertel, F.C., Zimmermann, H., Brandt, A.U. and Paul, F.
Nervenarzt 88 (12): 1411-1420. December 2017

Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.
Koduah, P., Paul, F. and Dörr, J.M.
EPMA Journal 8 (4): 313-325. December 2017

High risk of postpartum relapses in neuromyelitis optica spectrum disorder.
Klawiter, E.C., Bove, R., Elsone, L., Alvarez, E., Borisow, N., Cortez, M., Mateen, F., Mealy, M.A., Sorum, J., Mutch, K., Tobyne, S.M., Ruprecht, K., Buckle, G., Levy, M., Wingerchuk, D., Paul, F., Cross, A.H., Jacobs, A., Chitnis, T. and Weinshenker, B.
Neurology 89 (22): 2238-2244. 28 November 2017

The chronically inflamed central nervous system provides niches for long-lived plasma cells.
Pollok, K., Mothes, R., Ulbricht, C., Liebheit, A., Gerken, J.D., Uhlmann, S., Paul, F., Niesner, R., Radbruch, H. and Hauser, A.E.
Acta Neuropathologica Communications 5 (1): 88. 25 November 2017

Fatigue as a symptom or comorbidity of neurological diseases.
Penner, I.K. and Paul, F.
Nature Reviews Neurology 13 (11): 662-675. November 2017

Synapsin-antibodies in psychiatric and neurological disorders: prevalence and clinical findings.
Höltje, M., Mertens, R., Schou, M.B., Saether, S.G., Kochova, E., Jarius, S., Prüss, H., Komorowski, L., Probst, C., Paul, F., Bellmann-Strobl, J., Gitler, D., Benfenati, F., Piepgras, J., Ahnert-Hilger, G. and Ruprecht, K.
Brain Behavior and Immunity 66 : 125-134. November 2017

What should a person with relapsing-remitting multiple sclerosis know? - Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0).
Heesen, C., Pöttgen, J., Rahn, A.C., Liethmann, K., Kasper, J., Vahter, L., Drulovic, J., Van Nunen, A., Wilkie, D., Beckmann, Y., Paul, F., Köpke, S., Giordano, A. and Solari, A.
Multiple Sclerosis and Related Disorders 18 : 186-195. November 2017

Dynamics and heterogeneity of brain damage in multiple sclerosis.
Kotelnikova, E., Kiani, N.A., Abad, E., Martinez-Lapiscina, E.H., Andorra, M., Zubizarreta, I., Pulido-Valdeolivas, I., Pertsovskaya, I., Alexopoulos, L.G., Olsson, T., Martin, R., Paul, F., Tegnér, J., Garcia-Ojalvo, J. and Villoslada, P.
PLoS Computational Biology 13 (10): e1005757. 26 October 2017

Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: a multicenter cohort study.
Kessler, R.A., Mealy, M.A., Jimenez-Arango, J.A., Quan, C., Paul, F., López, R., Hopkins, S. and Levy, M.
Multiple Sclerosis and Related Disorders 17 : 198-201. October 2017

Brain iron accumulation in Wilson disease: a post-mortem 7 Tesla MRI - histopathological study.
Dusek, P., Bahn, E., Litwin, T., Jabłonka-Salach, K., Łuciuk, A., Huelnhagen, T., Madai, V.I., Dieringer, M.A., Bulska, E., Knauth, M., Niendorf, T., Sobesky, J., Paul, F., Schneider, S.A., Czlonkowska, A., Brück, W., Wegner, C. and Wuerfel, J.
Neuropathology and Applied Neurobiology 43 (6): 514-532. October 2017

Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study.
Peer, M., Prüss, H., Ben-Dayan, I., Paul, F., Arzy, S. and Finke, C.
Lancet Psychiatry 4 (10): 768-774. October 2017

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
Petzold, A., Balcer, L.J., Calabresi, P.A., Costello, F., Frohman, T.C., Frohman, E.M., Martinez-Lapiscina, E.H., Green, A.J., Kardon, R., Outteryck, O., Paul, F., Schippling, S., Vermersch, P., Villoslada, P. and Balk, L.J.
Lancet Neurology 16 (10): 797-812. October 2017

CuBe: parametric modeling of 3D foveal shape using cubic Bézier.
Yadav, S.K., Motamedi, S., Oberwahrenbrock, T., Oertel, F.C., Polthier, K., Paul, F., Kadas, E.M. and Brandt, A.U.
Biomedical Optics Express 8 (9): 4181-4199. 1 September 2017

Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.
Kuchling, J., Brandt, A.U., Paul, F. and Scheel, M.
EPMA Journal 8 (3): 279-294. September 2017

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.
Ziemssen, T., Tumani, H., Sehr, T., Thomas, K., Paul, F., Richter, N., Samara, E., Spiegelstein, O., Sorani, E., Bar-Ilan, O., Mimrod, D. and Hayardeny, L.
Journal of Neuroinflammation 14 (1): 172. 31 August 2017

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
Jarius, S., König, F.B., Metz, I., Ruprecht, K., Paul, F., Brück, W. and Wildemann, B.
Journal of Neuroinflammation 14 (1): 171. 29 August 2017

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.
Stellmann, J.P., Krumbholz, M., Friede, T., Gahlen, A., Borisow, N., Fischer, K., Hellwig, K., Pache, F., Ruprecht, K., Havla, J., Kümpfel, T., Aktas, O., Hartung, H.P., Ringelstein, M., Geis, C., Kleinschnitz, C., Berthele, A., Hemmer, B., Angstwurm, K., Young, K.L., Schuster, S., Stangel, M., Lauda, F., Tumani, H., Mayer, C., Zeltner, L., Ziemann, U., Linker, R.A., Schwab, M., Marziniak, M., Then Bergh, F., Hofstadt-van Oy, U., Neuhaus, O., Zettl, U., Faiss, J., Wildemann, B., Paul, F., Jarius, S., Trebst, C. and Kleiter, I.
Journal of Neurology Neurosurgery and Psychiatry 88 (8): 639-647. August 2017

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.
Asgari, N., Flanagan, E.P., Fujihara, K., Kim, H.J., Skejoe, H.P., Wuerfel, J., Kuroda, H., Kim, S.H., Maillart, E., Marignier, R., Pittock, S.J., Paul, F. and Weinshenker, B.G.
Neurology Neuroimmunology & Neuroinflammation 4 (4): e343. July 2017

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.
Borisow, N., Kleiter, I., Gahlen, A., Fischer, K., Wernecke, K.D., Pache, F., Ruprecht, K., Havla, J., Krumbholz, M., Kümpfel, T., Aktas, O., Ringelstein, M., Geis, C., Kleinschnitz, C., Berthele, A., Hemmer, B., Angstwurm, K., Weissert, R., Stellmann, J.P., Schuster, S., Stangel, M., Lauda, F., Tumani, H., Mayer, C., Zeltner, L., Ziemann, U., Linker, R.A., Schwab, M., Marziniak, M., Then Bergh, F., Hofstadt-van Oy, U., Neuhaus, O., Winkelmann, A., Marouf, W., Rückriem, L., Faiss, J., Wildemann, B., Paul, F., Jarius, S., Trebst, C. and Hellwig, K.
Multiple Sclerosis Journal 23 (8): 1092-1103. July 2017

Olfactory dysfunction in patients with primary progressive MS.
Schmidt, F.A., Maas, M.B., Geran, R., Schmidt, C., Kunte, H., Ruprecht, K., Paul, F., Göktas, Ö. and Harms, L.
Neurology Neuroimmunology & Neuroinflammation 4 (4): e369. July 2017

Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.
Albrecht, P., Blasberg, C., Ringelstein, M., Mueller, A.K., Finis, D., Guthoff, R., Kadas, E.M., Lagreze, W., Aktas, O., Hartung, H.P., Paul, F., Brandt, A.U. and Methner, A.
Journal of Neurology 264 (7): 1370-1380. July 2017

Single-subject independent component analysis-based intensity normalization in non-quantitative multi-modal structural MRI.
Papazoglou, S., Würfel, J., Paul, F., Brandt, A.U. and Scheel, M.
Human Brain Mapping 38 (7): 3615-3622. July 2017

Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis.
Hahn, S., Trendelenburg, G., Scharf, M., Denno, Y., Brakopp, S., Teegen, B., Probst, C., Wandinger, K.P., Buttmann, M., Haarmann, A., Szabados, F., Vom Dahl, M., Kuempfel, T., Eichhorn, P., Gold, H., Paul, F., Jarius, S., Melzer, N., Stöcker, W. and Komorowski, L.
Journal of Neuroinflammation 14 (1): 123. 23 June 2017

Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Schlemm, L., Chien, C., Bellmann-Strobl, J., Dörr, J., Wuerfel, J., Brandt, A.U., Paul, F. and Scheel, M.
Multiple Sclerosis Journal 23 (7): 963-972. June 2017

Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD.
Oertel, F.C., Zimmermann, H., Mikolajczak, J., Weinhold, M., Kadas, E.M., Oberwahrenbrock, T., Pache, F., Bellmann-Strobl, J., Ruprecht, K., Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 4 (3): e338. May 2017

Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study.
Bove, R., Elsone, L., Alvarez, E., Borisow, N., Cortez, M.M., Mateen, F.J., Mealy, M.A., Mutch, K., Tobyne, S., Ruprecht, K., Buckle, G., Levy, M., Wingerchuk, D.M., Paul, F., Cross, A.H., Weinshenker, B., Jacob, A., Klawiter, E.C. and Chitnis, T.
Neurology Neuroimmunology & Neuroinflammation 4 (3): e339. May 2017

Inflammation-induced brain endothelial activation leads to uptake of electrostatically stabilized iron oxide nanoparticles via sulfated glycosaminoglycans.
Berndt, D., Millward, J.M., Schnorr, J., Taupitz, M., Stangl, V., Paul, F., Wagner, S., Wuerfel, J.T., Sack, I., Ludwig, A. and Infante-Duarte, C.
Nanomedicine: Nanotechnology, Biology and Medicine 13 (4): 1411-1421. May 2017

Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.
Oertel, F.C., Kuchling, J., Zimmermann, H., Chien, C., Schmidt, F., Knier, B., Bellmann-Strobl, J., Korn, T., Scheel, M., Klistorner, A., Ruprecht, K., Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 4 (3): e334. May 2017

Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder.
Streitberger, K.J., Fehlner, A., Pache, F., Lacheta, A., Papazoglou, S., Bellmann-Strobl, J., Ruprecht, K., Brandt, A., Braun, J., Sack, I., Paul, F. and Wuerfel, J.
European Radiology 27 (5): 2206-2215. May 2017

Alzheimer's disease: elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin.
Lang, V., Zille, M., Infante-Duarte, C., Jarius, S., Jahn, H., Paul, F., Ruprecht, K. and Pina, A.L.
Journal of the Neurological Sciences 375 : 123-128. 15 April 2017

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
Gieß, R.M., Pfuhl, C., Behrens, J.R., Rasche, L., Freitag, E., Khalighy, N., Otto, C., Wuerfel, J., Brandt, A.U., Hofmann, J., Eberspächer, B., Bellmann-Strobl, J., Paul, F. and Ruprecht, K.
PLoS ONE 12 (4): e0175279. 7 April 2017

Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.
Dianzani, C., Bellavista, E., Liepe, J., Verderio, Cl., Martucci, M., Santoro, A., Chiocchetti, A., Luca Gigliotti, C., Boggio, E., Ferrara, B., Riganti, L., Keller, C., Janek, K., Niewienda, A., Fenoglio, C., Sorosina, M., Cantello, R., Kloetzel, P.M., Stumpf, M.P.H., Paul, F., Ruprecht, K., Galimberti, D., Martinelli Boneschi, F., Comi, C., Dianzani, U. and Mishto, M.
Scientific Reports 7 : 43718. 9 March 2017

Histopathologic assessment of neurotoxicity after repeated administration of gadodiamide in healthy rats.
Schlemm, L., Radbruch, H., Brandt, A.U., Scheel, M. and Paul, F.
Radiology 282 (3): 925-926. March 2017

Neuromyelitis optica.
Pache, F., Wildemann, B., Paul, F. and Jarius, S.
Fortschritte der Neurologie Psychiatrie 85 (2): 100-114. February 2017

The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice.
Siegert, E., Paul, F., Rothe, M. and Weylandt, K.H.
BMC Neuroscience 18 (1): 19. 24 January 2017

Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life.
Krüger, T., Behrens, J.R., Grobelny, A., Otte, K., Mansow-Model, S., Kayser, B., Bellmann-Strobl, J., Brandt, A.U., Paul, F. and Schmitz-Hübsch, T.
BMC Neurology 17 (1): 10. 13 January 2017

Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies.
Finke, C., Prüss, H., Heine, J., Reuter, S., Kopp, U.A., Wegner, F., Then Bergh, F., Koch, S., Jansen, O., Münte, T., Deuschl, G., Ruprecht, K., Stöcker, W., Wandinger, K.P., Paul, F. and Bartsch, T.
JAMA Neurology 74 (1): 50-59. January 2017

Severe structural and functional visual system damage leads to profound loss of Vision-related quality of life in patients with neuromyelitis optica spectrum disorders.
Schmidt, F., Zimmermann, H., Mikolajczak, J., Oertel, F.C., Pache, F., Weinhold, M., Schinzel, J., Bellmann-Strobl, J., Ruprecht, K., Paul, F. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 11 : 45-50. January 2017

Kognitive Stoerungen bei Multipler Sklerose und anderen autoimmunen Erkrankungen des zentralen Nervensystems [Cognitive dysfunction in multiple sclerosis and other autoimmune disorders in central nervous system].
Paul, F.
Journal fuer Neurologie Neurochirurgie und Psychiatrie 18 (1): 4-10. 2017

Untersuchungen des visuellen Systems in der Neurologie: aktuelle Forschung und klinische Relevanz [Investigation of the visual system in neurology: Current research and clinical relevance].
Brandt, A., Zimmermann, H., Scheel, M., Finke, C., Albrecht, P. and Paul, F.
Aktuelle Neurologie 44 (1): 27-45. 2017

2016

Diagnostic criteria for Susac syndrome.
Kleffner, I., Dörr, J., Ringelstein, M., Gross, C.C., Böckenfeld, Y., Schwindt, W., Sundermann, B., Lohmann, H., Wersching, H., Promesberger, J., von Königsmarck, N., Alex, A., Guthoff, R., Frijns, C.J.M., Kappelle, L.J., Jarius, S., Wildemann, B., Aktas, O., Paul, F., Wiendl, H. and Duning, T.
Journal of Neurology Neurosurgery and Psychiatry 87 (12): 1287-1295. 25 December 2016

Longitudinal intravital imaging of the retina reveals long-term dynamics of immune infiltration and its effects on the glial network in experimental autoimmune uveoretinitis, without evident signs of neuronal dysfunction in the ganglion cell layer.
Bremer, D., Pache, F., Guenther, R., Hornow, J., Andresen, V., Leben, R., Mothes, R., Zimmermann, H., Brandt, A.U., Paul, F., Hauser, A.E., Radbruch, H. and Niesner, R.
Frontiers in Immunology 7 : 642. 23 December 2016

Brain parenchymal damage in neuromyelitis optica spectrum disorder - a multimodal MRI study.
Pache, F., Zimmermann, H., Finke, C., Lacheta, A., Papazoglou, S., Kuchling, J., Wuerfel, J., Hamm, B., Ruprecht, K., Paul, F., Brandt, A.U. and Scheel, M.
European Radiology 26 (12): 4413-4422. December 2016

Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.
Huss, A.M., Halbgebauer, S., Öckl, P., Trebst, C., Spreer, A., Borisow, N., Harrer, A., Brecht, I., Balint, B., Stich, O., Schlegel, S., Retzlaff, N., Winkelmann, A., Roesler, R., Lauda, F., Yildiz, O., Voss, E., Muche, R., Rauer, S., Bergh, F.T., Otto, M., Paul, F., Wildemann, B., Kraus, J., Ruprecht, K., Stangel, M., Buttmann, M., Zettl, U.K. and Tumani, H.
Journal of Neurology 263 (12): 2499-2504. December 2016

Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Chavarro, V.S., Mealy, M.A., Simpson, A., Lacheta, A., Pache, F., Ruprecht, K., Gold, S.M., Paul, F., Brandt, A.U. and Levy, M.
Neurology Neuroimmunology & Neuroinflammation 3 (6): e286. December 2016

Therapie der Fatigue bei Multipler Sklerose: Ein Behandlungsalgorithmus [Therapy of fatigue in multiple sclerosis : a treatment algorithm].
Veauthier, C. and Paul, F.
Nervenarzt 87 (12): 1310-1321. December 2016

The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue.
Veauthier, C., Hasselmann, H., Gold, S.M. and Paul, F.
EPMA Journal 7 : 25. 24 November 2016

Progressive multifocal leukoencephalopathy in a multiple Sclerosis patient diagnosed after switching from natalizumab to fingolimod.
Sinnecker, T., Othman, J., Kühl, M., Metz, I., Niendorf, T., Kunkel, A., Paul, F., Wuerfel, J. and Faiss, Juergen
Case Reports in Neurological Medicine 2016 : 5876798. 22 November 2016

Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.
Weygandt, M., Meyer-Arndt, L., Behrens, J.R., Wakonig, K., Bellmann-Strobl, J., Ritter, K., Scheel, M., Brandt, A.U., Labadie, C., Hetzer, S., Gold, S.M., Paul, F. and Haynes, J.D.
Proceedings of the National Academy of Sciences of the United States of America 113 (47): 13444-13449. 22 November 2016

Accuracy and reliability of the kinect version 2 for clinical measurement of motor function.
Otte, K., Kayser, B., Mansow-Model, S., Verrel, J., Paul, F., Brandt, A.U. and Schmitz-Hübsch, T.
PLoS ONE 11 (11): e0166532. 18 November 2016

Retinal imaging and axonal degeneration in later onset multiple sclerosis.
Huhn, K., Laemmer, R., Zimmermann, H., Lämmer, A., Waschbisch, A., Utz, K., Gieß, R.M., Paul, F., Linker, R.A. and Lee, D.H.
Journal of the Neurological Sciences 370 : 1-6. 15 November 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Jarius, S., Kleiter, I., Ruprecht, K., Asgari, N., Pitarokoili, K., Borisow, N., Hümmert, M.W., Trebst, C., Pache, F., Winkelmann, A., Beume, L.A., Ringelstein, M., Stich, O., Aktas, O., Korporal-Kuhnke, M., Schwarz, A., Lukas, C., Haas, J., Fechner, K., Buttmann, M., Bellmann-Strobl, J., Zimmermann, H., Brandt, A.U., Franciotta, D., Schanda, K., Paul, F., Reindl, M. and Wildemann, B.
Journal of Neuroinflammation 13 (1): 281. 1 November 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
Pache, F., Zimmermann, H., Mikolajczak, J., Schumacher, S., Lacheta, A., Oertel, F.C., Bellmann-Strobl, J., Jarius, S., Wildemann, B., Reindl, M., Waldman, A., Soelberg, K., Asgari, N., Ringelstein, M., Aktas, O., Gross, N., Buttmann, Ma., Ach, T., Ruprecht, K., Paul, F. and Brandt, A.U.
Journal of Neuroinflammation 13 (1): 282. 1 November 2016

Ranking of dystonia severity by pairwise video comparison.
Ellermeyer, T., Otte, K., Heinrich, F., Mansow-Model, S., Kayser, B., Lipp, A., Seidel, A., Krause, P., Lauritsch, K., Gusho, E., Paul, F., Kühn, A.A., Brandt, A.U. and Schmitz-Hübsch, T.
Movement Disorders Clinical Practice 3 (6): 587-595. November 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.A., Hümmert, M.W., Ringelstein, M., Trebst, C., Winkelmann, A., Schwarz, A., Buttmann, M., Zimmermann, H., Kuchling, J., Franciotta, D., Capobianco, M., Siebert, E., Lukas, C., Korporal-Kuhnke, M., Haas, J., Fechner, K., Brandt, A.U., Schanda, K., Aktas, O., Paul, F., Reindl, M. and Wildemann, B.
Journal of Neuroinflammation 13 (1): 280. 28 October 2016

Afferent visual pathway affection in patients with PMP22 deletion-related hereditary neuropathy with liability to pressure palsies.
Brandt, A.U., Meinert-Bohn, E., Rinnenthal, J., Zimmermann, H., Mikolajczak, J., Oberwahrenbrock, T., Papazoglou, S., Pfüller, C.F., Schinzel, J., Tackenberg, B., Paul, F., Hahn, K. and Bellmann-Strobl, J.
PLoS ONE 11 (10): e0164617. 17 October 2016

Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis.
Kreye, J., Wenke, N.K., Chayka, M., Leubner, J., Murugan, R., Maier, N., Jurek, B., Ly, L.T., Brandl, D., Rost, B.R., Stumpf, A., Schulz, P., Radbruch, H., Hauser, A.E., Pache, F., Meisel, A., Harms, L., Paul, F., Dirnagl, U., Garner, C., Schmitz, D., Wardemann, H. and Prüss, H.
Brain 139 (10): 2641-2652. 1 October 2016

Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.
Hasselmann, H., Bellmann-Strobl, J., Ricken, R., Oberwahrenbrock, T., Rose, M., Otte, C., Adli, M., Paul, F., Brandt, A.U., Finke, C. and Gold, S.M.
Multiple Sclerosis Journal 22 (11): 1476-1484. October 2016

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Jarius, S., Metz, I., König, F.B., Ruprecht, K., Reindl, M., Paul, F., Brück, W. and Wildemann, B.
Multiple Sclerosis Journal 22 (12): 1541-1549. October 2016

Validity of visual perceptive computing for static posturography in patients with multiple sclerosis.
Behrens, J.R., Mertens, S., Krüger, T., Grobelny, A., Otte, K., Mansow-Model, S., Gusho, E., Paul, F., Brandt, A.U. and Schmitz-Hübsch, T.
Multiple Sclerosis Journal 22 (12): 1596-1606. October 2016

What is the future of proof of concept studies in multiple sclerosis?
Paul, F.
Lancet Neurology 15 (11): 1107-1109. October 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.A., Hümmert, M.W., Trebst, C., Ringelstein, M., Aktas, O., Winkelmann, A., Buttmann, M., Schwarz, A., Zimmermann, H., Brandt, A.U., Franciotta, D., Capobianco, M., Kuchling, J., Haas, J., Korporal-Kuhnke, M., Lillevang, S.T., Fechner, K., Schanda, K., Paul, F., Wildemann, B. and Reindl, M.
Journal of Neuroinflammation 13 (1): 279. 26 September 2016

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Waters, P., Reindl, M., Saiz, A., Schanda, K., Tuller, F., Kral, V., Nytrova, P., Sobek, O., Nielsen, H.H., Barington, T., Lillevang, S.T., Illes, Z., Rentzsch, K., Berthele, A., Berki, T., Granieri, L., Bertolotto, A., Giometto, B., Zuliani, L., Hamann, D., van Pelt, E.D., Hintzen, R., Höftberger, R., Costa, C., Comabella, M., Montalban, X., Tintoré, M., Siva, A., Altintas, A., Deniz, G., Woodhall, M., Palace, J., Paul, F., Hartung, H.P., Aktas, O., Jarius, S., Wildemann, B., Vedeler, C., Ruiz, A., Leite, M.I., Trillenberg, P., Probst, M., Saschenbrecker, S., Vincent, A. and Marignier, R.
Journal of Neurology Neurosurgery and Psychiatry 87 (9): 1005-1015. September 2016

Pathology and MRI: exploring cognitive impairment in MS.
Paul, F.
Acta Neurologica Scandinavica 134 (Suppl 200): 24-33. September 2016

Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: a peptide microarray-based case-control study.
Schlemm, L., Giess, R.M., Rasche, L., Pfuhl, C., Wakonig, K., Behrens, J.R., Scheibenbogen, C., Bellmann-Strobl, J., Paul, F., Reimer, U. and Ruprecht, K.
Journal of Neuroimmunology 297 : 56-62. 15 August 2016

Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.
Soelberg, K., Larsen, S.R., Moerch, M.T., Thomassen, M., Brusgaard, K., Paul, F., Smith, T.J., Godballe, C., Grauslund, J., Lillevang, S.T. and Asgari, N.
Neurology Neuroimmunology & Neuroinflammation 3 (4): e252. August 2016

MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T.
Sinnecker, T., Schumacher, S., Mueller, K., Pache, F., Dusek, P., Harms, L., Ruprecht, K., Nytrova, P., Chawla, S., Niendorf, T., Kister, I., Paul, F., Ge, Y. and Wuerfel, J.
Neurology Neuroimmunology & Neuroinflammation 3 (4): e259. August 2016

Power estimation for non-standardized multisite studies.
Keshavan, A., Paul, F., Beyer, M.K., Zhu, A.H., Papinutto, N., Shinohara, R.T., Stern, W., Amann, M., Bakshi, R., Bischof, A., Carriero, A., Comabella, M., Crane, J.C., D'Alfonso, S., Demaerel, P., Dubois, B., Filippi, M., Fleischer, V., Fontaine, B., Gaetano, L., Goris, A., Graetz, C., Gröger, A., Groppa, S., Hafler, D.A., Harbo, H.F., Hemmer, B., Jordan, K., Kappos, L., Kirkish, G., Llufriu, S., Magon, S., Martinelli-Boneschi, F., McCauley, J., Montalban, X., Muhlau, M., Pelletier, D., Pattany, P.M., Pericak-Vance, M., Rebeix, I., Rocca, M., Rovira, A., Schlaeger, R., Saiz, A., Sprenger, T., Stecco, A., Uitdehaag, B.M.J., Villoslada, P., Wattjes, M.P., Weiner, H., Wuerfel, J., Zimmer, C., Zipp, F., Hauser, S., Oksenberg, J.R. and Henry, R.G.
NeuroImage 134 : 281-294. 1 July 2016

Accuracy and repeatability of two methods of gait analysis - GaitRite(TM) und Mobility Lab(TM) - in subjects with cerebellar ataxia.
Schmitz-Hübsch, T., Brandt, A.U., Pfueller, C., Zange, L., Seidel, A., Kühn, A.A., Paul, F., Minnerop, M. and Doss, S.
Gait & Posture 48 : 194-201. July 2016

Higher-resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome.
Fehlner, A., Behrens, J.R., Streitberger, K.J., Papazoglou, S., Braun, J., Bellmann-Strobl, J., Ruprecht, K., Paul, F., Würfel, J. and Sack, I.
Journal of Magnetic Resonance Imaging 44 (1): 51-58. July 2016

Iron and non-iron-related characteristics of multiple sclerosis and neuromyelitis optica lesions at 7T MRI.
Chawla, S., Kister, I., Wuerfel, J., Brisset, J.C., Liu, S., Sinnecker, T., Dusek, P., Haacke, E.M., Paul, F. and Ge, Y.
American Journal of Neuroradiology 37 (7): 1223-1230. July 2016

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.
Andlauer, T.F.M., Buck, D., Antony, G., Bayas, A., Bechmann, L., Berthele, A., Chan, A., Gasperi, C., Gold, R., Graetz, C., Haas, J., Hecker, M., Infante-Duarte, C., Knop, M., Kümpfel, T., Limmroth, V., Linker, R.A., Loleit, V., Luessi, F., Meuth, S.G., Muehlau, M., Nischwitz, S., Paul, F., Pütz, M., Ruck, T., Salmen, A., Stangel, M., Stellmann, J.P., Stuerner, K.H., Tackenberg, B., Then Bergh, F., Tumani, H., Warnke, C., Weber, F., Wiendl, H., Wildemann, B., Zettl, U.K., Ziemann, U., Zipp, F., Arloth, J., Weber, P., Radivojkov-Blagojevic, M., Scheinhardt, M.O., Dankowski, T., Bettecken, T., Lichtner, P., Czamara, D., Carrillo-Roa, T., Binder, E.B., Berger, K., Bertram, L., Franke, A., Gieger, C., Herms, S., Homuth, G., Ising, M., Jöckel, K.H., Kacprowski, T., Kloiber, S., Laudes, M., Lieb, W., Lill, C.M., Lucae, S., Meitinger, T., Moebus, S., Mueller-Nurasyid, M., Nöthen, M.M., Petersmann, A., Rawal, R., Schminke, U., Strauch, K., Völzke, H., Waldenberger, M., Wellmann, J., Porcu, E., Mulas, A., Pitzalis, M., Sidore, C., Zara, I., Cucca, F., Zoledziewska, M., Ziegler, A., Hemmer, B. and Müller-Myhsok, B.
Science Advances 2 (6): e1501678. 17 June 2016

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies.
Cruz-Herranz, A., Balk, L.J., Oberwahrenbrock, T., Saidha, S., Martinez-Lapiscina, E.H., Lagreze, W.A., Schuman, J.S., Villoslada, P., Calabresi, P., Balcer, L., Petzold, A., Green, A.J., Paul, F., Brandt, A.U. and Albrecht, P.
Neurology 86 (24): 2303-2309. 14 June 2016

A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms.
Choi, I.Y., Piccio, L., Childress, P., Bollman, B., Ghosh, A., Brandhorst, S., Suarez, J., Michalsen, A., Cross, A.H., Morgan, T.E., Wei, M., Paul, F., Bock, M. and Longo, V.D.
Cell Reports 15 (10): 2136-2146. 7 June 2016

Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie : Substanzspezifische Relevanz und aktuelle Handlungsempfehlungen [Monitoring of blood parameters under course-modified MS therapy : substance-specific relevance and current recommendations for action].
Klotz, L., Berthele, A., Brück, W., Chan, A., Flachenecker, P., Gold, R., Haghikia, A., Hellwig, K., Hemmer, B., Hohlfeld, R., Korn, T., Kümpfel, T., Lang, M., Limmroth, V., Linker, R.A., Meier, U., Meuth, S.G., Paul, F., Salmen, A., Stangel, M., Tackenberg, B., Tumani, H., Warnke, C., Weber, M.S., Ziemssen, T., Zipp, F. and Wiendl, H.
Nervenarzt 87 (6): 645-659. June 2016

Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.
Schumacher, S., Pache, F., Bellmann-Strobl, J., Behrens, J., Dusek, P., Harms, L., Ruprecht, K., Nytrova, P., Chawla, S., Niendorf, T., Kister, I., Paul, F., Ge, Y., Wuerfel, J. and Sinnecker, T.
Magnetic Resonance Materials in Physics Biology and Medicine 29 (3): 535-541. June 2016

Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
Finke, C., Heine, J., Pache, F., Lacheta, A., Borisow, N., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 3 (3): e229. June 2016

Placebo-controlled study in neuromyelitis optica : ethical and design considerations.
Cree, B.A.C., Bennett, J.L., Sheehan, M., Cohen, J., Hartung, H.P., Aktas, O., Kim, H.J., Paul, F., Pittock, S., Weinshenker, B., Wingerchuk, D., Fujihara, K., Cutter, G., Patra, K., Flor, A., Barron, G., Madani, S., Ratchford, J.N. and Katz, E.
Multiple Sclerosis Journal 22 (7): 862-872. June 2016

Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI.
Blaabjerg, M., Ruprecht, K., Sinnecker, T., Kondziella, D., Niendorf, T., Kerrn-Jespersen, B.M., Lindelof, M., Lassmann, H., Kristensen, B.W., Paul, F. and Illes, Z.
Neurology Neuroimmunology & Neuroinflammation 3 (3): e226. June 2016

Structural hippocampal damage following anti-N-methyl-D-aspartate receptor encephalitis.
Finke, C., Kopp, U.A., Pajkert, A., Behrens, J.R., Leypoldt, F., Wuerfel, J.T., Ploner, C.J., Prüss, H. and Paul, F.
Biological Psychiatry 79 (9): 727-734. 1 May 2016

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Martinez-Lapiscina, E.H., Arnow, S., Wilson, J.A., Saidha, S., Preiningerova, J.L., Oberwahrenbrock, T., Brandt, A.U., Pablo, L.E., Guerrieri, S., Gonzalez, I., Outteryck, O., Mueller, A.K., Albrecht, P., Chan, W., Lukas, S., Balk, L.J., Fraser, C., Frederiksen, J.L., Resto, J., Frohman, T., Cordano, C., Zubizarreta, I., Andorra, M., Sanchez-Dalmau, B., Saiz, A., Bermel, R., Klistorner, A., Petzold, A., Schippling, S., Costello, F., Aktas, O., Vermersch, P., Oreja-Guevara, C., Comi, G., Leocani, L., Garcia-Martin, E., Paul, F., Havrdova, E., Frohman, E., Balcer, L.J., Green, A.J., Calabresi, P.A. and Villoslada, P.
Lancet Neurology 15 (6): 574-584. May 2016

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.
Metz, I., Beißbarth, T., Ellenberger, D., Pache, F., Stork, L., Ringelstein, M., Aktas, O., Jarius, S., Wildemann, B., Dihazi, H., Friede, T., Brück, W., Ruprecht, K. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 3 (2): e204. April 2016

The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Levin, J., Maaß, S., Schuberth, M., Respondek, G., Paul, F., Mansmann, U., Oertel, W.H., Lorenzl, S., Krismer, F., Seppi, K., Poewe, W., Wenning, G., Giese, A., Boetzel, K. and Hoeglinger, G.
Journal of Neural Transmission 123 (4): 439-445. April 2016

Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis.
Brandt, A.U., Oberwahrenbrock, T., Mikolajczak, J., Zimmermann, H., Prüss, H., Paul, F. and Finke, C.
Neurology Neuroimmunology & Neuroinflammation 3 (2): e198. April 2016

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Ayzenberg, I., Schöllhammer, J., Hoepner, R., Hellwig, K., Ringelstein, M., Aktas, O., Kümpfel, T., Krumbholz, M., Trebst, C., Paul, F., Pache, F., Obermann, M., Zeltner, L., Schwab, M., Berthele, A., Jarius, S. and Kleiter, I.
Journal of Neurology 263 (3): 575-582. March 2016

Safety and clinical outcomes of rituximab treatment in patients with multiple sclerosis and neuromyelitis optica: experience from a national online registry (GRAID).
Rommer, P.S., Dörner, T., Freivogel, K., Haas, J., Kieseier, B.C., Kümpfel, T., Paul, F., Proft, F., Schulze-Koops, H., Schmidt, E., Wiendl, H., Ziemann, U. and Zettl, U.K.
Journal of Neuroimmune Pharmacology 11 (1): 1-8. March 2016

Untersuchung des Farbsehens bei akuter einseitiger Neuritis nervi optici mittels eines webbasierten Farbsehtests [Investigation of color vision in acute unilateral optic neuritis using a web-based color vision test].
Kuchenbecker, J., Blum, M. and Paul, F.
Ophthalmologe 113 (3): 223-229. March 2016

Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.
Miyaji, K., Paul, F., Shahrizaila, N., Umapathi, T. and Yuki, N.
Journal of Neuroimmunology 291 : 78-81. 15 February 2016

Altered paired associative stimulation-induced plasticity in NMDAR encephalitis.
Volz, M.S., Finke, C., Harms, L., Jurek, B., Paul, F., Flöel, A. and Prüss, H.
Annals of Clinical and Translational Neurology 3 (2): 101-113. February 2016

Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
Hertwig, L., Pache, F., Romero-Suarez, S., Stuerner, K.H., Borisow, N., Behrens, J., Bellmann-Strobl, J., Seeger, B., Asselborn, N., Ruprecht, K., Millward, J.M., Infante-Duarte, C. and Paul, F.
Multiple Sclerosis Journal 22 (2): 160-173. February 2016

Neuromyelitis optica: evaluation of 871 attacks and 1153 treatment courses.
Kleiter, I., Gahlen, A., Borisow, N., Fischer, K., Wernecke, K.D., Wegner, B., Hellwig, K., Pache, F., Ruprecht, K., Havla, J., Krumbholz, M., Kümpfel, T., Aktas, O., Hartung, H.P., Ringelstein, M., Geis, C., Kleinschnitz, C., Berthele, A., Hemmer, B., Angstwurm, K., Stellmann, J.P., Schuster, S., Stangel, M., Lauda, F., Tumani, H., Mayer, C., Zeltner, L., Ziemann, U., Linker, R., Schwab, M., Marziniak, M., Bergh, F.T., Hofstadt-van Oy, U., Neuhaus, O., Winkelmann, A., Marouf, W., Faiss, J., Wildemann, B., Paul, F., Jarius, S. and Trebst, C.
Annals of Neurology 79 (2): 206-216. February 2016

Retinal lesion evolution in susac syndrome.
Brandt, A.U., Oberwahrenbrock, T., Costello, F., Fielden, M., Gertz, K., Kleffner, I., Paul, F., Bergholz, R. and Doerr, J.
Retina 36 (2): 366-374. February 2016

Analysis of lymphocytic DNA damage in early multiple sclerosis by automated γ-H2AX and 53BP1 foci detection: A case control study.
Rasche, L., Heiserich, L., Behrens, J.R., Lenz, K., Pfuhl, C., Wakonig, K., Gieß, R.M., Freitag, E., Eberle, C., Wuerfel, J., Doerr, J., Bauer, P., Bellmann-Strobl, J., Paul, F., Roggenbuck, D. and Ruprecht, K.
PLoS ONE 11 (1): e0147968. 28 January 2016

Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Behrens, J.R., Rasche, L., Giess, R.M., Pfuhl, C., Wakonig, K., Freitag, E., Deuschle, K., Bellmann-Strobl, J., Paul, F., Ruprecht, K. and Doerr, J.
European Journal of Neurology 23 (1): 62-67. January 2016

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
Juryńczyk, M., Weinshenker, B., Akman-Demir, G., Asgari, N., Barnes, D., Boggild, M., Chaudhuri, A., D'hooghe, M., Evangelou, N., Geraldes, R., Illes, Z., Jacob, A., Kim, H.J., Kleiter, I., Levy, M., Marignier, R., McGuigan, C., Murray, K., Nakashima, I., Pandit, L., Paul, F., Pittock, S., Selmaj, K., de Sèze, J., Siva, A., Tanasescu, R., Vukusic, S., Wingerchuk, D., Wren, D., Leite, I. and Palace, J.
Journal of Neurology 263 (1): 140-149. January 2016

Poor sleep in multiple sclerosis correlates with Beck Depression Inventory values, but not with polysomnographic data.
Veauthier, C., Gaede, G., Radbruch, H., Wernecke, K.D. and Paul, F.
Sleep Disorders 2016 : 8378423. 2016

2015

Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.
Hoffmann, S., Siedler, J., Brandt, A.U., Piper, S.K., Kohler, S., Sass, C., Paul, F., Reilmann, R. and Meisel, A.
BMC Neurology 15 (1): 265. 23 December 2015

7T MRI in natalizumab-associated PML and ongoing MS disease activity: a case study.
Sinnecker, T., Othman, J., Kühl, M., Mekle, R., Selbig, I., Niendorf, T., Kunkel, A., Wienecke, P., Kern, P., Paul, F., Faiss, J. and Wuerfel, J.
Neurology Neuroimmunology & Neuroinflammation 2 (6): e171. December 2015

Successful replication of GWAS hits for multiple sclerosis in 10,000 Germans using the exome array.
Dankowski, T., Buck, D., Andlauer, T.F.M., Antony, G., Bayas, A., Bechmann, L., Berthele, A., Bettecken, T., Chan, A., Franke, A., Gold, R., Graetz, C., Haas, J., Hecker, M., Herms, S., Infante-Duarte, C., Jöckel, K.H., Kieseier, B.C., Knier, B., Knop, M., Kümpfel, T., Lichtner, P., Lieb, W., Lill, C.M., Limmroth, V., Linker, R.A., Loleit, V., Meuth, S.G., Moebus, S., Müller-Myhsok, B., Nischwitz, S., Nöthen, M.M., Paul, F., Puetz, M., Ruck, T., Salmen, A., Stangel, M., Stellmann, J.P., Strauch, K., Stürner, K.H., Tackenberg, B., Then Bergh, F., Tumani, H., Waldenberger, M., Weber, F., Wiendl, H., Wildemann, B., Zettl, U.K., Ziemann, U., Zipp, F., Hemmer, B. and Ziegler, A.
Genetic Epidemiology 39 (8): 601-608. December 2015

Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Mossakowski, A.A., Pohlan, J., Bremer, D., Lindquist, R., Millward, J.M., Bock, M., Pollok, K., Mothes, R., Viohl, L., Radbruch, M., Gerhard, J., Bellmann-Strobl, J., Behrens, J., Infante-Duarte, C., Mähler, A., Boschmann, M., Rinnenthal, J.L., Füchtemeier, M., Herz, J., Pache, F.C., Bardua, M., Priller, J., Hauser, A.E., Paul, F., Niesner, R. and Radbruch, H.
Acta Neuropathologica 130 (6): 799-814. December 2015

Imaging of autoimmune encephalitis - relevance for clinical practice and hippocampal function.
Heine, J., Prüss, H., Bartsch, T., Ploner, C.J., Paul, F. and Finke, C.
Neuroscience 309 : 68-83. 19 November 2015

Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Keller, A., Leidinger, P., Meese, E., Haas, J., Backes, C., Rasche, L., Behrens, J.R., Pfuhl, C., Wakonig, K., Gieß, R.M., Jarius, S., Meder, B., Bellmann-Strobl, J., Paul, F., Pache, F.C. and Ruprecht, K.
Journal of Neuroinflammation 12 (1): 196. 31 October 2015

Iridodonesis as a cause of recurrent vertigo.
Kunte, H., Paul, F., Pache, F., Doerr, J., Bellmann-Strobl, J., Harms, L. and Kronenberg, G.
Neurology 85 (15): 1353. 13 October 2015

Studying axonal outgrowth and regeneration of the corticospinal tract in organotypic slice cultures.
Pohland, M., Glumm, R., Stoenica, L., Höltje, M., Kiwit, J., Ahnert-Hilger, G., Strauss, U., Bräuer, A.U., Paul, F. and Glumm, J.
Journal of Neurotrauma 32 (19): 1465-1477. 1 October 2015

Axonal damage in papilledema linked to idiopathic intracranial hypertension as revealed by multifocal visual evoked potentials.
Hartmann, C.J., Klistorner, A.I., Brandt, A.U., Schroeder, K., Kolbe, R., Cohn, E., Goebels, N., Guthoff, R., Aktas, O., Hartung, H.P. and Albrecht, P.
Clinical Neurophysiology 126 (10): 2040-2041. October 2015

Effects of diazoxide in multiple sclerosis: a randomized, double-blind phase 2 clinical trial.
Villoslada, P., Rovira, A., Montalban, X., Arroyo, R., Paul, F., Meca-Lallana, V., Ramo, C., Fernandez, O., Saiz, A., Garcia-Merino, A., Ramió-Torrentà, L., Casanova, B., Oreja-Guevara, C., Muñoz, D., Martinez-Rodriguez, J.E., Lensch, E., Prieto, J.M., Meuth, S.G., Nuñez, X., Campás, C. and Pugliese, M.
Neurology Neuroimmunology & Neuroinflammation 2 (5): e147. October 2015

Temporal retinal nerve fibre layer thinning in cluster headache patients detected by optical coherence tomography.
Ewering, C., Haşal, N., Alten, F., Clemens, C.R., Eter, N., Oberwahrenbrock, T., Kadas, E.M., Zimmermann, H., Brandt, A.U., Osada, N., Paul, F. and Marziniak, M.
Cephalalgia 35 (11): 946-958. October 2015

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity.
Veauthier, C., Gaede, G., Radbruch, H., Sieb, J.P., Wernecke, K.D. and Paul, F.
Neuropsychiatric Disease and Treatment 11 : 2323-2329. 9 September 2015

Reliability of intra-retinal layer thickness estimates.
Oberwahrenbrock, T., Weinhold, M., Mikolajczak, J., Zimmermann, H., Paul, F., Beckers, I. and Brandt, A.U.
PLoS ONE 10 (9): e0137316. 8 September 2015

Comparison of standard versus wide-field composite images of the corneal subbasal layer by In vivo confocal microscopy.
Kheirkhah, A., Muller, R., Mikolajczak, J., Ren, A., Kadas, E.M., Zimmermann, H., Pruess, H., Paul, F., Brandt, A.U. and Hamrah, P.
Investigative Ophthalmology & Visual Science 56 (10): 5801-5807. 1 September 2015

Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.
Sinnecker, T., Kuchling, J., Dusek, P., Dörr, J., Niendorf, T., Paul, F. and Wuerfel, J.
EPMA Journal 6 (1): 16. 27 August 2015

Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography.
Ringelstein, M., Albrecht, P., Kleffner, I., Bühn, B., Harmel, J., Müller, A.K., Finis, D., Guthoff, R., Bergholz, R., Duning, T., Krämer, M., Paul, F., Brandt, A., Oberwahrenbrock, T., Mikolajczak, J., Wildemann, B., Jarius, S., Hartung, H.P., Aktas, O. and Dörr, J.
Neurology 85 (7): 610-618. 18 August 2015

Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis.
Pfuhl, C., Oechtering, J., Rasche, L., Gieß, R.M., Behrens, J.R., Wakonig, K., Freitag, E., Pache, F.C., Otto, C., Hofmann, J., Eberspächer, B., Bellmann-Strobl, J., Paul, F. and Ruprecht, K.
Journal of Neuroimmunology 285 : 156-160. 15 August 2015

Toxoplasma gondii seropositivity is negatively associated with multiple sclerosis.
Stascheit, F., Paul, F., Harms, L. and Rosche, B.
Journal of Neuroimmunology 285 : 119-124. 15 August 2015

Retinal pathology in idiopathic moyamoya angiopathy detected by optical coherence tomography.
Albrecht, P., Blasberg, C., Lukas, S., Ringelstein, M., Müller, A.K., Harmel, J., Kadas, E.M., Finis, D., Guthoff, R., Aktas, O., Hartung, H.P., Paul, F., Brandt, A.U., Berlit, P., Methner, A. and Kraemer, M.
Neurology 85 (6): 521-527. 11 August 2015

Assessing mitochondrial movement within neurons: manual versus automated tracking methods.
Bros, H., Hauser, A., Paul, F., Niesner, R. and Infante-Duarte, C.
Traffic 16 (8): 906-917. August 2015

Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.
Doss, S., Rinnenthal, J.L., Schmitz-Hübsch, T., Brandt, A.U., Papazoglou, S., Lux, S., Maul, S., Würfel, J., Endres, M., Klockgether, T., Minnerop, M. and Paul, F.
Journal of Neurology 262 (8): 1927-1935. August 2015

Current immunotherapy of multiple sclerosis [Aktuelle Immuntherapie der Multiplen Sklerose].
Paul, F. and Ruprecht, K.
Nervenarzt 86 (8): 1031-1044. August 2015

Update on biomarkers in neuromyelitis optica.
Melamed, E., Levy, M., Waters, P.J., Sato, D.K., Bennett, J.L., John, G.R., Hooper, D.C., Saiz, A., Bar-Or, A., Kim, H.J., Pandit, L., Leite, M.I., Asgari, N., Kissani, N., Hintzen, R., Marignier, R., Jarius, S., Marcelletti, J., Smith, T.J., Yeaman, M.R. and Han, M.H.
Neurology Neuroimmunology & Neuroinflammation 2 (4): e134. 23 July 2015

Sleep disorders reduce health-related quality of life in multiple sclerosis (Nottingham Health Profile data in patients with multiple sclerosis).
Veauthier, C., Gaede, G., Radbruch, H., Wernecke, K.D. and Paul, F.
International Journal of Molecular Sciences 16 (7): 16514-16528. 21 July 2015

Magnetic resonance phase alterations in multiple sclerosis patients with short and long disease duration.
Bozin, I., Ge, Y., Kuchling, J., Dusek, P., Chawla, S., Harms, L., Ruprecht, K., Niendorf, T., Paul, F., Kister, I., Sinnecker, T. and Wuerfel, J.
PLoS ONE 10 (7): e0128386. 17 July 2015

Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?
Kister, I. and Paul, F.
Neurology 85 (2): 118-119. 14 July 2015

Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder.
Kremer, S., Renard, F., Achard, S., Lana-Peixoto, M.A., Palace, J., Asgari, N., Klawiter, E.C., Tenembaum, S.N., Banwell, B., Greenberg, B.M., Bennett, J.L., Levy, M., Villoslada, P., Saiz, A., Fujihara, K., Chan, K.H., Schippling, S., Paul, F., Kim, H.J., de Seze, J. and Wuerfel, J.T.
JAMA Neurology 72 (7): 815-822. July 2015

Treatment of chronic experimental autoimmune encephalomyelitis with epigallocatechin-3-gallate and glatiramer acetate alters expression of heme-oxygenase-1.
Janssen, A., Fiebiger, S., Bros, H., Hertwig, L., Romero-Suarez, S., Hamann, I., Chanvillard, C., Bellmann-Strobl, J., Paul, F., Millward, J.M. and Infante-Duarte, C.
PLoS ONE 10 (6): e0130251. 26 June 2015

Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue.
Finke, C., Schlichting, J., Papazoglou, S., Scheel, M., Freing, A., Soemmer, C., Pech, L.M., Pajkert, A., Pfueller, C.J., Wuerfel, J.T., Ploner, C., Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 21 (7): 925-934. June 2015

Demographic and clinical features of neuromyelitis optica: A review.
Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M.I., Kleiter, I. and Chitnis, T.
Multiple Sclerosis Journal 21 (7): 845-853. June 2015

Does Nrf2 help nerves to survive?
Ruprecht, K. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 2 (3): e105. June 2015

The transition from first-line to second-line therapy in multiple sclerosis.
Dörr, J. and Paul, F.
Current Treatment Options in Neurology 17 (6): 354. June 2015

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.
Bennett, J.L., de Seze, J., Lana-Peixoto, M., Palace, J., Waldman, A., Schippling, S., Tenembaum, S., Banwell, B., Greenberg, B., Levy, M., Fujihara, K., Chan, K.H., Kim, H.J., Asgari, N., Sato, D.K., Saiz, A., Wuerfel, J., Zimmermann, H., Green, A., Villoslada, P. and Paul, F.
Multiple Sclerosis Journal 21 (6): 678-688. May 2015

Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.
Krumbholz, M., Hofstadt-van Oy, U., Angstwurm, K., Kleiter, I., Jarius, S., Paul, F., Aktas, O., Buchholz, G., Kern, P., Straube, A. and Kümpfel, T.
Journal of Neurology 262 (5): 1379-1384. May 2015

MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Kim, H.J., Paul, F., Lana-Peixoto, M.A., Tenembaum, S., Asgari, N., Palace, J., Klawiter, E.C., Sato, D.K., de Seze, J., Wuerfel, J., Banwell, B.L., Villoslada, P., Saiz, A., Fujihara, K. and Kim, S.H.
Neurology 84 (11): 1165-1173. 17 March 2015

Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Mähler, A., Steiniger, J., Bock, M., Klug, L., Parreidt, N., Lorenz, M., Zimmermann, B.F., Krannich, A., Paul, F. and Boschmann, M.
American Journal of Clinical Nutrition 101 (3): 487-495. March 2015

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
Schippling, S., Balk, L., Costello, F., Albrecht, P., Balcer, L., Calabresi, P., Frederiksen, J., Frohman, E., Green, A., Klistorner, A., Outteryck, O., Paul, F., Plant, G., Traber, G., Vermersch, P., Villoslada, P., Wolf, S. and Petzold, A.
Multiple Sclerosis Journal 21 (2): 163-170. February 2015

Signaling networks in MS: a systems-based approach to developing new pharmacological therapies.
Kotelnikova, E., Bernardo-Faura, M., Silberberg, G., Kiani, N.A., Messinis, D., Melas, I.N., Artigas, L., Schwartz, E., Mazo, I., Masso, M., Alexopoulos, L.G., Mas, J.M., Olsson, T., Tegner, J., Martin, R., Zamora, A., Paul, F., Saez-Rodriguez, J. and Villoslada, P.
Multiple Sclerosis Journal 21 (2): 138-146. February 2015

Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning - an ultrahigh-field MR pilot study.
Sinnecker, T., Oberwahrenbrock, T., Metz, I., Zimmermann, H., Pfueller, C.F., Harms, L., Ruprecht, K., Ramien, C., Hahn, K., Brück, W., Niendorf, T., Paul, F., Brandt, A.U., Dörr, J. and Wuerfel, J.
European Radiology 25 (1): 122-131. January 2015

Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage.
Huhn, K., Lämmer, R., Oberwahrenbrock, T., Lämmer, A., Waschbisch, A., Gosar, D., Brandt, A., Paul, F., Linker, R.A. and Lee, D.H.
European Journal of Neurology 22 (1): 86-92. January 2015

No evidence for retinal damage evolving from reduced retinal blood flow in carotid artery disease.
Heßler, H., Zimmermann, H., Oberwahrenbrock, T., Kadas, E.M., Mikolajczak, J., Brandt, A.U., Kauert, A., Paul, F. and Schreiber, S.J.
BioMed Research International 2015 : 604028. 2015

Treatment of multiple sclerosis - relationship between vitamin d and interferon β-1b.
Taylor, B., Moses, H., Paul, F., Suarez, G. and Rametta, M.
European Neurological Review 10 (2): 124-130. 2015

2014

7‐Tesla magnetic resonance imaging for brain iron quantification in homozygous and heterozygous PANK2 mutation carriers.
Dusek, P., Tovar Martinez, E.M., Madai, V.I., Jech, R., Sobesky, J., Paul, F., Niendorf, T., Wuerfel, J. and Schneider, S.A.
Movement Disorders Clinical Practice 1 (4): 329-335. December 2014

Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Kuchling, J., Ramien, C., Bozin, I., Dörr, J., Harms, L., Rosche, B., Niendorf, T., Paul, F., Sinnecker, T. and Wuerfel, J.
Multiple Sclerosis Journal 20 (14): 1866-1871. December 2014

Retinal nerve fibre layer thickness correlates with brain white matter damage in multiple sclerosis: a combined optical coherence tomography and diffusion tensor imaging study.
Scheel, M., Finke, C., Oberwahrenbrock, T., Freing, A., Pech, L.M., Schlichting, J., Sömmer, C., Wuerfel, J., Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 20 (14): 1904-1907. December 2014

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.
Lee, D.H., Heidecke, H., Schröder, A., Paul, F., Wachter, R., Hoffmann, R., Ellrichmann, G., Dragun, D., Waschbisch, A., Stegbauer, J., Klotz, P., Gold, R., Dechend, R., Müller, D.N., Saft, C. and Linker, R.A.
Molecular Neurodegeneration 9 (1): 49. 15 November 2014

Multimodal retinal vessel analysis in CADASIL patients.
Alten, F., Motte, J., Ewering, C., Osada, N., Clemens, C.R., Kadas, E.M., Eter, N., Paul, F. and Marziniak, M.
PLoS ONE 9 (11): e112311. 5 November 2014

Complement regulatory proteins (CD46, 55 and 59) expressed on Schwann cells: Immune targets in demyelinating neuropathies?
Miyaji, K., Paul, F., Shahrizaila, N., Umapathi, T. and Yuki, N.
Journal of Neuroimmunology 276 (1-2): 172-174. November 2014

Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons.
Bros, H., Millward, J.M., Paul, F., Niesner, R. and Infante-Duarte, C.
Experimental Neurology 261 (11): 127-135. November 2014

The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo.
Lorenz, M., Paul, F., Moobed, M., Baumann, G., Zimmermann, B.F., Stangl, K. and Stangl, V.
European Journal of Pharmacology 740 : 645-651. 5 October 2014

Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T.
Mueller, K., Kuchling, J., Doerr, J., Harms, L., Ruprecht, K., Niendorf, T., Wuerfel, J., Paul, F. and Sinnecker, T.
Journal of Neurology 261 (10): 2032-2036. October 2014

High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.
Doss, S., Wandinger, K.P., Hyman, B.T., Panzer, J.A., Synofzik, M., Dickerson, B., Mollenhauer, B., Scherzer, C.R., Ivinson, A.J., Finke, C., Schöls, L., Müller vom Hagen, J., Trenkwalder, C., Jahn, H., Höltje, M., Biswal, B.B., Harms, L., Ruprecht, K., Buchert, R., Höglinger, G.U., Oertel, W.H., Unger, M.M., Körtvélyessy, P., Bittner, D., Priller, J., Spruth, E.J., Paul, F., Meisel, A., Lynch, D.R., Dirnagl, U., Endres, M., Teegen, B., Probst, C., Komorowski, L., Stöcker, W., Dalmau, J. and Pruess, H.
Annals of Clinical and Translational Neurology 1 (10): 822-832. October 2014

Vessel labeling in combined confocal scanning laser ophthalmoscopy and optical coherence tomography Images : criteria for blood vessel discrimination.
Motte, J., Alten, F., Ewering, C., Osada, N., Kadas, E.M., Brandt, A.U., Oberwahrenbrock, T., Clemens, C.R., Eter, N., Paul, F. and Marziniak, M.
PLoS ONE 9 (9): e102034. 9 September 2014

Optimal management of multiple sclerosis during pregnancy: current perspectives.
Borisow, N., Paul, F. and Doerr, J.
Degenerative Neurological and Neuromuscular Disease 4 : 111-120. 5 August 2014

Retinal segmentation to demonstrate hyperplasia in ataxia of charlevoix-saguenay: critique on study methodology and results.
Albrecht, P., Balk, L., Oberwahrenbrock, T., Petzold, A. and Paul, F.
Investigative Ophthalmology & Visual Science 55 (8): 4728. 4 August 2014

Increased catabolic state in spinocerebellar ataxia type 1 patients.
Mähler, A., Steiniger, J., Endres, M., Paul, F., Boschmann, M. and Doss, S.
Cerebellum 13 (4): 440-446. August 2014

Photoreceptor layer thinning in idiopathic Parkinson's disease.
Roth, N.M., Saidha, S., Zimmermann, H., Brandt, A.U., Isensee, J., Benkhellouf-Rutkowska, A., Dornauer, M., Kühn, A.A., Mueller, T., Calabresi, P.A. and Paul, F.
Movement Disorders 29 (9): 1163-1170. August 2014

Reply to: Photoreceptor layer thinning in Parkinsonian syndromes.
Brandt, A.U., Paul, F. and Saidha, S.
Movement Disorders 29 (9): 1222-1223. August 2014

The investigation of acute optic neuritis: a review and proposed protocol.
Petzold, A., Wattjes, M.P., Costello, F., Flores-Rivera, J., Fraser, C.L., Fujihara, K., Leavitt, J., Marignier, R., Paul, F., Schippling, S., Sindic, C., Villoslada, P., Weinshenker, B. and Plant, G.T.
Nature Reviews Neurology 10 (8): 447-458. August 2014

Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.
Jarius, S., Paul, F., Fechner, K., Ruprecht, K., Kleiter, I., Franciotta, D., Ringelstein, M., Pache, F., Aktas, O. and Wildemann, B.
Journal of Neuroinflammation 11 (1): 129. 29 July 2014

Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Ruprecht, K., Wunderlich, B., Gieß, R., Meyer, P., Loebel, M., Lenz, K., Hofmann, J., Rosche, B., Wengert, O., Paul, F., Reimer, U. and Scheibenbogen, C.
Journal of Neuroimmunology 272 (1-2): 56-61. 15 July 2014

Dynamic formation of macular microcysts independent of vitreous traction changes.
Brandt, A.U., Oberwahrenbrock, T., Kadas, E.M., Lagrèze, W.A. and Paul, F.
Neurology 83 (1): 73-77. 1 July 2014

Pregnancy in multiple sclerosis: a questionnaire study.
Borisow, N., Paul, F., Ohlraun, S., Pach, D., Fischer, F. and Dörr, J.
PLoS ONE 9 (6): e99106. 5 June 2014

Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
Kremer, L., Mealy, M., Jacob, A., Nakashima, I., Cabre, P., Bigi, S., Paul, F., Jarius, S., Aktas, O., Elsone, L., Mutch, K., Levy, M., Takai, Y., Collongues, N., Banwell, B., Fujihara, K. and de Seze, J.
Multiple Sclerosis Journal 20 (7): 843-847. June 2014

Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Ringelstein, M., Metz, I., Ruprecht, K., Koch, A., Rappold, J., Ingwersen, J., Mathys, C., Jarius, S., Brück, W., Hartung, H.P., Paul, F. and Aktas, O.
Multiple Sclerosis Journal 20 (7): 882-888. June 2014

Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.
Behrens, J., Pfueller, C., Mansow-Model, S., Otte, K., Paul, F. and Brandt, A.U.
Journal of Neuroengineering and Rehabilitation 11 : 89. 27 May 2014

Neuromyelitis optica: clinical features, immunopathogenesis and treatment.
Jarius, S., Wildemann, B. and Paul, F.
Clinical and Experimental Immunology 176 (2): 149-164. May 2014

Effects of deep repetitive transcranial magnetic stimulation on brain-derived neurotrophic factor serum concentration in healthy volunteers.
Gaede, G., Hellweg, R., Zimmermann, H., Brandt, A.U., Dörr, J., Bellmann-Strobl, J., Zangen, A., Paul, F. and Pfueller, C.F.
Neuropsychobiology 69 (2): 112-119. April 2014

Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial.
Köpke, S., Kern, S., Ziemssen, T., Berghoff, M., Kleiter, I., Marziniak, M., Paul, F., Vettorazzi, E., Pöttgen, J., Fischer, K., Kasper, J. and Heesen, C.
Journal of Neurology Neurosurgery and Psychiatry 85 (4): 411-418. April 2014

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.
Doss, S., Brandt, A.U., Oberwahrenbrock, T., Endres, M., Paul, F. and Rinnenthal, J.L.
Cerebellum 13 (2): 199-206. April 2014

Ultrahochfeld-MRT im Kontext neurologischer Erkrankungen [Ultrahigh field MRI in context of neurological diseases].
Kuchling, J., Sinnecker, T., Bozin, I., Dörr, J., Madai, V.I., Sobesky, J., Niendorf, T., Paul, F. and Wuerfel, J.
Nervenarzt 85 (4): 445-458. April 2014

Visual evoked potentials in neuromyelitis optica and its spectrum disorders.
Ringelstein, M., Kleiter, I., Ayzenberg, I., Borisow, N., Paul, F., Ruprecht, K., Kraemer, M., Cohn, E., Wildemann, B., Jarius, S., Hartung, H.P., Aktas, O. and Albrecht, P.
Multiple Sclerosis Journal 20 (5): 617-620. April 2014

Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.
Jarius, S., Kleffner, I., Dörr, J.M., Sastre-Garriga, J., Illes, Z., Eggenberger, E., Chalk, C., Ringelstein, M., Aktas, O., Montalban, X., Fechner, K., Stöcker, W., Ringelstein, E.B., Paul, F. and Wildemann, B.
Journal of Neuroinflammation 11 : 46. 8 March 2014

Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Keller, A., Leidinger, P., Steinmeyer, F., Stähler, C., Franke, A., Hemmrich-Stanisak, G., Kappel, A., Wright, I., Dörr, J., Paul, F., Diem, R., Tocariu-Krick, B., Meder, B., Backes, C., Meese, E. and Ruprecht, K.
Multiple Sclerosis Journal 20 (3): 295-303. March 2014

Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
Schinzel, J., Zimmermann, H., Paul, F., Ruprecht, K., Hahn, K., Brandt, A.U. and Dörr, J.
BMC Neurology 14 : 31. 20 February 2014

Chronic cerebrospinal venous insufficiency in multiple sclerosis: the final curtain.
Paul, F. and Wattjes, M.P.
Lancet 383 (9912): 106-108. 11 January 2014

Sleep disorders in multiple sclerosis and their relationship to fatigue.
Veauthier, C. and Paul, F.
Sleep Medicine 15 (1): 5-14. January 2014

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).
Trebst, C., Jarius, S., Berthele, A., Paul, F., Schippling, S., Wildemann, B., Borisow, N., Kleiter, I., Aktas, O. and Kümpfel, T.
Journal of Neurology 261 (1): 1-16. January 2014

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Collongues, N., Marignier, R., Jacob, A., Leite, M., Siva, A., Paul, F., Zephir, H., Akman-Demir, G., Elsone, L., Jarius, S., Papeix, C., Mutch, K., Saip, S., Wildemann, B., Kitley, J., Karabudak, R., Aktas, O., Kuscu, D., Altintas, A., Palace, J., Confavreux, C. and De Seze, J.
Multiple Sclerosis Journal 20 (8): 1086-1094. 2014

2013

Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Oberwahrenbrock, T., Ringelstein, M., Jentschke, S., Deuschle, K., Klumbies, K., Bellmann-Strobl, J., Harmel, J., Ruprecht, K., Schippling, S., Hartung, H.P., Aktas, O., Brandt, A.U. and Paul, F.
Multiple Sclerosis Journal 19 (14): 1887-1895. December 2013

Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.
Wieder, L., Gäde, G., Pech, L.M., Zimmermann, H., Wernecke, K.D., Dörr, J.M., Bellmann-Strobl, J., Paul, F. and Brandt, A.U.
BMC Neurology 13 : 167. 8 November 2013

Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease.
Lipp, A., Trbojevic, R., Paul, F., Fehlner, A., Hirsch, S., Scheel, M., Noack, C., Braun, J. and Sack, I.
NeuroImage: Clinical 3 : 381-387. 20 September 2013

The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Fiebiger, S.M., Bros, H., Grobosch, T., Janssen, A., Chanvillard, C., Paul, F., Dörr, J., Millward, J.M. and Infante-Duarte, C.
Journal of Neuroimmunology 262 (1-2): 66-71. 15 September 2013

Treatment of sleep disorders may improve fatigue in multiple sclerosis.
Veauthier, C., Gaede, G., Radbruch, H., Gottschalk, S., Wernecke, K.D. and Paul, F.
Clinical Neurology and Neurosurgery 115 (9): 1826-1830. September 2013

T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients.
Balint, B., Haas, J., Schwarz, A., Jarius, S., Fürwentsches, A., Engelhardt, K., Bussmann, C., Ebinger, F., Fritzsching, B., Paul, F., Seidel, U., Vlaho, S., Huppke, P., Gärtner, J. and Wildemann, B.
Neurology 81 (9): 784-792. 27 August 2013

Enlargement of cerebral ventricles as an early indicator of encephalomyelitis.
Lepore, S., Waiczies, H., Hentschel, J., Ji, Y., Skodowski, J., Pohlmann, A., Millward, J.M., Paul, F., Wuerfel, J., Niendorf, T. and Waiczies, S.
PLoS ONE 8 (8): e72841. 22 August 2013

Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
Derkow, K., Bauer, J.M.J., Hecker, M., Paap, B.K., Thamilarasan, M., Koczan, D., Schott, E., Deuschle, K., Bellmann-Strobl, J., Paul, F., Zettl, U.K., Ruprecht, K. and Lehnardt, S.
PLoS ONE 8 (8): e70626. 12 August 2013

Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis.
Kaufhold, F., Zimmermann, H., Schneider, E., Ruprecht, K., Paul, F., Oberwahrenbrock, T. and Brandt, A.U.
PLoS ONE 8 (8): e71145. 6 August 2013

Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Deuschle, K., Hofmann, J., Otto, C., Bellmann-Strobl, J., Scherner, O., Klumbies, K., Schneider, E., Broddack, J., Paul, F. and Ruprecht, K.
Multiple Sclerosis Journal 19 (9): 1242-1243. August 2013

Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis.
Finke, C., Kopp, U.A., Scheel, M., Pech, L.M., Soemmer, C., Schlichting, J., Leypoldt, F., Brandt, A.U., Wuerfel, J., Probst, C., Ploner, C.J., Prüss, H. and Paul, F.
Annals of Neurology 74 (2): 284-296. August 2013

Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis.
Roth, N.M., Saidha, S., Zimmermann, H., Brandt, A.U., Oberwahrenbrock, T., Maragakis, N.J., Tumani, H., Ludolph, A.C., Meyer, T., Calabresi, P.A. and Paul, F.
European Journal of Neurology 20 (8): 1170-1176. August 2013

A blood based 12-miRNA signature of Alzheimer disease patients.
Leidinger, P., Backes, C., Deutscher, S., Schmitt, K., Mueller, S.C., Frese, K., Haas, J., Ruprecht, K., Paul, F., Stähler, C., Lang, C.J.G., Meder, B., Bartfai, T., Meese, E. and Keller, A.
Genome Biology 14 (7): R78. 29 July 2013

Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis.
Schneider, E., Zimmermann, H., Oberwahrenbrock, T., Kaufhold, F., Kadas, E.M., Petzold, A., Bilger, F., Borisow, N., Jarius, S., Wildemann, B., Ruprecht, K., Brandt, A.U. and Paul, F.
PLoS ONE 8 (6): e66151. 21 June 2013

Characteristics of Susac syndrome: a review of all reported cases.
Dörr, J., Krautwald, S., Wildemann, B., Jarius, S., Ringelstein, M., Duning, T., Aktas, O., Ringelstein, E.B., Paul, F. and Kleffner, I.
Nature Reviews Neurology 9 (6): 307-316. June 2013

Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Young, K.L., Brandt, A.U., Petzold, A., Reitz, L.Y., Lintze, F., Paul, F., Martin, R. and Schippling, S.
European Journal of Neurology 20 (5): 803-811. May 2013

What went wrong? The flawed concept of cerebrospinal venous insufficiency.
Valdueza, J.M., Doepp, F., Schreiber, S.J., van Oosten, B.W., Schmierer, K., Paul, F. and Wattjes, M.P.
Journal of Cerebral Blood Flow and Metabolism 33 (5): 657-668. May 2013

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial.
Rosche, B., Wernecke, K.D., Ohlraun, S., Dörr, J.M. and Paul, F.
Trials 14 : 112. 25 April 2013

Bilateral vertebral artery dissection, agenesis of both ICAs, and connective tissue aberrations.
Lill, C.M., Guenther-Kunkel, K., Hoch, H., Paul, F., Grond-Ginsbach, C., Hausser, I. and Zipp, F.
Neurology 80 (15): 1442-1443. 9 April 2013

Breastfeeding is associated with lower risk for multiple sclerosis.
Conradi, S., Malzahn, U., Paul, F., Quill, S., Harms, L., Then Bergh, F., Ditzenbach, A., Georgi, T., Heuschmann, P. and Rosche, B.
Multiple Sclerosis Journal 19 (5): 553-558. April 2013

Diagnostik und Verlaufsbeurteilung der Multiplen Sklerose: Stellenwert der optischen Kohaerenztomographie [Diagnosis and monitoring of multiple sclerosis: the value of optical coherence tomography].
Bock, M., Paul, F. and Dörr, J.
Nervenarzt 84 (4): 483-492. April 2013

Neuromyelitis optica.
Wildemann, B., Jarius, S. and Paul, F.
Nervenarzt 84 (4): 436-441. April 2013

Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Zimmermann, H., Freing, A., Kaufhold, F., Gaede, G., Bohn, E., Bock, M., Oberwahrenbrock, T., Young, K.L., Dörr, J., Wuerfel, J.T., Schippling, S., Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 19 (4): 443-450. April 2013

Therapieoptionen bei immunvermittelten Enzephalomyelitiden [Therapeutic options for autoimmune encephalomyelitis].
Borisow, N., Prüss, H. and Paul, F.
Nervenarzt 84 (4): 461-465. April 2013

'Obstructive sleep apnea is associated with fatigue in multiple sclerosis' by Kaminska et al.
Veauthier, C., Blau, A. and Paul, F.
Multiple Sclerosis Journal 19 (3): 372-373. March 2013

Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
Sinnecker, T., Bozin, I., Dörr, J., Pfueller, C.F., Harms, L., Niendorf, T., Brandt, A.U., Paul, F. and Wuerfel, J.
Multiple Sclerosis Journal 19 (3): 316-325. March 2013

Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases.
Mähler, A., Mandel, S., Lorenz, M., Ruegg, U., Wanker, E.E., Boschmann, M. and Paul, F.
EPMA Journal 4 (1): 5. 18 February 2013

Vitamin D und Multiple Sklerose: Der Stellenwert fuer das Erkrankungsrisiko und die Behandlung [Vitamin D and multiple sclerosis: the role for risk of disease and treatment].
Döring, A., Paul, F. and Dörr, J.
Nervenarzt 84 (2): 173-189. February 2013

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Dörr, J., Döring, A. and Paul, F.
EPMA Journal 4 : 4. 29 January 2013

Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Borisow, N., Meyer, T. and Paul, F.
BMJ Case Reports 2013 23 January 2013

Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Hamann, I., Dörr, J., Glumm, R., Chanvillard, C., Janssen, A., Millward, J.M., Paul, F., Ransohoff, R.M. and Infante-Duarte, C.
Journal of Neuroimmunology 254 (1-2): 165-169. 15 January 2013

2012

Dynamics of saccade parameters in multiple sclerosis patients with fatigue.
Finke, C., Pech, L.M., Soemmer, C., Schlichting, J., Stricker, S., Endres, M., Ostendorf, F., Ploner, C.J., Brandt, A.U. and Paul, F.
Journal of Neurology 259 (12): 2656-2663. December 2012

Fatigue and sleep disorders in multiple sclerosis: is obstructive sleep apnea a link?
Paul, F. and Veauthier, C.
Sleep & Breathing 16 (4): 949-950. December 2012

Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis.
Riek, K., Millward, J.M., Hamann, I., Mueller, S., Pfueller, C.F., Paul, F., Braun, J., Infante-Duarte, C. and Sack, I.
NeuroImage: Clinical 1 (1): 81-90. 12 November 2012

Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.
Wuerfel, J., Sinnecker, T., Ringelstein, E.B., Jarius, S., Schwindt, W., Niendorf, T., Paul, F., Kleffner, I. and Doerr, J.
Multiple Sclerosis Journal 18 (11): 1592-1599. November 2012

Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Hackmack, K., Weygandt, M., Wuerfel, J., Pfueller, C.F., Bellmann-Strobl, J., Paul, F. and Haynes, J.D.
Journal of Neurology 259 (10): 2151-2160. October 2012

Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.
Jarius, S., Franciotta, D., Paul, F., Bergamaschi, R., Rommer, P.S., Ruprecht, K., Ringelstein, M., Aktas, O., Kristoferitsch, W. and Wildemann, B.
Journal of the Neurological Sciences 320 (1-2): 32-37. 15 September 2012

Is metabolic flexibility altered in multiple sclerosis patients?
Mähler, A., Steiniger, J., Bock, M., Brandt, A.U., Haas, V., Boschmann, M. and Paul, F.
PLoS ONE 7 (8): e43675. 28 August 2012

Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
Sinnecker, T., Doerr, J., Pfueller, C.F., Harms, L., Ruprecht, K., Jarius, S., Brueck, W., Niendorf, T., Wuerfel, J. and Paul, F.
Neurology 79 (7): 708-714. 14 August 2012

Multi-scale classification of disease using structural MRI and wavelet transform.
Hackmack, K., Paul, F., Weygandt, M., Allefeld, C. and Haynes, J.D.
NeuroImage 62 (1): 48-58. 1 August 2012

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.
Jarius, S., Paul, F., Franciotta, D., de Seze, J., Muench, C., Salvetti, M., Ruprecht, K., Liebetrau, M., Wandinger, K., Akman-Demir, G., Melms, A., Kristoferitsch, W. and Wildemann, B.
Multiple Sclerosis Journal 18 (8): 1135-1143. August 2012

Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography.
Oberwahrenbrock, T., Schippling, S., Ringelstein, M., Kaufhold, F., Zimmermann, H., Keser, N., Young, K.L., Harmel, J., Hartung, H.P., Martin, R., Paul, F., Aktas, O. and Brandt, A.U.
Multiple Sclerosis International 2012 : 530305. 25 July 2012

The German healthcare system.
Döring, A. and Paul, F.
In: Healthcare Overview. Advances in Predictive, Preventive and Personalised Medicine, 1 . Springer, Dordrecht, Netherlands, 45-67. ISBN 9789400746022 17 July 2012

Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Chanvillard, C., Millward, J.M., Lozano, M., Hamann, I., Paul, F., Zipp, F., Doerr, J. and Infante-Duarte, C.
PLoS ONE 7 (6): e39625. 29 June 2012

Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
Schinzel, J., Schwarzlose, L., Dietze, H., Bartusch, K., Weiss, S., Ohlraun, S., Paul, F. and Doerr, J.
Trials 13 : 94. 28 June 2012

Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy.
Borisow, N., Doering, A., Pfueller, C.F., Paul, F., Doerr, J. and Hellwig, K.
EPMA Journal 3 (1): 9. 22 June 2012

Patterns of retinal damage facilitate differential diagnosis between susac syndrome and MS.
Brandt, A.U., Zimmermann, H., Kaufhold, F., Promesberger, J., Schippling, S., Finis, D., Aktas, O., Geis, C., Ringelstein, M., Ringelstein, E.B., Hartung, H.P., Paul, F., Kleffner, I. and Doerr, J.
PLoS ONE 7 (6): e38741. 11 June 2012

Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker, T., Mittelstaedt, P., Doerr, J., Pfueller, C.F., Harms, L., Niendorf, T., Paul, F. and Wuerfel, J.
Archives of Neurology 69 (6): 739-745. June 2012

Immunmodulatorische Therapie mit Interferon β-1b bei klinisch isoliertem Syndrom [Immunomodulatory therapy with interferon β-1b in clinically isolated syndrome.
Paul, F.
Aktuelle Neurologie 39 (S1): S16-S18. 22 May 2012

Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT.
Kaufhold, F., Kadas, E.M., Schmidt, C., Kunte, H., Hoffmann, J., Zimmermann, H., Oberwahrenbrock, T., Harms, L., Polthier, K., Brandt, A.U. and Paul, F.
PLoS ONE 7 (5): e36965. 15 May 2012

Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Stroet, A., Hemmelmann, C., Starck, M., Zettl, U., Doerr, J., Paul, F., Flachenecker, P., Fleischer, V., Zipp, F., Nueckel, H., Kieseier, B.C., Ziegler, A., Gold, R. and Chan, A.
Therapeutic Advances in Neurological Disorders 5 (2): 75-79. March 2012

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial.
Doerr, J., Ohlraun, S., Skarabis, H. and Paul, F.
Trials 13 : 15. 8 February 2012

Failure of natalizumab to prevent relapses in neuromyelitis optica.
Kleiter, I., Hellwig, K., Berthele, A., Kuempfel, T., Linker, R.A., Hartung, H.P., Paul, F. and Aktas, O.
Archives of Neurology 69 (2): 239-245. February 2012

Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?
Veauthier, C. and Paul, F.
Multiple Sclerosis Journal 18 (2): 248-249. February 2012

Neuromyelitis optica.
Wildemann, B., Jarius, S. and Paul, F.
Aktuelle Neurologie 39 (1): 33-41. February 2012

Brain viscoelasticity alteration in chronic-progressive multiple sclerosis.
Streitberger, K.J., Sack, I., Krefting, D., Pfueller, C., Braun, J., Paul, F. and Wuerfel, J.
PLoS ONE 7 (1): e29888. 20 January 2012

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.
Jarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., Kleiter, I., Kleinschnitz, C., Berthele, A., Brettschneider, J., Hellwig, K., Hemmer, B., Linker, R.A., Lauda, F., Mayer, C.A., Tumani, H., Melms, A., Trebst, C., Stangel, M., Marziniak, M., Hoffmann, F., Schippling, S., Faiss, J.H., Neuhaus, O., Ettrich, B., Zentner, C., Guthke, K., Hofstadt-van Oy, U., Reuss, R., Pellkofer, H., Ziemann, U., Kern, P., Wandinger, K.P., Bergh, F.T., Boettcher, T., Langel, S., Liebetrau, M., Rommer, P.S., Niehaus, S., Muench, C., Winkelmann, A., Zettl U, U.K., Metz, I., Veauthier, C., Sieb, J.P., Wilke, C., Hartung, H.P., Aktas, O. and Paul, F.
Journal of Neuroinflammation 9 : 14. 19 January 2012

Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis.
Bock, M., Brandt, A.U., Kuchenbecker, J., Doerr, J., Pfueller, C.F., Weinges-Evers, N., Gaede, G., Zimmermann, H., Bellmann-Strobl, J., Ohlraun, S., Zipp, F. and Paul, F.
British Journal of Ophthalmology 96 (1): 62-67. January 2012

2011

Exercise in multiple sclerosis - an integral component of disease management.
Doering, A., Pfueller, C.F., Paul, F. and Doerr, J.
EPMA Journal 3 : 2. 24 December 2011

Venous drainage in multiple sclerosis: A combined MRI and ultrasound study.
Doepp, F., Wuerfel, J.T., Pfueller, C.F., Valdueza, J.M., Petersen, D., Paul, F. and Schreiber, S.J.
Neurology 77 (19): 1745-1751. 8 November 2011

Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
Brandt, A.U., Oberwahrenbrock, T., Ringelstein, M., Young, K.L., Tiede, M., Hartung, H.P., Martin, R., Aktas, O., Paul, F. and Schippling, S.
Brain 134 (Pt 11): e193. November 2011

Chronisch venoese Insuffizienz als Ursache der Multiplen Sklerose? [Is chronic cerebrospinal venous insufficiency a cause of multiple sclerosis?].
Doepp, F., Paul, F., Valdueza, J.M. and Schreiber, S.J.
Aktuelle Neurologie 38 (7): 332-338. 24 October 2011

Environmental factors in early childhood are associated with multiple sclerosis: a case-control study.
Conradi, S., Malzahn, U., Schroeter, F., Paul, F., Quill, S., Spruth, E., Harms, L., Then Bergh, F., Ditzenbach, A., Georgi, T., Heuschmann, P. and Rosche, B.
BMC Neurology 11 : 123. 6 October 2011

Susac-Syndrom: Eine interdisziplinaere Herausforderung [Susac syndrome: an interdisciplinary challenge].
Doerr, J., Jarius, S., Wildemann, B., Ringelstein, E.B., Schwindt, W., Deppe, M., Wandinger, K.P., Promesberger, J., Paul, F. and Kleffner, I.
Nervenarzt 82 (10): 1250-1263. October 2011

The influence of physiological aging and atrophy on brain viscoelastic properties in humans.
Sack, I., Streitberger, K.J., Krefting, D., Paul, F. and Braun, J.
PLoS ONE 6 (9): e23451. 12 September 2011

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Jarius, S., Jacobi, C., de Seze, J., Zephir, H., Paul, F., Franciotta, D., Rommer, P., Mader, S., Kleiter, I., Reindl, M., Akman-Demir, G., Seifert-Held, T., Kristoferitsch, W., Melms, A., Wandinger, K.P. and Wildemann, B.
Multiple Sclerosis Journal 17 (9): 1067-1073. September 2011

Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1.
Stricker, S., Oberwahrenbrock, T., Zimmermann, H., Schroeter, J., Endres, M., Brandt, A.U. and Paul, F.
PLoS ONE 6 (7): e23024. 29 July 2011

Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells.
Waiczies, H., Lepore, S., Janitzek, N., Hagen, U., Seifert, F., Ittermann, B., Purfürst, B., Pezzutto, A., Paul, F., Niendorf, T. and Waiczies, S.
PLoS ONE 6 (7): e21981. 19 July 2011

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius, S., Paul, F., Franciotta, D., Ruprecht, K., Ringelstein, M., Bergamaschi, R., Rommer, P., Kleiter, I., Stich, O., Reuss, R., Rauer, S., Zettl, U.K., Wandinger, K.P., Melms, A., Aktas, O., Kristoferitsch, W. and Wildemann, B.
Journal of the Neurological Sciences 306 (1-2): 82-90. 15 July 2011

MRI pattern recognition in multiple sclerosis normal-appearing brain areas.
Weygandt, M., Hackmack, K., Pfueller, C., Bellmann-Strobl, J., Paul, F., Zipp, F. and Haynes, J.D.
PLoS ONE 6 (6): e21138. 17 June 2011

Diagnostik und Therapie der Neuromyelitis optica: Konsensusempfehlungen der Neuromyelitis optica Studiengruppe [Diagnosis and treatment of neuromyelitis optica: Consensus recommendations of the Neuromyelitis Optica Study Group].
Trebst, C., Berthele, A., Jarius, S., Kuempfel, T., Schippling, S., Wildemann, B. and Wilke, C.
Nervenarzt 82 (6): 768-777. June 2011

Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
Veauthier, C., Radbruch, H., Gaede, G., Pfueller, C., Doerr, J., Bellmann-Strobl, J., Wernecke, K.D., Zipp, F., Paul, F. and Sieb, J.
Multiple Sclerosis Journal 17 (5): 613-622. May 2011

Association of retinal and macular damage with brain atrophy in multiple sclerosis.
Doerr, J., Wernecke, K.D., Bock, M., Gaede, G., Wuerfel, J.T., Pfueller, C.F., Bellmann-Strobl, J., Freing, A., Brandt, A.U. and Paul, F.
PLoS ONE 6 (4): e18132. 8 April 2011

Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis.
Pfueller, C.F., Brandt, A.U., Schubert, F., Bock, M., Walaszek, B., Waiczies, H., Schwenteck, T., Doerr, J., Bellmann-Strobl, J., Mohr, C., Weinges-Evers, N., Ittermann, B., Wuerfel, J.T. and Paul, F.
PLoS ONE 6 (4): e18019. 6 April 2011

Imaging the visual pathway in neuromyelitis optica.
Pfueller, C.F. and Paul, F.
Multiple Sclerosis International 2011 : 869814. 16 March 2011

Multiple Sklerose - klinisch relevante Themen.
Paul, F.
Nervenheilkunde 30 (7): 461-462. 2011

Optische Kohaerenztomografie in der Multiplen Sklerose.
Woelbert, M., Brandt, A.U., Paul, F. and Schippling, S.
Nervenheilkunde 30 (7): 493-497. 2011

2010

No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
Hohn, O., Strohschein, K., Brandt, A.U., Seeher, S., Klein, S., Kurth, R., Paul, F., Meisel, C., Scheibenbogen, C. and Bannert, N.
PLoS ONE 5 (12): e15632. 22 December 2010

The German healthcare system.
Doering, A. and Paul, F.
EPMA Journal 1 (4): 535-547. December 2010

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.
Jarius, S., Frederikson, J., Waters, P., Paul, F., Akman-Demir, G., Marignier, R., Franciotta, D., Ruprecht, K., Kuenz, B., Rommer, P., Kristoferitsch, W., Wildemann, B. and Vincent, A.
Journal of the Neurological Sciences 298 (1-2): 158-162. 15 November 2010

Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses.
Sellner, J., Cepok, S., Kalluri, S.R., Nestler, A., Kleiter, I., Kuempfel, T., Linker, R., Melms, A., Menge, T., Tumani, H., Paul, F., Hemmer, B. and Berthele, A.
Neurochemistry International 57 (6): 662-667. November 2010

Flupirtine add-on to IFN β-1b in RRMS.
Paul, F. and Doerr, J.M.
Nervenarzt 81 (Suppl 1): 28-29. October 2010

Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients.
Bock, M., Brandt, A.U., Doerr, J., Kraft, H., Weinges-Evers, N., Gaede, G., Pfueller, C.F., Herges, K., Radbruch, H., Ohlraun, S., Bellmann-Strobl, J., Kuchenbecker, J., Zipp, F. and Paul, F.
Clinical Neurology and Neurosurgery 112 (8): 647-652. October 2010

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.
Jarius, S., Franciotta, D., Paul, F., Ruprecht, K., Bergamaschi, R., Rommer, P.S., Reuss, R., Probst, C., Kristoferitsch, W., Wandinger, K.P. and Wildemann, B.
Journal of Neuroinflammation 7 : 52. 8 September 2010

Correlation of self-assessed fatigue and alertness in multiple sclerosis.
Weinges-Evers, N., Brandt, A.U., Bock, M., Pfueller, C.F., Doerr, J., Bellmann-Strobl, J., Scherer, P., Urbanek, C., Boers, C., Ohlraun, S., Zipp, F. and Paul, F.
Multiple Sclerosis 16 (9): 1134-1140. September 2010

No cerebrocervical venous congestion in patients with multiple sclerosis.
Doepp, F., Paul, F., Valdueza, J.M., Schmierer, K. and Schreiber, S.J.
Annals of Neurology 68 (2): 173-183. August 2010

Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study.
Bock, M., Brandt, A.U., Doerr, J., Pfueller, C.F., Ohlraun, S., Zipp, F. and Paul, F.
Multiple Sclerosis 16 (7): 893-896. July 2010

MR-elastography reveals degradation of tissue integrity in multiple sclerosis.
Wuerfel, J., Paul, F., Beierbach, B., Hamhaber, U., Klatt, D., Papazoglou, S., Zipp, F., Martus, P., Braun, J. and Sack, I.
NeuroImage 49 (3): 2520-2525. 1 February 2010

Attention Network Test reveals alerting network dysfunction in multiple sclerosis.
Urbanek, C., Weinges-Evers, N., Bellmann-Strobl, J., Bock, M., Doerr, J., Hahn, E., Neuhaus, A.H., Opgen-Rhein, C., Ta, T.M., Herges, K., Pfueller, C.F., Radbruch, H., Wernecke, K.D., Ohlraun, S., Zipp, F., Dettling, M. and Paul, F.
Multiple Sclerosis 16 (1): 93-99. January 2010

2009

Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
Bellmann-Strobl, J., Wuerfel, J., Aktas, O., Doerr, J., Wernecke, K.D., Zipp, F. and Paul, F.
Neurology 73 (20): 1624-1627. 17 November 2009

2007

Perioperative fluctuations of lamotrigine serum levels in patients undergoing epilepsy surgery.
Paul, F., Veauthier, C., Fritz, G., Lehmann, T.N., Aktas, O., Zipp, F. and Meencke, H.J.
Seizure 16 (6): 479-484. September 2007

This list was generated on Sat Dec 14 11:09:27 2024 UTC.
Open Access
MDC Library